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General introduction 
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General introduction 
Telomeres are nucleoprotein structures at the end of chromosomes. They 
prevent chromosomal ends from being recognized as double strand breaks and 
protect them from end to end fusion and degradation [1-3]. Telomeres consist 
of stretches of repetitive DNA with a high G-C content [4,5]. Figure 1 illustrates 
the structure of the telomeres. In humans, the telomere terminus consists of 4 
to 15 kbp of the hexanucleotides 5’-TTAGGG-3’ [6,7]. At  each chromosomal 
end, the G-rich telomeric DNA strand runs 5’ to 3’ towards the terminus and 
protrudes 100-150 nucleotides beyond the complementary C-rich strand [3]. It 
is protected from degradation by intercalation into the double stranded 
telomere DNA, forming a telomeric loop (t-loop) [8]. 
 
Figure 1. Structure of telomeres 
 
In most proliferating cells telomere length (TL) is dynamic, and with each cell 
division the lengths of telomeres in human somatic cells decrease gradually by 
20 to 200 base pairs. Partially, this loss of base pairs is a consequence of the so-
called end-replication problem. DNA polymerases are not able to replicate 
chromosomes completely, since one RNA primer remains on each daughter 
DNA strand. The last primers are removed by a 5’-3’ exonuclease, but DNA 
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polymerases cannot fill the gaps because there is no 3’-OH available to which a 
nucleotide can be added. As a consequence, the replication machinery has to 
leave a small region at the end (a piece of the telomere) uncopied. The end-
replication problem leads to chromosome shortening with each round of cell 
division. Eventually, this will lead to elimination of the telomeres and, as a 
consequence, apoptosis or an irreversible growth arrest of the cells [9]. These 
senescent cells are irreversibly arrested in the G1 phase of the cell cycle [10]. 
For this reason telomeres may serve as a biological clock of the cell. 
Besides the end-replication problem, other factors may contribute to 
telomere shortening.  
Since human telomeres contain G-rich overhangs, the action of a 5’-to-3’ 
specific exonuclease was suggested. The action of this exonuclease would 
shorten each telomere by half the overhang length per round of replication and 
it was suggested to be involved in the final degradation of RNA primers from 
the lagging strand of the DNA [11-13]. 
Both the end replication problem and the existence of an exonuclease 
only partially account for the loss of telomeres seen in cells, and therefore it 
was suggested that other mechanisms may be involved in accelerated telomere 
shortening. One of these mechanisms, DNA damage induced by oxidative stress, 
has been extensively studied and described by von Zglinicki et al. [6,8,11,14-18]. 
This lead to the hypothesis that measurement of TL can be used as a biomarker 
of chronic oxidative stress.  
 
Techniques to measure TL 
First, the different methods that are used to analyze TL are described, since the 
assessment of TL is important in understanding the relationship between 
oxidative stress and TL regulation.  
In recent reviews by Nakagawa et al. [19] and by Lin et al. [20], the most 
important techniques to measure TL are discussed. The most widely used 
method is the telomere restriction fragment (TRF) assay with Southern blot 
analysis. In this method, average lengths of telomeres are measured by creating 
TRFs using specific restriction enzymes and hybridization with a radioactive or 
fluorescent probe. The main disadvantage of this assay is the subjectivity of the 
results, since TRF lengths can differ as much as 5% depending on which 
restriction enzyme is used. This means that subtelomeric regions might be 
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included in the determination of the TL. Other disadvantages of this method are 
the requirement of large amounts of DNA and the fact that the procedure is 
relatively time consuming [19,20].  
A second important method used to measure TL is the fluorescence in 
situ hybridization (FISH), which can be subdivided in flow Fish and quantitative 
Fish. It allows the direct labeling of oligonucleotide probes to telomere 
sequences at the individual cell level. In this method, fluorescent dyes are used 
to visualize telomeres with fluorescence microscopy or with a digital imaging 
system. Flow FISH uses fluorescence activated cell sorting (FACS) to sort 
different types of cells, while quantitative FISH provides measurements of 
telomere lengths of individual chromosomes. In contrast to quantitative FISH, 
flow FISH allows the analysis of telomeres in cycling and non-cycling cells 
instead of metaphase preparation and the procedure can be carried out in one 
day. A disadvantage of this method is that it uses whole cells, which limits its 
suitability in studies where only DNA is available [19,20]. 
A method that is recently developed by Baird [21], is the single TL 
analysis (STELA), which is a PCR based method that measures the lengths of 
telomeres at the individual chromosome level. First, a linker which consists of 7 
repeats of TTAGGG followed by a 20 nucleotides containing non-
complementary tail, is annealed to the telomeric G-rich strand 3’-overhang. In 
the second step the linker is ligated to the 5’-end of the complementary strand 
of the chromosome. PCR can then be performed using a primer that is identical 
to this tail, together with a chromosome-specific upstream primer located in 
the subtelomeric region, which can be made allele-specific by known 
polymorphisms in this region. The STELA was first developed for analysis of the 
human sex chromosome, the X and Y chromosomes, and it is suggested that 
this method can also be applied to other chromosomes [20,21]. However, its 
extension to all human telomeres will require sequence information for each 
allele as well as information on allelic frequencies. Since chromosome-specific 
primers are needed, chromosome-specific information can be obtained. This 
can either be an advantage or a disadvantage, depending on the purpose of the 
study.  
Another PCR-based method is the quantitative polymerase chain 
reaction described by Cawthon [22]. It avoids many of the problems 
encountered by TRF analysis by using primers that are specifically designed to 
amplify telomeric hexamer repeats without generating primer dimer-derived 
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products. In these primer template hybridizations, every sixth base is 
mismatched, whereas the last five bases at the 3’-end of the primers are 
perfectly matched to complementary bases in the template [22]. This method 
measures relative telomere lengths by determining the factor by which a 
sample DNA differs from an arbitrary reference DNA in its ratio of telomere 
repeat copy number to single gene copy number. A disadvantage of this 
technique is that it does not provide absolute telomere lengths. This problem 
can be overcome by the use of cell lines with known TL. By adding reference 
DNA to each PCR reaction, a standard curve can be created and the absolute TL 
of the samples can be calculated. It has to be noted that the DNA has to be of 
good quality in order to get reproducible results. In comparison to TRF analysis 
and quantitative FISH, the measurement of telomere by quantitative PCR does 
not include the subtelomeric region which is highly variable between 
individuals. Furthermore, due to its simplicity and high throughput, it is very 
useful for large population studies where only DNA is required in stead of cells 
or tissue [19,20,22,23].  
The last method that will be discussed is the telomeric-oligonucleotide 
ligation assay (T-OLA). T-OLA measures the length of the G-rich telomeric 3’ 
overhang by ligating telomeric repeat oligonucleotides hybridized to the 
overhang. Telomere shortening is proportional to the size of G-rich overhangs in 
human tissues. A difficulty with this method is, that it is unclear whether short 
overhangs imply slow telomere shortening or that it means that there are many 
senescent cells [19,24]. 
As described above, there are different methods to determine TL and it 
depends on the type and aim of the study which method should be used. Each 
method has its specific advantages and disadvantages that make it more or less 
useful for a specific purpose. The discussed methods are shown in table 1. 
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Table 1. Techniques to measure telomere length 
Technique Procedure Possible source of error Remarks 
TRF (Southern Blot) Using specific restriction 
enzymes, TRFs are created. 
The next step is hybridization 
with a radioactive or 
fluorescent probe  
Subtelomeric regions 
might be included 
• Large amounts of 
DNA needed  
• Time consuming 
Quantitative FISH Fluorescent dyes are used  
to visualize telomeres with 
fluorescence microscopy or 
with a digital imaging system 
Performed on metaphase 
spreads 
• Time consuming 
• Small datasets 
• Chromosome 
specific 
Flow-FISH Flow-FISH uses fluorescence 
activated cell sorting (FACS) 
 to sort different types of  
cells 
Tight adherence to an 
optimized protocol is a 
premise 
• Use of whole cells 
• Small datasets 
STELA PCR based method that  
uses a linker of 7 TTAGGG 
repeats 
Chromosome specific 
primers are needed 
• Chromosome 
specific 
Quantitative PCR PCR based method that  
uses primers that are 
specifically designed to 
amplify telomeric hexamer 
repeats without generating 
primer dimer-derived 
products 
DNA has to be of good 
quality 
• High throughput 
• Does not provide 
absolute 
telomere lengths 
Factors influencing telomere regulation 
Before discussing the role of oxidative stress in telomere shortening, other 
factors that are involved in telomere regulation will be discussed. In contrast to 
stem cells and germ line cells, telomeres in somatic cells shorten with each cell 
division. Cell proliferation is therefore considered to be one of the most 
important causes of telomere shortening. For instance, human diploid 
fibroblasts have a limited replicative life span in vitro due to telomere attrition, 
which leads to cellular senescence [1,25]. 
In addition, the enzyme telomerase is also involved in telomere stability 
and telomere shortening. Telomerase is a cellular reverse transcriptase that 
consists of two components, a reverse transcriptase subunit known as 
Telomerase Reverse Transcriptase (hTERT) and a Telomerase RNA Component 
(hTERC) [26]. Telomerase recognizes the tip of a G-rich strand of a telomeric 
DNA repeat sequence and elongates the telomere in the 5’-3’ direction. The 
telomerase enzyme synthesizes a new copy of the repeat by using its RNA 
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template (hTERC) [26]. After a couple of extension rounds of the parental DNA 
strand by telomerase, replication of the end of the chromosome can take place 
by using the “extensions” as template [27]. Regulation of telomerase activity is 
an area of intense investigation, but the exact mechanisms are not yet 
elucidated [28]. Human telomerase ribonucleoproteins pass through several 
stages before they start with telomere elongation, i.e. accumulation of RNA and 
regulation of hTERT transcription, transport to the nucleus, catalytic activation 
of the telomerase holoenzyme and recruitment of the telomerase enzyme to 
the telomeres [28,29]. Yet, in most human somatic cells telomerase activity is 
absent or very low. Only germ line cells and stem cells express sufficient 
telomerase to maintain their telomeres in a functional state for infinite time 
[15].  
 
TL in different cell types and tissues 
TL has been determined in a variety of tissues and it was observed that TL varies 
considerably from tissue to tissue. Cells in different tissues differ enormously in 
their turnover rate. Many of the differentiated cells that need continual 
replacement are unable to divide themselves. Replacement cells need to be 
generated from a stock of precursor cells, the stem cells or progenitor cells [27]. 
Most mature cells of the hematopoietic system are relatively short-lived. A 
relatively small population of hematopoietic stem cells divides and 
differentiates into other cell types. TL of human stem cells have been found to 
range from approximately 8 to 10 kbp, while the TL of lymphocytes was 
reported to be approximately 6 to 8 kbp. TL measured in whole blood ranged 
from 7 to 8 kbp and TL measured in fetal tissues was found to be approximately 
13 kbp [22,30,31]. 
Although telomeres of stem cells are relatively long, the proliferative 
potential of most hematopoietic stem cells appears to be also limited and 
decreases with age [30]. In a study performed by Friedrich et al. [32], TL was 
measured by telomere restriction fragment analysis in three unrelated tissues 
(leukocytes, skin and synovial tissue) of nine elderly patients. Dependent on 
tissue specific proliferation rate, they found significantly shorter telomeres in 
leukocytes (6.5 kbp) compared to skin (7.8 kbp) and synovial tissue (7.9 kbp). A 
linear correlation was found after pair wise comparison of TL of two different 
tissues from the same donor. This suggests that genetic determination of the 
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regulation of TL is tissue-independent and indicates that measurement of TL in, 
for instance, leukocytes could serve as a surrogate for relative TL in other 
tissues.  
According to these data, it appears feasible to use easily accessible 
tissues to assess TL in stead of using tissues that are difficult to obtain. This was 
applied in a patient-control study by Broberg et al. [33], in which a negative 
association was found between TL in buccal cells and bladder cancer risk. TL 
was determined by quantitative PCR in buccal cells from 63 patients and 158 
controls. A confounding factor might be that buccal cells are directly exposed 
to, for instance, cigarette smoke, which may give biased results among smokers. 
However, in this study no difference was found in TL between current smokers, 
former smokers and non-smokers within the groups of controls and cases [33].   
From the currently available data it can be concluded that the rate of 
telomere shortening is approximately the same in different tissues, and 
therefore, easily accessible tissues, such as leukocytes from blood or buccal 
cells, may be used as surrogate tissue for TL assessment in tissues involved in 
the systemic effects of chronic diseases. 
 
Proteins involved in telomere regulation 
Various proteins play an important role in TL regulation. A complex formed by 
six telomere-specific proteins, namely telomeric repeat binding factors 1 and 2 
(TRF1 and TRF2), TRF1-interacting protein 2 (TIN2), repressor activator protein 1 
(Rap1), tripeptidyl peptidase 1 (TPP1), and protection of telomeres 1 (POT1), 
associates with the telomere sequence and protects the chromosome ends. 
These and some other important proteins at human telomeres, namely 
tankyrase 1 and 2, DNA-dependent protein kinase and Ku70/86 (the DNA-PK 
complex), ataxia telangiectasia mutated (ATM) and poly-ADP ribose 
polymerase-1 (PARP-1), which are involved in DNA repair and replication, are 
listed in table 2 [34-44]. 
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Table 2. Proteins involved in telomere length regulation 
Telomere-binding protein Function(s) 
Protection telomeres 
Telomeric repeat binding factor 1 (TRF-1) Protects chromosome ends 
Telomeric repeat binding factor 2 (TRF-2) Protects chromosome ends 
Repressor activator protein 1 (RAP-1) Binds telomere sequences and protects 
telomeres from non-homologous end-joining 
Protection of telomeres 1 (POT-1) Capping of the telomere 
Regulation telomeres 
Tankyrase 1 and 2  Telomere length regulation via ribosylation of 
TRF-1 
Telomeric repeat binding factor 1 (TRF-1) Tankyrase 1 poly(ADP-ribosyl)ates TRF-1, which 
then dissociates from the telomeric DNA. This 
renders the telomere accessible for telomerase 
and DNA repair enzymes 
TRF1-interacting protein 2 (TIN-2) 
 
TIN2 is a negative regulator of telomere 
elongation that interacts with TRF1. In the 
presence of telomerase activity, 
overexpression of TIN2 inhibits telomere 
elongation. 
DNA-dependent protein kinase + Ku70/86  
(DNA-PK complex) 
DNA damage repair and regulation of telomere 
length 
Ataxia telangiectasia mutated (ATM) ATM plays a dual role at telomeres, activating 
the DNA damage response program at 
dysfunctional telomeres and yet preventing 
this activation at functional telomeres 
Poly-ADP ribose polymerase 1 (PARP-1) Catalyzes the poly(ADP-ribosyl)ation of TRF-2, 
disassociating it from the telomere and 
allowing access to the DNA damage repair 
machineries to repair damage 
 
Since this thesis focuses on the relationship between TL regulation and 
oxidative stress, the role and function of the poly-ADP ribose polymerase 
(PARP) enzymes will be described specifically.  
PARP enzymes are members of a large family of enzymes that use NAD+ 
as a substrate to transfer ADP-ribose onto glutamic acid residues of proteins. 
Upon binding to nicked DNA, PARP-1 forms homodimers and heterodimers with 
PARP-2. The activated enzyme catalyzes the cleavage of NAD+ into nicotinamide 
and ADP-ribose, synthesizing linear and branched poly(ADP-ribose) polymers 
that are covalently attached to nuclear acceptor proteins. The covalently 
attached poly(ADP-ribose) polymers, that are negatively charged, dramatically 
affect the function and DNA binding of target proteins, among which the DNA 
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repair proteins XRCC1, DNA ligase III, BRCA-1 [45,46]. PARP enzymes therefore 
are considered to play an important role in maintaining genome integrity 
through modulation of multiple cellular responses and facilitating DNA repair 
[47,48]. Poly(ADP-ribosyl)ation represents a cellular response to DNA strand 
breakage induced by ionising radiation, alkylating agents or oxidative stress. In 
contrast to the cytoprotective effect of PARP-1 activity, severe damage to DNA 
can trigger over-activity of PARP-1, leading to severe NAD+ consumption as well 
as ATP depletion and consequently cell death due to failure of energy 
metabolism [49].  
Several members of the PARP family have been found in association with 
telomeric DNA and are able to poly(ADP-ribosyl)ate TRF-1 and TRF-2, two 
telomere-specific DNA binding proteins [49]. TRF1 is thought to regulate TL and 
TRF2 is thought to protect chromosome ends [50]. Before telomerase can 
access the telomere and telomere elongation can take place, the t-loop 
structure of the telomere has to become unfolded. Tankyrase 1, a member of 
the PARP family, interacts with TRF1 through its ankyrin repeats and binds the 
acidic domain of TRF1. This domain is unique to TRF1, and for this reason, 
tankyrase 1 does not interact with TRF2. Tankyrase 1 poly(ADP-ribosyl)ates TRF-
1, which then dissociates from the telomeric DNA [51]. This renders the 
telomere accessible for telomerase and DNA repair enzymes.  
In a study by Chang et al. [52], siRNa (small interfering RNA) was used to 
knock down tankyrase expression in human cells. In the absence of tankyrase 1, 
sister telomeres fail to separate and this leads to cell arrest in anaphase in 
human cells. In mice, tankyrase 2 appears not to be required for telomere 
maintenance, but is necessary for normal growth [53]. This might suggest that 
the mouse tankyrase 2 differs from human tankyrase 2 in its telomere function 
[54]. Additional studies, in which the gene encoding for PARP-1 is disrupted, 
support the role of PARP enzymes in TL regulation. PARP-1 knock-out mice 
show shorter telomeres in splenocytes and thymocytes as compared to wild-
type controls. Furthermore, PARP-1 knock-out cells display a higher level of 
chromosomal abnormalities. In an in vitro study by d`Adda di Fagagna et al. 
[55], cells of PARP-1 knock-out mice showed 20 end-to-end chromosome 
fusions in 80 metaphase spreads, but none were found in 70 metaphase 
spreads in the cells of wild-type mice. These fusions led to an increased number 
of broken chromosomes and a 14-fold greater number of aneuploïd cells [55]. 
These results indicate the importance of PARP1-protein function in telomere 
General introduction 
 19 
maintenance and telomere regulation. The involvement of PARP-1 and PARP-2 
in telomeric damage signaling suggests a possible link between DNA repair and 
TL regulation [49] which will be discussed in the next paragraph. 
How does oxidative stress cause telomere shortening? 
The contribution to telomere loss by oxidative DNA damage was, in many cases, 
reported to overrate the contribution by the end-replication problem [6]. Due 
to their high content of guanines, telomeres were demonstrated highly 
sensitive to damage by oxidative stress [56,57]. In addition, oxidative damage to 
bases has been reported to accumulate over the life span of a cell or an 
organism and may also significantly contribute to senescence. Senescent cells 
were found to contain 30% more oxidatively modified guanines in their DNA 
and four times as many free 8-oxodG bases [15]. Furthermore, reactive oxygen 
species (ROS), especially hydroxyl radicals, produce single strand breaks, either 
directly or as an intermediate step in the repair of oxidative base modifications. 
In contrast to the majority of genomic DNA, telomeric DNA was reported to be 
deficient in the repair of single strand breaks [58]. Consequently, telomeres 
appear to be especially sensitive for the accumulation of ROS-induced 8-oxodG 
DNA strand breaks [15,56]. Evidence for this increased sensitivity to ROS-
induced 8-oxodG was obtained from two studies by Oikawa et al. [59,60]. In the 
first study, exposure of calf thymus DNA to H2O2 plus Cu(II) caused oxidation of 
bases at the 5’ site of 5’-GGG-3’ in the telomere sequence as measured using 
HPLC coupled with an electrochemical detector (HPLC-ECD) [60]. In the other 
study, WI-38 fibroblasts were irradiated with UVA and TL was determined by 
terminal restriction fragment length analysis [59]. To distinguish between 
telomeric DNA and non-telomeric DNA, a single stranded DNA fragment 
containing the telomere sequence was phosphorylated. The telomeric DNA 
fragment was annealed to its complementary strand and a non-telomeric DNA 
fragment was annealed to its complementary strand. In both studies it was 
shown that exposure of DNA to oxidative stress induced 8-oxodG formation at a 
higher level in telomere sequences than in non-telomere sequences [59,60]. 
Since the presence of unrepaired nucleotides or base damage might interfere 
with the replication fork, this may be a mechanism by which oxidative stress 
increases telomere shortening [6].  
In addition to the direct effect of ROS on telomeric DNA, repair of 
oxidative lesions is less efficient in telomeres than in the rest of the genome. 
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This was investigated by Petersen et al. [58], who exposed human fibroblasts to 
H2O2 and measured the frequency of single stranded regions in telomeres and 
minisatellites. It was found that repeated exposure to oxidative stress increased 
the frequency of single strand breaks in both minisatellites and telomeres. 
However, single strand breaks in minisatellites were completely repaired after 1 
day, whereas the repair in telomeres was much slower and incomplete [58]. An 
explanation for the repair deficiency in telomeres might be that the binding of 
TRF2 to telomeres blocks the access of DNA repair enzymes to telomeric strand 
breaks [43,61]. Furthermore, TRF2 inhibits the phosphorylation of the ATM 
kinase, which leads to an impaired DNA damage response [61,62]. TRF2 also 
interacts with polymerase β, which might have a negative effect on DNA repair 
[61,63].  
An increase in pro-inflammatory cytokines is often associated with 
oxidative stress, and part of the inflammatory condition [64]. In two studies by 
Beyne-Rauzy et al. [65,66], telomerase activity was found to be negatively 
correlated with the pro-inflammatory cytokine tumor necrosis factor alpha 
(TNF-α). TNF-α activates nuclear factor kappa B (NF-κB) and activator protein-1 
(AP-1) transcription factors, and enhances the expression of pro-inflammatory 
genes, leading to an inflammatory response [67]. In KG1 cells (leukemic cells) 
that were treated with TNF-α, a significant reduction in TL, as determined by 
flow-FISH, was observed. Further measurements showed an increase in the 
number of senescent cells as determined by a β-galactosidase assay [66]. In the 
second study, KG1 cells as well as normal bone marrow CD34+ hematopoietic 
progenitor cells (HPCs) (obtained from hematologically healthy patients 
undergoing hip surgery) were treated with TNF-α every two days for 14 days. h-
TERT gene expression was measured by quantitative RT-PCR. This study showed 
that TNF-α down-regulates the expression of the h-TERT gene in normal as well 
as in leukemic cells [65].  
The autosomal recessive disorder ataxia-telangiectasia (A-T) represents a 
disease in which evidence was found for the relationship between chronic 
oxidative stress and telomere shortening. A-T is a disorder involving cerebellar 
degeneration, immunodeficiency and premature senescence. In most cases, 
mutations of the ataxia-telangiectasia mutated gene (ATM) account for this 
disease. ATM encodes a protein kinase that is activated in response to DNA 
strand breaks and is thought to be essential for maintaining chromosomal 
stability and telomere integrity. It has been suggested that A-T cells are in a 
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chronic state of oxidative stress and have a defective maintenance or repair of 
telomeric DNA, contributing to their enhanced telomere shortening [68].  In 
addition, after in vitro exposure to hydrogen peroxide, fibroblasts from patients 
with A-T displayed shorter telomeres than control fibroblasts, as determined by 
Q-FISH. The A-T cells were not only characterized by enhanced telomere loss 
but also by the presence of extra-chromosomal fragments of telomeric DNA. It 
was concluded that ATM-deficient fibroblasts were much more sensitive to free 
radicals generated by hydrogen peroxide. [68].  More evidence for the role of 
oxidative stress in A-T was obtained from a study by Kamsler et al. [69], in which 
markers of the redox state in brains of ATM deficient mice were analyzed. ATM 
deficient mice showed a significant increase in the activity of thioredoxin and 
MnSOD and a significant decrease in catalase activity in the cerebella, indicative 
of increased levels of ROS [69]. 
In a study by Passos et al. [70],  young and senescent cultures of human 
fibroblasts were compared. The senescent cells had higher ROS levels, 
dysfunctional mitochondria, more DNA double strand breaks and shorter 
telomeres and it was shown that mitochondrial ROS enhanced telomere-
dependent senescence [70].  
Antioxidants and telomere shortening 
Since oxidative modification and shortening of telomeres is induced by ROS, it is 
expected that antioxidants may be preventive. This appears to be supported by 
several studies. For example, Furumoto et al. [71] found an age-dependent 
telomere shortening in human vascular endothelial cells (HUVECs) in vitro, as 
determined by Southern blot analysis. This could be slowed down by Ascorbate-
2-O-phosphate (Asc2P), an oxidation-resistant derivative of vitamin C [71]. In 
this study, addition of 130 μM Asc2P to HUVECs led to an extension of the 
cellular life-span and prevented cell size enlargement, which is an indication of 
cellular senescence [71,72]. Furthermore, it was found that age-dependent 
decline of telomerase activity could be inhibited by addition of Asc2P as 
determined by the TRAP assay. Asc2P probably scavenges oxidative stressors in 
the cell, since fluorometry showed that Asc2P-treated cells had only half of the 
levels of oxidized reactive oxygen intermediates, as compared to non-treated 
cells [71]. Another study by Kashino et al. [72], showed that treatment of 
human embryonic cells (HE49) with 200 μM ascorbic acid phosphoric ester 
magnesium salt (APM) decreased the level of oxidative stress, determined using 
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a fluorogenic compound, prevented telomere attrition as measured by Soutern 
blot analysis and extended the replicative life span [72]. These results suggest 
that reduction of oxidative stress by antioxidant treatment might reduce the 
rate of telomere shortening and delay cellular senescence [71,72]. This has also 
been observed in chondrocytes by Yudoh et al. [73]. Chondrocyte senescence 
may contribute to the risk for cartilage degeneration by decreasing the ability of 
the cells to maintain and repair cartilage tissue. In this study, chondrocytes 
were isolated from cartilage explants and cultured in the presence of 100 μM 
Asc2P or 0.1 μM H2O2 in vitro and it was shown that oxidative stress induced 
telomere erosion, as determined by Southern blot analysis, and replicative 
senescence in chondrocytes. Treatment of chondrocytes with Asc2P showed a 
tendency to protect telomeres from shortening in comparison with the 
untreated control [73].  
Further in vivo support for the relationship between oxidative stress and 
telomere shortening was obtained from a study by Tarry-Adkins et al. [74], 
where several oxidative stress markers were studied in male and female rats of 
the same age. Male rats showed lower antioxidant capacity than female rats. 
Moreover, female rats exhibited longer telomeres than male rats, as measured 
by Southern blot analysis. Expression levels of abundant antioxidant enzymes 
such as MnSOD, glutathione peroxidase I (Gpx I) and glutathione reductase in 
the renal cortex and medulla, were compared by Western blot, and the levels of 
MnSOD were higher in the female cortex as compared to the male cortex. The 
authors explained this by the fact that female rats have higher levels of 
estrogen. Estrogen enhances gene expression of MnSOD [75]. The decreased 
antioxidant levels in males may be partially responsible for acceleration of age-
related kidney telomere shortening [74]. Furthermore, Borras et al. [76] showed 
in proliferating 3T3 fibroblasts exposed to 10 μM buthionine sulphoximine, 
depletion of cellular glutathione (GSH) and decreased telomerase activity. 
Repletion of cells with glutathione increased telomerase activity in a dose-
dependent manner [76]. In a recent cross-sectional study in Chinese elderly 
men it was found that the consumption of Chinese tea, which is rich in 
antioxidants, was positively correlated with TL [77]. Daily multivitamin use 
might also be beneficial for telomere maintenance as concluded from a study 
by Xu et al. They found a positive correlation between multivitamin use, 
especially the intake of vitamin E and C, and TL in women [78]. It can be 
concluded that antioxidants appear to support the maintenance of TL.  
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Chronic inflammatory diseases and oxidative stress 
Additional evidence for the role of oxidative stress in telomere shortening was 
found in mechanistic studies and population studies that investigated the 
association between TL and diseases in which chronic oxidative stress and 
inflammation play a major role.  
In an in vitro study performed by Xu et al. [79], a relationship between 
homocysteine and aging was demonstrated. Homocysteine has been reported 
to exert atherogenic effects and this has been ascribed to increased hydrogen 
peroxide generation [79]. In this study, human umbilical venous endothelial 
cells were exposed to homocysteine in combination with copper. The rate of 
telomere shortening, as determined by Southern blot analysis, was increased in 
homocysteine treated cells and this was even more apparent when TL was 
plotted as a function of population doublings. It was observed that 
homocysteine treatment resulted in a nearly three-fold increase in the rate of 
telomere shortening and that this effect could be attenuated by the addition of 
catalase. Intracellular adhesion molecule 1 (ICAM-1) as well as plasminogen 
activator inhibitor 1 (PAI-1) expression was increased after chronic 
homocysteine treatment. These markers appeared to be overexpressed in 
senescent cells and this may contribute to atherosclerosis. Similarly, 
homocysteine treatment resulted in an increase in total PAI-1 protein levels. 
These results provide a potential mechanism linking increased production of 
ROS and decreasing TL to the development of senescence [79].   
The possible association between telomere shortening and vascular 
pathobiology in vivo has been thoroughly reviewed by Edo and Andres [80]. 
Telomere shortening in circulating leukocytes has been associated with 
coronary and carotid atherosclerosis, premature myocardial infarction, and 
hypertension [81-83]. Age adjusted TRF length, as determined by Southern blot 
analysis, was shown to be shorter in hypertensive subjects with carotid artery 
plaques as compared to hypertensive subjects without plaques after 
adjustment for blood pressure levels, total cholesterol levels, presence of 
hypolipemic treatment, type of antihypertensive treatment and cigarette 
smoking [83]. Chang et al. [84] hypothesized that TL might serve as a marker of 
replicative age in human vascular tissue. In their study, human tissue samples 
were taken from the aortic arch, abdominal aorta, iliac artery and iliac vein. TL, 
determined by Southern blot analysis, showed an increased rate of telomere 
loss as a function of donor age in endothelial cells from iliac arteries compared 
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to iliac veins. This is consistent with the greater propensity of iliac arteries to 
form atherosclerotic plaques. According to these results, measurement of TL 
might be a useful procedure to detect alterations of cellular turnover in tissues 
associated with cardiovascular diseases [84]. Recently,  Brouilette et al. [85] 
compared telomere lengths at recruitment in 484 individuals who went on to 
develop coronary heart disease events with those from 1058 age-matched 
controls who remained free. They showed that individuals with shorter 
leukocyte TL, as determined by quantitative PCR, at the time of recruitment had 
a significantly higher risk of developing subsequent coronary heart disease. 
Similar findings were described by Yang et al. [86], showing that mean 
leukocyte TL is a potential predictor of coronary artery disease. These findings 
indicate that the association of shorter telomeres with coronary heart disease is 
not a consequence of the disease [85]. 
In an in vitro study, human aortic endothelial cells were retrovirally 
infected with a dominant-negative form of TRF2 lacking both the Myb DNA 
binding domain and the NH2-terminal basic domain (TRF2D/N). TRF2 is 
essential for the formation of duplex loops of the telomere ends. Introduction 
of the TRF2D/N induced a growth arrest, with phenotypic characteristics of 
cellular senescence, as determined by a β-galactosidase assay, enlarged cell 
shapes and an increased expression of the adhesion molecule ICAM-1 [87]. This 
suggested that vascular endothelial cells with senescence-associated 
phenotypes are present in human atherosclerotic lesions, and that endothelial 
cell senescence induced by telomere shortening may contribute to 
atherogenesis [87]. 
In animal models, the link between TL, oxidative stress and 
atherosclerosis has also been investigated. Spontaneously hypertensive rats 
(SHR) showed telomere attrition in the kidney as  determined by Southern blot 
analysis [80,88]. In addition, the half-life of cells in the kidney but also in the 
heart and the aorta was decreased by 50% in SHR compared with healthy 
controls. This suggests increased cellular turnover and therefore accelerated 
cell aging in hypertension [88]. 
In a study performed by Poch et al. [89], late generation mice doubly 
deficient for Terc and apolipoprotein E showed shorter telomeres, but were 
protected from diet-induced atherogenesis, compared to atherosclerosis-prone 
ApoE-null mice with an intact Terc gene and longer telomeres measured by 
quantitative FISH. A possible explanation for the observed effect, might be that 
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short telomeres limit the proliferation of leukocytes leading to a decreased 
atherogenicity [89]. It should also be taken into account that there are 
differences in telomere pathobiology between humans and mice, i.e. mice have 
much longer telomeres compared to humans and express telomerase activity in 
almost all their cells.  
Diabetes has also been associated with telomere attrition [90,91]. In 
leukocyte DNA as well as in monocyte DNA, telomere shortening is found in 
type 2 diabetes patients. Since type 2 diabetes is associated with obesitas; 
obesity, resulting from a high intake of energy from carbohydrates and fats, 
might thus be a pro-inflammatory state with oxidative stress. Furthermore, 
increased concentrations of TNF-α and interleukin 6 (IL-6), associated with 
obesity and type 2 diabetes, have been reported to interfere with insulin action 
by suppressing insulin signal transduction. An interruption of insulin signal 
transduction might suppress the anti-inflammatory effect of insulin, which in 
turn might promote inflammation and, as a possible consequence, telomere 
attrition. Moreover, it has been shown that a low dose infusion of insulin 
reduces ROS generation by mononuclear cells, suppresses NADPH oxidase 
expression and intranuclear NF-κB binding  [92-94].  
Inflammatory bowel disease is another disease in which chronic 
inflammation plays a major role. In a study by Kinouchi et al. [95], specimens of 
cecal and rectal mucosa were obtained from 17 patients with ulcerative colitis 
(UC) aged 44.1 ± 3.9 years, and from 17 individuals with colon cancer aged 52.8 
± 2.1 years, as noncolitis controls. TL was determined by Southern blot analysis 
of the DNA of the specimens. The results showed shortening of telomeres in the 
affected mucosa of individuals with UC. No relationship between TL and age 
was found [95]. However, no telomere shortening was observed in peripheral 
blood lymphocytes of patients with UC in a study by Getliffe et al. [96]. In this 
study, peripheral blood lymphocytes were isolated from 19 patients with 
ulcerative colitis, 17 patients with Crohn’s disease (CD) and 18 non-
inflammatory bowel disease control patients. Age-related telomere loss, as 
determined by quantitative PCR, in peripheral blood lymphocytes was similar in 
ulcerative colitis, Crohn’s disease and control patients. Among CD patients, 
those who smoked had lower levels of hTERT than non-smokers. In both the UC 
group and the control group only one patient smoked and this patient had 
lower hTERT levels than control non-smokers. With only two smokers included 
no detectable effect of smoking on telomerase activity or TL could be observed 
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in patients and control subjects [96]. Because of the small number of subjects 
studied, there is no statistical power to detect differences between the two 
groups. 
Prolonged, demanding, weight-bearing exercise has also been reported 
to cause both acute and more chronic muscle damage which may contribute to 
fatigued athlete myopathic syndrome (FAMS) [97]. In a study by Collins et al. 
[98], telomere lengths in muscle biopsies from athletes with exercise-associated 
fatigue were compared with those from controls. Subjects were matched for 
age, gender, height, weight and training history. It was demonstrated that these 
athletes had significantly shorter telomeres than their controls. The results 
suggested, that in an attempt to repair repeated bouts of exercise-induced 
muscle damage, the satellite cells of the patients had undergone more oxidative 
damage and more frequent rounds of replication, resulting in extensive 
shortening of the telomeres [98]. 
Besides the involvement of ROS in pathologies such as described above, 
these also appear to be involved in psychological pathologies [99]. This is 
supported in a study by Kuloglu et al. [100], where they found significant higher 
lipid peroxidation products in schizophrenic and bipolar disorder patients 
compared with healthy controls. In a study by Epel et al. [101], it was found that 
psychological stress, both perceived stress and chronicity of stress, was 
significantly associated with increased oxidative stress as determined by F2-
isoprostanes levels quantified from a 12-hour nocturnal urine sample. The study 
was performed in 58 premenopausal women who were biological mothers of 
either a healthy child or a chronically ill child, of which the latter were predicted 
to have greater environmental exposure to stress. In peripheral blood 
mononuclear cells, lower telomerase activity and shorter telomeres were 
detected, determined by the TRAP assay and quantitative PCR, in the group 
with greater exposure to stress. The groups were similar with respect to age, 
smoking behavior and vitamin use, but the high stress group had a significantly 
higher body mass index [101]. This may also be an explanation for the shorter 
telomeres detected in these women, since a higher body mass index is 
associated with higher leptin concentrations and increased NF-κB activation, 
indicative for increased inflammation [92,102]. Furthermore, obesity is the 
result of an increase in the number of adipocytes and these cells can secrete 
cytokines such as TNF-α and IL-6 [103]. 
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A similar study was performed by Simon et al. [104]. TL was measured in 
15 individuals with a mood disorder, 15 with a bipolar disorder with comorbid 
anxiety disorder, 14 with a bipolar disorder without anxiety and 44 age-
matched control subjects. DNA was extracted from leukocytes and TL was 
determined by Southern blot analysis. Adjustments were made for smoking 
behavior, age and gender. The study showed accelerated telomere shortening 
in individuals with mood disorders when compared to healthy control subjects. 
Smoking itself was not predictive of TL. Furthermore, in this study, no data on 
body mass index (BMI) or obesity were available and its role as a possible 
confounder could therefore not be determined. Since mood disorders might 
activate stress response mediators, chronic oxidative stress may have been the 
cause of the accelerated telomere shortening seen in these patients [104]. 
Recently, it was also found that childhood maltreatment is associated 
with shorter telomeres at adult age, as measured by quantitative PCR in 
leukocytes [105].  
Both obesity and cigarette smoking are important risk factors in many 
age-related diseases, and are associated with increased oxidative stress and 
inflammation [92,106]. In a study by Valdes et al. [102], an association was 
found between obesity, cigarette smoking and TL. Venous blood samples were 
taken from women aged 18 to 76, and DNA was extracted from white blood 
cells. Individuals who had never smoked had longer telomeres than smokers, as 
determined by Southern blot analysis, and TL was negatively associated with 
leptin concentration in serum. BMI was not related to telomere shortening, 
suggesting that the mechanisms by which obesity affects TL might be better 
represented by leptin concentration than by BMI [102].  A possible mechanism 
that may be involved is the effect of obesity on leptin levels. Obesity has been 
associated with high serum concentrations of leptin and leptin is associated 
with NF-κB activation, which is a mediating factor in the production of reactive 
oxygen species and inflammatory cytokines [92,102]. In a very recent study, no 
relationship between TL and several measures of obesity could be found, but it 
should be noted that the study population was racially diverse, indicating other 
factors influencing TL [107].   
The described studies provide evidence for an association between 
inflammation, oxidative stress and telomere shortening and it appears 
therefore relevant to investigate telomere shortening in other inflammatory 
diseases with low grade systemic inflammation and its possible contribution to 
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disease pathophysiology. Most human studies focus on the relationship 
between TL and a specific disease, such as atherosclerosis, inflammatory bowel 
disease, obesity or diabetes. These are all diseases in which chronic 
inflammation plays a major role, as discussed above. Another group of diseases 
in which chronic inflammation plays a major role is the group of chronic lung 
diseases. A recent study investigated telomere shortening in smokers with and 
without chronic obstructive pulmonary disease (COPD). TL was determined by 
fluorescence in situ hybridization in circulating lymphocytes of non-smokers, 
smokers with normal lung function and smokers with moderate-to-severe 
airflow obstruction. In contrast to non-smokers, TL decreased faster with age in 
smokers. This study did not provide evidence for an enhanced telomere 
shortening in smokers developing COPD [108]. Another recent study did find an 
association between telomere shortening and COPD. Shorter telomeres were 
detected in COPD patients indicating an accelerated aging process. They could 
not find an association between TL and tobacco exposure [109].  
Possible models to investigate the relationship between TL and 
oxidative stress 
Various models have been developed and applied to investigate the 
relationship between TL and oxidative stress. The most common models used 
are in vitro studies, in which different cell lines are exposed to an oxidative 
stressor, such as hydrogen peroxide or tert-butyl hydroperoxide, for several 
passage numbers. Several studies have shown that chronic oxidative stress 
leads to enhanced telomere shortening in cultured cells [11,17,56,57,68,110-
112]. In a study performed by Kawanishi et al. [56], fibroblasts were irradiated 
with UVA. TL, as determined by terminal restriction fragment analysis, 
decreased with increasing irradiation dose. Furthermore, UVA irradiation dose-
dependently increased the formation of 8-oxodG in both fibroblasts and HL-60 
cells [56]. In another study, human umbilical vein endothelial cells were 
exposed to 0.1 µM tert-butyl hydroperoxide, a substrate of glutathione 
peroxidase, or 10 µM L-buthionine-[S,R]-sulphoximine (BSO), an inhibitor of 
glutathione synthesis. Both treatments induced intracellular oxidative stress but 
had no cytotoxic or cytostatic effects. Nonetheless, treated cultures entered 
senescence prematurely as determined by a β-galactosidase assay. In cultures 
subjected to oxidative stress, Southern blot analysis demonstrated faster 
telomere shortening [110]. In addition to studies of telomere shortening in cell 
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lines, animal models (mainly mice) have been studied extensively. In contrast to 
humans, rodent telomeres are generally much longer [113]. Especially mice 
have extremely long telomeres (up to 150 kbp) and express telomerase in many 
tissues. Nevertheless, telomere shortening is broadly studied in mice, especially 
in telomerase knock-out mice [114,115]. Telomerase knock-out mice as well as 
Ku86 knock-out mice have been developed to study telomere shortening. Ku86 
has a protective role at mammalian telomeres and, as a consequence, Ku86 
deficiency in mice results in telomeric fusion between long telomeres [115]. 
However, it is only after four to six generations that telomere shortening 
becomes a critical issue in these mice [116]. This makes mice a questionable 
model to study the relationship between telomere shortening and oxidative 
stress in humans. An alternative model is the rat, with telomere lengths ranging 
from 20 to 100 kbp and in which, as opposed to mice, telomeres shorten with 
age in various tissues [116]. Since rat telomeres do not have to be modulated to 
detect shortening, a rat model might be more feasible in this perspective [117]. 
In a study by Cherif et al. [116], telomere lengths were assessed by Southern 
blot analysis in the kidney, pancreas, liver, lung and brain of male and female 
Wistar rats to determine lifespan. Previous studies reported relationships 
between kidney telomere shortening and longevity in the rat and differences in 
longevity between male and female rats. Males seem to have a shortened 
lifespan compared to their female counterparts [118,119]. In this study the 
percentage of short telomeres increased with age in the kidney, liver, pancreas 
and lung of both males and females, but not in the brain. Males had shorter 
telomeres than females in all organs, except in the brain, where lengths were 
similar. This suggests that there is a gender-related difference in lifespan and a 
tissue specific regulation of TL in the rat [116].  
In addition to mouse and rat models, telomere biology has also been 
studied in dogs [120]. In a study by Nasir et al. [120], the dog is proposed as an 
alternative model system. Telomere lengths measured by Southern blot analysis 
in canine PBMCs and tissues ranged from 12 to 23 kbp and telomerase activity 
was detected only in tumor tissue and testis. This indicated that dogs share 
more similarities in telomere and telomerase biology with humans and for this 
reason might also be a more feasible model than the mouse [120]. Although 
chicken telomeres seem to resemble human telomeres for the greater part with 
lengths ranging from 8 to 20 kbp, the distribution of telomerase activity is 
similar to that in mice with many tissues displaying telomerase activity [121]. 
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Since the dog model as well as the chicken model have not been investigated 
very thoroughly yet, it is unclear at the present whether these are feasible 
models to study the relationship between TL and oxidative stress in humans. TL 
has also been studied in bird species and in cattle. It has been shown that 
telomeres shorten more slowly in long-lived birds than in short-lived ones [122]. 
A recent study showed that the shortening rate of telomeres in free living 
corvids predicted survival. They concluded from their longitudinal data that the 
shortening rate of long telomeres may be a measure of 'life stress' may thus be 
a promising biomarker of the remaining lifespan [123]. In cattle it was found 
that there is a highly characteristic and individual TL pattern in each animal 
[124]. The applicability of these models in human telomere research has to be 
studied in more detail.  
Other important features of TL 
A reliable assessment of TL is also important in investigating the relationship 
between oxidative stress and TL regulation, and there are different methods 
that are applied to analyze TL [19,20]. The choice for a specific method to 
determine TL will depend on the type and aim of the study. Each method has its 
advantages and disadvantages that make it more or less suitable for a specific 
purpose.  
Another important feature of TL is heritability. TL appears not only to be 
determined by environmental factors, but also genetically [125-127]. In a recent 
study by Starr et al. [128], it was found that some polymorphisms related to 
oxidative stress are linked to increased telomere shortening.  
Since telomere stability is influenced by multiple factors, genetic as well 
as environmental, it has been suggested that telomere shortening might serve 
as a biomarker of oxidative stress and disease progression and as a predictor of 
life expectancy [125]. This is illustrated by figure 2.  
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Figure 2. Telomere length as biomarker of disease progression 
 
Recent studies have shown that telomere shortening can be a biomarker of 
premature cell senescence in vascular diseases and metabolic disorders, 
indicating the prognostic value of TL [129,130]. Telomere attrition in white 
blood cells seemed to be more closely associated with endothelial damage and 
atherosclerosis than chronological aging [129]. This was further supported in a 
study by Brouilette et al. [130], in which a strong association between leukocyte 
TL and premature myocardial infarction was found [130].  
It appears therefore relevant to evaluate potential interventions to 
prevent or diminish telomere shortening as is illustrated in figure 2. Anti-
inflammatory medication and antioxidant supplementation, reducing the state 
of chronic inflammation, appear to support telomere maintenance. In addition, 
stimulating the DNA repair capacity or the telomerase activity might also be 
advantageous to telomere maintenance and postpone cell senescence.  
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Aim and outline of this thesis 
Telomeres shorten with each cell division and are important in the maintenance 
of chromosomes. When the telomeres reach a critical length (threshold) the cell 
will go into senescence, leading to an irreversible growth arrest. Since TL in the 
somatic cells determines the number of cell divisions, TL has been proposed as 
a marker for biological age. Under conditions of chronic oxidative stress the rate 
of telomere shortening is increased. Since telomeres consist of the repetitive 
sequence TTAGGG, and have a high GC content, they are very vulnerable to 
base oxidation. Additionally, DNA strand breaks are less efficiently repaired at 
the telomeres when compared to the rest of our genome. This means that 
reactive oxygen species cause more damage to the telomeres and this damage 
is less well repaired. 
Several inflammatory diseases have been linked to chronic oxidative 
stress and accelerated telomere shortening, such as diabetes, inflammatory 
bowel disease, atherosclerosis, chronic obstructive pulmonary disease and 
psychological health. It might therefore be of relevance to use TL as a marker of 
disease progression and survival. Besides oxidative stress, there are several 
other factors influencing TL and the rate of telomere shortening. Genetics play 
an important role in determining TL, but environmental and lifestyle factors 
such as smoking, alcohol consumption, physical activity, body composition and 
coffee and tea consumption which affect oxidative stress levels, may contribute 
significantly to accelerated telomere shortening. Since oxidative modification 
and shortening of telomeres is induced by reactive oxygen species, it is 
expected that antioxidants may be preventive. Dietary interventions with 
antioxidants and/or anti-inflammatory agents might increase longevity by 
decreasing the levels of oxidative stress.  
There are still many mechanisms that need to be unraveled and it is not 
clear yet whether TL is a useful biomarker. 
The overall aim of this thesis was to evaluate the effects of chronic 
oxidative stress on telomere shortening and the possible use of TL as a 
biological marker of disease progression and aging. 
 
The primary objectives of this thesis are: 
• To investigate differences in TL, oxidative stress markers and antioxidant 
status between elderly men from the Netherlands and from Greece 
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• To determine whether telomere shortening is a predictor of mortality  
• To examine telomere shortening in COPD patients  
• To assess telomere shortening in COPD patients and relate these findings 
to lifestyle factors such as coffee and alcohol consumption. 
• To investigate the effects of interventions with the flavonoid fisetin and 
the antioxidant n-acetylcysteine on telomere shortening and markers of 
oxidative stress in a diabetic rat model. 
 
To study the effects of chronic oxidative stress and the antioxidant status on TL, 
in chapter 2 the results are described of a cross-country study of elderly men in 
the Netherlands and in Greece. In this study TL was measured by quantitative 
PCR and markers of oxidative stress and antioxidant status were determined to 
unravel the differences in TL between these two countries. In chapter 3 the 
possible use of TL as a marker for mortality is discussed, which was studied in 
the Zutphen elderly study. In this longitudinal study we measured telomere 
shortening over a period of 7 years. This study gives information on individual 
telomere shortening and its possible relationship with all-cause mortality, and 
disease specific mortality. In chapter 4 differences in TL between healthy 
controls and COPD patients were evaluated. TL was determined and SOD 
activity was measured to investigate the possible relationship between TL and 
antioxidant capacity.  
Chapter 5 also describes patient-control study with healthy controls and 
COPD patients. In this study we confirmed previous results (chapter 4) and we 
measured additional relevant markers of oxidative stress and inflammation, i.e 
cytokines and we collected data on coffee, caffeine and alcohol consumption to 
investigate the possible effects of these dietary compounds on markers of 
oxidative stress and TL. In this study we also measured homocysteine levels. In 
chapter 6 we describe the effects of food interventions on TL in a diabetic rat 
model. Rats were injected with streptozotocin to induce diabetes, a disease 
that is marked by chronic oxidative stress. Two groups received either fisetin, a 
flavonoid, or n-acetylcysteine, an antioxidant, through their food. Several 
markers of oxidative stress were measured, TL was determined and gene 
expression of relevant genes was measured by quantitative PCR. Finally, in 
chapter 7, a general discussion of these findings together with their potential 
implications and future prospects is presented.  
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Abstract 
The incidence of major chronic diseases such as cardiovascular diseases is lower 
in Mediterranean Southern Europe than Northern Europe. This may be due to a 
lower level of oxidative stress and a higher antioxidant status in people living 
around the Mediterranean Sea. Oxidative stress may influence the rate of 
shortening of telomeres, the nucleoprotein structures at the ends of 
chromosomes. We aimed to compare leukocyte telomere length (LTL) in elderly 
men from Northern and Southern Europe and to investigate the possible 
relationship between LTL and indicators of oxidative stress and antioxidant 
status.  
LTL was measured by quantitative PCR and indicators of oxidative stress 
were measured in serum, antioxidant vitamins in plasma and endogenous 
antioxidants in serum.   
We examined 143 elderly Dutch men (mean age 83.9 years) and 109 
Greek elderly men (mean age 84.6 years) and found that the Greek men had 
significantly longer telomeres (geometric mean 4.95 kbp, 95% confidence 
interval (CI): 4.71-5.23 kbp) compared to the men from the Netherlands (4.76 
kbp,95% CI: 4.55-4.98 kbp; P=0.001). Age was inversely associated with LTL (β=-
0.10, P=0.31 in Cretan men and β=-0.19, P=0.02 in Dutch men). In all men LTL 
was not related to indicators of oxidative stress and plasma antioxidants. 
However, the endogenous antioxidants serum albumin (β=0.18, P=0.007) and 
uric acid (β=0.13, P=0.045) were positively associated with LTL. The age-
adjusted difference between Crete and Zutphen was reduced by 30% after 
adjustment for serum albumin and uric acid. 
We conclude that Greek elderly men have significantly longer LTL 
compared to Dutch counterparts. The endogenous antioxidants albumin and 
uric acid were positively associated with longer telomeres and may explain part 
of the longer LTL in Greek than in Dutch men. 
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Introduction 
Oxidative stress causes extensive damage to DNA, proteins, and lipids. This 
damage is a major contributor to aging and may afflict widely different 
degenerative diseases, such as cardiovascular diseases [1]. Blood levels of 
indicators of oxidative stress were higher and those of antioxidants were lower 
in Northern Europe compared to Mediterranean Southern Europe [2-5]. This 
may be one of the reasons for a lower occurrence of cardiovascular diseases in 
Mediterranean Southern compared to Northern Europe.  
Recent studies suggested that the disturbance of the oxidative balance 
may play an important role in the rate of telomere shortening [6-8]. Telomeres 
are nucleoprotein structures at the end of chromosomes and shorten with each 
cell division in somatic cells, which can be explained by the end replication 
problem. However, under conditions of oxidative stress the rate of telomere 
shortening was increased [9,10]. Chronic oxidative stress is involved in many 
inflammatory diseases, and it has been frequently observed that telomeres 
shorten faster in subjects with chronic diseases such as cardiovascular diseases, 
inflammatory bowel disease, type 2 diabetes and chronic obstructive 
pulmonary disease [11-14].  
We hypothesized that Greek elderly men might have longer leukocyte 
telomeres compared to Dutch counterparts, due to a lower level of oxidative 
stress because of differences in the balance between reactive oxygen species 
(ROS) and antioxidants. In this study telomere length of elderly men from Crete 
and The Netherlands were compared and we investigated the possible 
relationship between leukocyte telomere length (LTL) and markers of 
antioxidant status and oxidative stress within these two population groups. 
Materials and Methods 
Study population 
The study population consisted of men aged at least 79 years living on Crete 
(Greece) and men of the same age living in Zutphen (The Netherlands). Both 
cohorts belong to the Seven Countries Study, a longitudinal study in which the 
relations of diet and other risk factors for chronic diseases are investigated [15].  
In Crete 165 men (24%) aged 79-96 were still alive in 2000 and leukocyte DNA 
could be obtained from 109 (66%). In the Zutphen Elderly Study 240 men aged 
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80-98 were still alive in 2000 and leukocyte DNA was available from 143 (60%). 
The survey took place in Crete between May and August 2000, and in Zutphen 
between March and June 2000. 
The Zutphen Elderly Study was approved by the Medical Ethics 
Committee of The Netherlands Organisation for Applied Scientific Research 
(TNO) and the study on Crete by a local medical ethics committee.  
Collection of data on risk factors and history of chronic diseases 
Body weight and height were measured according to standardized procedures. 
Body mass index (BMI) was calculated by dividing weight (kg) by the square of 
the height (m2). Information on cigarette smoking and alcohol consumption 
was collected by standardized questionnaires. The history of chronic diseases 
such as myocardial infarction, stroke, diabetes or cancer, and the presence of 
diabetes was assessed by questionnaire information and confirmed by letters 
from general practitioners.  
Leukocyte telomere length measurement 
Non-fasting blood samples were collected in the morning. In Crete, blood 
samples were allowed to stand for 2h at room temperature, after which plasma 
en serum were obtained. In Zutphen, the samples were kept cool in a box with 
cool elements, and plasma and serum were obtained in the afternoon. Before 
transport within a few days of collection to the National Institute for Public 
Health and Environment (RIVM), the Netherlands, samples were stored in 
Zutphen at –30 ºC and in Crete at -80ºC. Samples from Crete were transported 
to the Netherlands on dry ice by plane. After arrival at the RIVM, all samples 
were stored at –80ºC until analyses. An aliquot of 200 µl of buffy coat was used 
to extract genomic DNA with the QIAamp DNA Mini Kit (Qiagen, Venlo, The 
Netherlands) according to the manufacturer’s protocol. The DNA was quantified 
using a Nanodrop instrument (Isogen Life Science, Belgium).  
LTL was determined by quantitative PCR as described previously [12,16]. 
For 20 samples we repeated the telomere length measurement by using an 
additional reference gene, acidic ribosomal phosphoprotein PO (36B4), 300 nM 
forward primer (5’- CAGCAAGTGGGAAGGTGTAATCC -3’), 500 nM reverse 
primer (5’- CCCATTCTATCATCAACGGGTACAA -3’), to study the correlation 
between the two measurements and to confirm the reproducibility of the 
method.  
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Measurement of indicators of oxidative stress and antioxidants 
The following serum indicators of oxidative stress were measured: 
hydroperoxides  (enzymatic method, OxyStat assay; Biomedica, Vienna, 
Austria), malondialdehyde, (high-performance liquid chromatography, 
Chromsystems, Munich, Germany) and gamma-glutamyl transferase (Technicon 
SMAC analyser (Technicon Instruments Corp., Tarrytown, New York, USA). For 
the plasma antioxidant vitamins, the following parameters were measured: 
carotenoïds and tocopherols, both measured by high-performance liquid 
chromatography in the laboratory of the Division of Human Nutrition 
(Wageningen University, the Netherlands). The endogenous antioxidants 
albumin, total bilirubin and uric acid were measured in serum using a Technicon 
SMAC analyzer at the Leiden University Medical Center [2].  
Statistical analysis 
All data were presented as number (percentage), mean ± SD, or back 
transformed geometric mean (25th percentile, 75th percentile), when 
appropriate. LTL and plasma oxidative stress and antioxidant markers were 
logarithmically transformed before analysis to approach normal distributions. 
For testing of differences between Cretan and Zutphen elderly men unpaired t-
test, Mann Whitney U test, or chi-squared test was used. Regression analysis 
was used to analyse the difference in LTL between countries while adjusting for 
age. In subsequent regression analyses, we adjusted for age, BMI, smoking 
status, alcohol use, history of chronic diseases (and country when all men were 
combined). Two-tailed p<0.05 was considered statistically significant. Statistical 
analyses were performed with SPSS for Windows (SPSS 17.0; SPSS Inc, Chicago, 
IL, USA). 
Results 
The characteristics of elderly men in Crete and Zutphen are described in Table 
1. The mean age of Cretan men was 84.6 years and of men from Zutphen was 
83.8 years. Among the Zutphen men there were more alcohol users and they 
had a higher average BMI compared to the men from Crete. In Zutphen, a 
history of chronic diseases was significantly more frequently present than in 
Crete, mainly due to the higher prevalence of cancer and stroke.  
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Levels of oxidative stress parameters were significantly higher in Zutphen 
than in Crete. Cretan men had significantly higher levels of carotenoïds with the 
exception of beta-cryptoxanthin, whereas men in Zutphen had higher levels of 
tocopherols. The average levels of the serum endogenous antioxidants albumin 
and uric acid were significantly higher in Crete compared to Zutphen. 
 
Table 1. Characteristics of elderly men in Crete (Greece) and Zutphen (The Netherlands) in 2000 
 n Crete n Zutphen P-value* 
Age (years) 109 84.6 (4) 143 83.9 (3.4) 0.11 
Cigarette smoking, no. (%) 109 11 (10.1%) 143 14 (9.8%) 0.94 
Alcohol consumption, no. (%) 109 66 (60.6%) 143 108 (75.5%) 0.01 
Body mass index (kg/m2) 109 24.5 (4.1) 143 25.8 (3.7) 0.01 
History of chronic diseases 
Myocardial infarction, no. (%) 109 16 (14.7%) 143 23 (16.1%) 0.76 
Stroke, no. (%) 109 5 (4.6%) 143 23 (16.1%) 0.04 
Diabetes, no. (%) 109 9 (8.3%) 143 18 (12.6%) 0.27 
Cancer, no. (%) 109 6 (5.5%) 143 29 (20.3%) 0.001 
Any chronic disease, no. (%) 109 28 (25.7%) 143 70 (49.0%) < 0.001 
Telomere length (kbp) 109 4.95 (4.71; 5.23) 143 4.76 (4.55; 4.98) 0.001 
Indicators of oxidative stress: 
Hydroperoxides (mmol/l) 109 32.5 (14.2; 61.1) 143 56.5 (21.1; 142.5) 0.002 
Malondialdehyde (mmol/l) 109 96 (80; 110) 143 102 (90; 110) 0.02 
Gamma-glutamyl transferase 
(U/l) 
109 20.3 (15.0; 24.0) 143 26.1 (19.0; 35.0) 0.001 
Plasma antioxidant vitamins: 
Carotenoids (mg/100ml): 
Beta-cryptoxanthin 109 7.15 (4.57; 13.39) 140 7.24 (4.54; 13.74) 0.91 
Lycopene 108 12.5 (7.8; 21.4) 106 4.3 (2.7; 7.2) < 0.001 
Beta-carotene 109 20.9 (13.4; 34.9) 140 12.8 (8.4; 19.9) < 0.001 
Zeaxanthin 109 2.24 (1.65; 3.28) 108 1.38 (0.99; 2.18) < 0.001 
Lutein 109 20.4 (15.2; 29.5) 140 11.5 (8.2; 16.3) < 0.001 
Tocopherols (mg/100 ml): 
Alpha-tocopherol 103 1.12 (0.68; 1.76) 139 2.15 (1.50; 3.22) < 0.001 
Gamma-tocopherol 109 69.7 (55.8; 87.6) 140 84.5 (69.3; 117.2) < 0.001 
Serum endogenous antioxidants: 
Albumin (g/l) 109 41.4 (40; 44) 143 39.6 (38; 42) < 0.001 
Total bilirubin (mmol/l) 109 9.2 (7.0; 12.0) 143 9.3 (7.0; 12.0) 0.89 
Uric acid (mmol/l) 108 0.38 (0.31; 0.47) 143 0.35 (0.30; 0.41) 0.009 
* P-value for differences between Cretan and Zutphen elderly men based on unpaired t-test, Mann–
Whitney U test, or chi-squared test. Data are mean (standard deviation), number (percentage) or 
back-transformed geometric mean (25th percentile, 75th percentile). 
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Figure 1 shows that the median leukocyte TL was 190 bp longer in men from 
Crete than in men from Zutphen (p = 0.001). After adjusting for age, the 
difference between the two populations did not change. Age was inversely 
associated with TL (β=-0.10, P=0.31 in Cretan men and β=-0.19, P=0.02 in Dutch 
men).  
 
 
Figure 1. Leukocyte telomere length in 144 men from Zutphen in 2000, and 123 men from Crete in 
2000. Error bars indicate the geometric mean with standard deviation. The overall univariate 
analysis of variance test for the difference between countries was P = 0.001. 
 
Consistent relationships of LTL with indicators of oxidative stress and plasma 
antioxidant vitamins were not observed in Crete and Zutphen. However, the 
serum endogenous antioxidants albumin and uric acid were positively 
associated with TL (Table 2 and Figure 2). The association with serum albumin 
was stronger in Crete and that with uric acid in Zutphen. These associations 
were also statistically significant in the combined group of Cretan and Zutphen 
men, also after adjustment for country. The age-adjusted difference in LTL 
between Crete and Zutphen men declined by 30% (with beta´s changing from –
0.233 to –0.162) after adjustment for serum albumin and uric acid.  
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Table 2. Beta-coefficients of the relationship between telomere length and serum indicators of 
oxidative stress and antioxidant (capacity) in elderly men living in Crete and Zutphen in 2000 
 
 Unadjusted Adjusted* 
 Crete Zutphen Crete Zutphen All men 
 (n=109) (n=143) (n=109) (n=143) (n=252) 
Indicators of oxidative stress: 
Hydroperoxides  –0.08 0.2 –0.02 0.18 0.08 
(mmol/l) (P=0.39) (P=0.02) (P=0.86) (P=0.04) (P=0.19) 
Malondialdehyde  0.05 0.08 0.03 0.06 0.05 
(mmol/l) (P=0.59) (P=0.40) (P=0.75) (P=0.57) (P=0.44) 
Gamma-glutamyl  0.04 0.05 0.04 0.03 0.03 
transferase (U/l) (P=0.67) (P=0.56) (P=0.67) (P=0.75) (P=0.67) 
Plasma antioxidant vitamins: 
Carotenoids (mg/100ml): 
Beta-cryptoxanthin 0.15 0.01 0.13 0.01 0.07 
 (P=0.11) (P=0.91) (P=0.20) (P=0.90) (P=0.29) 
Lycopene 0.15 0.06 0.12 0.01 0.09 
 (P=0.12) (P=0.56) (P=0.25) (P=0.91) (P=0.30) 
Beta-carotene 0 0.07 –0.01 0.07 0.02 
 (P=0.99) (P=0.42) (P=0.93) (P=0.44) (P=0.78) 
Zeaxanthin 0.24 –0.02 0.24 –0.06 0.1 
 (P=0.01) (P=0.81) (P=0.02) (P=0.54) (P=0.19) 
Lutein 0.12 0.12 0.09 0.11 0.1 
 (P=0.23) (P=0.18) (P=0.37) (P=0.19) (P=0.15) 
Tocopherols (mg/100 ml): 
Alpha-tocopherol 0.09 0.04 0.11 0.01 0.04 
 (P=0.36) (P=0.64) (P=0.31) (P=0.89) (P=0.54) 
Gamma-tocopherol 0.19 0.06 0.17 0.06 0.09 
 (P=0.05) (P=0.47) (P=0.10) (P=0.53) (P=0.19) 
Serum endogenous antioxidants: 
Albumin (g/l) 0.27 0.15 0.25 0.1 0.18 
 (P=0.005) (P=0.08) (P=0.02) (P=0.28) (P=0.007) 
Total bilirubin (mmol/l) 0 0.16 –0.02 0.17 0.07 
 (P=0.98) (P=0.06) (P=0.83) (P=0.05) (P=0.29) 
Uric acid (mmol/l) 0.13 0.13 0.13 0.17 0.13 
 (P=0.18) (P=0.14) (P=0.20) (P=0.05) (P=0.045) 
* Adjusted for age (continuous), body mass index (continuous), smoking (yes or no), alcohol use (yes 
or no), history of chronic diseases (and country, when all men are combined). P-values mentioned 
are based on testing whether beta-coefficients significantly differ from zero. 
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Figure 2. Bubble plots of serum levels of the endogenous antioxidants albumin and uric acid (on 
logarithmic scales) in relation with telomere length in elderly men living in Crete (○) and Zutphen 
(●). The bubble areas are proportional to the number of men. Univariate regression lines are shown 
for both populations combined, with non-parametric Spearman’s correlation coefficients with its 
accompanying P-values. 
Discussion 
In this cross-cultural study, elderly men in Crete had significantly longer median 
leukocyte TL than Dutch counterparts. LTL was in both populations inversely 
related to age. Indicators of oxidative stress and of plasma antioxidant vitamins 
were not associated with LTL. The endogenous antioxidants serum albumin and 
uric acid were higher in Crete than in Zutphen and were positively associated 
with LTL. The age adjusted difference in LTL between Crete and Zutphen 
diminished after adjustment for serum albumin and uric acid.  
Compared to Zutphen elderly men, the medium LTL was 190 bp longer in 
Cretan men. Leukocyte telomeres shorten on average with 30-40 bp per year , 
which may indicate that the biological age of Cretan men is approximately 5 
years younger than that of men from Zutphen [17-22]. This is compatible with 
the much lower all-cause mortality of the Cretan compared with the Zutphen 
cohort between 1960 and 2000 [23]. The inverse association between LTL and 
age was stronger in Zutphen than in Crete. This also suggests a better survival of 
the Cretan compared to the Zutphen men. 
The observed higher LTL in Cretan compared to Zutphen elderly men 
may partly be explained by the higher level of serum albumin and uric acid in 
the Cretan men. Also the analysis that showed that 30% of the difference in LTL 
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between Crete and Zutphen could be explained by serum albumin and uric acid 
supports this hypothesis. In contrast we did not find associations of plasma 
vitamin antioxidants with LTL. Our results suggest that endogenous 
antioxidants, and not plasma antioxidant vitamins, are of greatest importance 
in relation to LTL in elderly men. 
To the best of our knowledge this is the first study that showed an 
association of LTL with serum albumin and uric acid and LTL. Both antioxidants 
are involved in scavenging lipid radicals. Albumin may provide antioxidant 
protection by functioning as a serum peroxidase in the presence of reduced 
glutathione, which is an intracellular antioxidant [24]. Albumin is an important 
extracellular antioxidant [25] and a marker for nutritional status [26], and many 
potential associations between its plasma concentration or modifications and 
mortality have been observed [27,28]. Higher concentrations of albumin were 
associated with lower mortality rates from cardiovascular disease and cancer 
[28], supporting the positive association between albumin and leukocyte TL, 
that we found in our study.  
Uric acid is an antioxidant that prevents ascorbic acid oxidation; it 
scavenges peroxyl, hydroperoxyl superoxide radicals by binding transition 
metals, thereby preventing free radical reproduction [24]. Ames et al. 
hypothesized that uric acid may be an evolutionary antioxidant substitute for 
the loss of ability to synthesize ascorbate in higher primates. In humans, uric 
acid is present in blood at concentration close to maximum solubility. He 
suggested that these high levels may be the result of the evolution of effective 
protective mechanisms against oxygen radicals and may increase lifespan [29]. 
This hypothesis is compatible with our finding that increased serum uric acid 
concentrations were associated with longer leukocyte telomeres. It has also to 
be noted that uric acid has not only antioxidant, but also pro-oxidant properties 
and a high level of uric acid has been proposed as a risk factor for coronary 
heart disease [30].  
Potential limitations of our study should be considered. The study 
participants were elderly men, which may limit the generalizability of our 
findings to men of younger age and to women. Survivor bias might have played 
a role, since our participants were very old and probably unusually healthy 
compared to their counterparts who already died. Moreover, the number of 
subjects was relatively small in this study. The study has also several strengths. 
We confirmed our LTL analysis by repetition of 20 samples with a different 
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reference gene and found a strong correlation (reliability coefficient of 0.87, 
p<0.001), excluding methodological variation due to potential fragmentation or 
loss of DNA during isolation. Various endogenous antioxidant parameters and 
indicators of oxidative stress were measured giving an overview of the oxidative 
balance in these subjects.  
In summary, we conclude that Cretan elderly men have significantly 
longer leukocyte telomeres compared to Dutch counterparts. This is compatible 
with the higher life expectancy of the Cretan men. High levels of the serum 
endogenous antioxidants albumin and uric acid were associated with longer 
telomeres. Whether these associations are causal needs to be established in 
future studies.  
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Abstract 
Telomere shortening is a marker of aging and therefore telomere length (TL) 
might be related to disease progression and survival. To address these 
questions, we measured leukocyte telomere length (LTL) in male subjects from 
the Zutphen Elderly Study. LTL was measured by quantitative polymerase chain 
reaction in 203 men; mean aged 78 years in 1993 and 75 surviving subjects 
mean aged 83 years in 2000. During 7 years of follow-up 105 men died. Cox 
proportional hazards models were used to estimate hazard ratios (HR) for all–
cause and cause-specific mortality. We found that LTL declined with a mean of 
40.2 bp per year and LTL values measured in 1993 and 2000 correlated 
significantly (r=0.51; p<0.001). Longer telomeres at baseline were not predictive 
for all-cause mortality, cardiovascular mortality or cancer mortality. These 
results suggest that LTL is not a marker of mortality in men over age 70.  
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Introduction 
In human somatic cells, telomeres, the nucleoprotein structures at the end of 
chromosomes, shorten with each cell division leading to an irreversible growth 
arrest of the cell. This process of senescence is associated with the aging 
process and telomeres have therefore been proposed as markers for biological 
aging [1,2].  
Most studies investigating telomere shortening are cross-sectional, 
focussing on differences between groups of subjects. Unfortunately, these 
studies give no information on the individual rate of telomere shortening over a 
period of time, rendering them inconclusive on individual susceptibility. 
Furthermore, it can also not be concluded from these studies whether there is 
an association between TL and (disease-specific) mortality. It is therefore 
relevant to perform longitudinal studies in which these relationships are 
investigated [3-14].  
Several chronic diseases have been linked to chronic oxidative stress and 
accelerated telomere shortening, such as cardiovascular disease (CVD) and 
cancer [8,15,16]. Epel et al. showed that short baseline TL was related to 
greater mortality from CVD in women. For men, the rate of telomere shortening 
was related to greater cardiovascular mortality [8]. The association of shorter 
telomeres with cancer morbidity and mortality is inconsistent. Although some 
studies show a relationship between short telomeres and cancer risk [17,18] 
there are also studies showing an inverse relationship [16,19,20].  
We hypothesized that leukocyte telomere length (LTL) is a biological 
marker of all-cause and cause-specific mortality. To investigate this, we 
prospectively evaluated the rate of telomere shortening over a period of seven 
years in 203 men who were 73 to 91 years old at baseline as part of the 
Zutphen Elderly Study cohort. Furthermore, we investigated the relationship 
between LTL and all–cause and cause-specific mortality during seven years of 
follow-up.  
Materials and Methods 
Study population 
The Zutphen Elderly Study consisted of 887 subjects in 1985 (response rate 
70.1%). Because no whole blood samples were available in 1985, we defined 
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1993 as our baseline measurement for the present analyses. The cohort of The 
Zutphen Elderly Study consists of men born between 1900 and 1920. The study 
started in 1960 as the Dutch contribution to the Seven Countries Study. 
Between 1985 and 2000 the men were examined every 5 years. The purpose of 
the more recent survey was to gain insight into the changes and risk factors 
associated with physical, social, psychosocial, cognitive functions, and perceived 
health in very old men. The Zutphen Elderly Study consisted of 553 men in 
1993, of whom 390 participated (response rate 71%), and 345 had a blood 
sample. However, only 203 (59%) buffy coats could be used for DNA isolation 
since 142 samples were unavailable. For the follow-up examination in 2000, 176 
men enrolled in the study in Zutphen. Blood samples were available from 146 
individuals. Because of the insufficient quality of the DNA of two of the 
participants, 144 men (82%) were finally included in the present analysis. Only 
75 men had also a blood sample available both in 1993 and in 2000. Written 
informed consent was obtained from all participants. The Zutphen Elderly Study 
(in 1993 and in 2000) was approved by the Medical Ethics Committee of the 
Netherlands Organization for Applied Scientific Research (TNO).  
Leukocyte telomere length measurement 
Non-fasting blood samples were collected in the morning. The samples were 
kept cool in a box with cooling elements, and plasma and serum were obtained 
in the afternoon. Samples were stored in Zutphen at –30 ºC before transport to 
the National Institute for Public Health and Environment (RIVM), Bilthoven, the 
Netherlands, which took place within a few days after collection. After arrival at 
the RIVM, all samples were stored at –80ºC until analyses. An aliquot of 200 µl 
of buffy coat was used to extract genomic DNA with the QIAamp DNA Mini Kit 
(Qiagen, Venlo, The Netherlands) according to the manufacturer’s protocol. The 
DNA was quantified using a Nanodrop instrument (Isogen Life Science, 
Belgium).  
LTL was determined by quantitative polymerase chain reaction (qPCR) as 
described previously [21,22]. Two master mixes were prepared, one with 
telomere primers and one with Human β globin (HBG) primers (1x IQ SYBRgreen 
supermix from BioRad, CA, USA). To confirm reproducibility of the applied 
method, we repeated for 20 samples the leukocyte LTL measurement by using 
an additional reference gene, acidic ribosomal phosphoprotein PO (36B4), 300 
nM forward primer (5’-CAGCAAGTGGGAAGGTGTAATCC -3’), 500nM reverse 
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primer (5’- CCCATTCTATCATCAACGGGTACAA -3’). Sample DNA was pipetted in a 
96-wells plate at a final concentration of 10 ng/µl. Subsequently, 20µl of the 
mastermix was added and the plate was shortly centrifuged. Each sample was 
run in triplicates. The coefficient of variation for the triplicates of the telomere 
reaction was 4.11% and for the reference gene 3.03%. For the standard curve a 
reference DNA sample was diluted serially to produce three concentrations of 
1.25, 5, and 10 ng/µl. In every run, negative controls (MQ + mastermix) and 
reference samples were included. The references were derived from two 
different Hela cell lines, one with relatively short telomeres (Hela S3: 5.5 kb) 
and one with long telomeres (Hela 229: 14-15 kb). Hela cell lines were kindly 
provided by Prof. Alexander Bürkle, University of Konstanz, Germany. Thermal 
cycling profile of the PCR protocol were as follows: Telomere PCR: cycle 1 (1x): 
95°C for 03.00, cycle 2 (30x):  95°C for 00.15 and 54°C for 02.00, cycle 3 (1x): 
95°C for 01.00, cycle 4 (1x): 65°C for 01.00 and cycle 5 (60x): 65°C for 00.10 
(melt curve). HBG PCR: cycle 1 (1x): 95°C for 03.00, cycle 2 (40x):  95°C for 00.15 
and 58°C for 01.00, cycle 3 (1x): 95°C for 01.00, cycle 4 (1x): 65°C for 01.00 and 
cycle 5 (60x): 65°C for 00.10 (melt curve). The polymerase chain reaction (PCR) 
was performed using a BioRad MyiQ iCycler Single Color RT-PCR detection 
system using iQTM SYBR® Green Supermix, containing iTaq Polymerase, dNTPs, 
SYBRGreen I, and buffers (BioRad, CA, USA). 
Collection of data on lifestyle and history of chronic diseases 
Information on cigarette smoking was collected by standardized questionnaires. 
Information about habitual consumption of foods, including alcohol, coffee and 
tea beverages, was collected in 1993 by using the cross-check, dietary history 
method, adapted to the Dutch food consumption pattern [23]. During a physical 
examination, height and body weight were measured according to standardized 
procedures. Body mass index (BMI) was calculated by dividing weight (kg) by 
the square of the height (m2). As a sedentary lifestyle was associated with 
shorter LTL [24], a validated questionnaire on physical activity designed for 
retired men (that participants were asked to complete at home) was used to 
calculate the total minutes spent in physical activity per week [of an intensity of 
more than 2 kcal/(kg•h)] [25]. Information on marital status (dichotomized) and 
education (dichotomized into lower and higher education, the later defined as 
higher vocational education, college, or university) was obtained by a self-
administered questionnaire. The prevalence of chronic diseases such as 
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cardiovascular diseases, cancer, and the presence of diabetes mellitus was 
assessed by questionnaire and verified by information from general 
practitioners. Information on the vital status of the participants until July 1, 
2000 was obtained from municipal population registries and the participants' 
general practitioners. Information was verified with either hospital discharge 
data or information from the Netherlands Cancer Registry. The initial coding of 
the causes of death was done by 3 physicians and the final coding by an 
experienced clinical epidemiologist, who was unaware of the outcome of the 
LTL measurement. CVD was defined as codes 390 to 459 as the primary cause of 
death according to the International Classification of Diseases, Ninth Revision 
(ICD-9), and cancer as codes 140–172 and 174–208 (referring to malignant 
neoplasm, except non-melanocytic skin cancers).  
Statistical analysis 
All data are presented as number (percentage), mean ± SD, or median, when 
appropriate. The baseline characteristics of the participants were compared 
according to tertiles of LTL by using the one-way analysis of variance or the chi-
square test, when appropriate. The mean LTL shortening over 7 years was 
estimated using a t-test for paired samples. The Pearson’s correlation 
coefficient was used to analyse LTL data from 1993 and 2000. Although we 
tested for normality, and this showed a near normal distribution, the analyses 
with mortality were performed with tertiles of LTL, in which a normal 
distribution is of minor importance. The Kaplan-Meier method was used to 
present crude all-cause mortality and cause-specific mortality. Hazard ratios 
with 95% confidence intervals (CI) of all three endpoints were estimated by Cox 
proportional hazards models. Three multivariate models were tested. First, we 
tested the association in a crude model. Subsequently, two additional 
multivariable models were tested. Model 1 adjusted for age, and in model 2 we 
additionally adjusted for potential confounders such as smoking [26,27], alcohol 
use [28], BMI [27], education (and the related socioeconomic status) [29], 
marital status, physical activity [30] and the presence of chronic diseases 
[6,22,31-35], since they were associated with TL in previous studies [9,14,22].  
Furthermore, we performed two sensitivity analyses in which we first 
repeated the Cox proportional hazards models using data from 193 men who 
died after a lag time of 1 year of follow-up, excluding 10 subjects who had died 
within the first year of follow-up, and subsequently using data from 144 men 
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without a history of chronic diseases. Tests of linear trend across increasing 
tertiles of LTL were performed by using the median values of LTL for each 
tertile. Two-tailed p < 0.05 was considered statistically significant. Statistical 
analyses were performed with SPSS for Windows (SPSS 17.0; SPSS Inc, Chicago, 
IL, USA). 
Results 
Sociodemographic and clinical characteristics at baseline are presented in Table 
1. The mean age at baseline was 78 years (range: 73-91 years). During 7 years of 
follow-up, 105 men died (51.7%), of whom 45 (42.9%) from cardiovascular 
causes, 36 (34.3%) from cancer (of whom 12 from lung cancer). The 75 surviving 
and participating men had an average age of 83.1 years (range: 79-92) in 2000. 
No association was found of sociodemographic and lifestyle factors with tertiles 
of LTL. 
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Table 1. Sociodemographic and lifestyle factors of 203 Dutch men from Zutphen in 1993 according 
to tertiles of leukocyte telomere length    
 Telomere length in 1993  
 Tertile 1 Tertile 2 Tertile 3 P-value for trend* 
No of participants 67 68 68  
Telomere length (Kbp), 
median (range) 
4.6 (3.8-4.8) 5.0 (4.8-5.2) 5.5 (5.2-6.4) – 
Age (years), mean ± SD 78.8 ± 4.1 78.5 ± 4.7 78.1 ± 4.1 0.38 
Education, n (%) 
Lower 51 (78.5%) 51 (77.3%) 51 (83.6%) 0.48 
Higher 14 (21.5%) 15 (22.7%) 10 (16.4%)  
Marital status, n (%) 
Unmarried 16 (23.9%) 20 (29.9%) 17 (26.2%) 0.76 
Married 51 (76.1%) 47 (70.1%) 48 (73.8%)  
Smoking status, n (%) 
Never 15 (23.8%) 6 (9.5%) 11 (17.5%) 0.5 
Former 32 (50.8%) 36 (57.1%) 35 (55.6%)  
Current 16 (25.4%) 21 (33.3%) 17 (27.0%)  
Alcohol intake, n (%) 
0 g/d 21 (34.4%) 13 (21.0%) 10 (16.1%) 0.28 
1-19 g/d 29 (47.5%) 43 (69.4%) 45 (72.6%)  
≥ 20g/d 11 (18.0%) 6 (9.7%) 7 (11.3%)  
Coffee, non-users 2 (3.2%) 2 (3.1%) 1 (1.6%) 0.56 
Tea, non-users 7 (11.5%) 5 (8.8%) 5 (8.3%) 0.8 
Self-rated health, n (%) 
Healthy 25 (37.3%) 27 (40.3%) 32 (47.1%) 0.25 
Unhealthy 42 (62.7%) 40 (59.7%) 36 (52.9%)  
Chronic diseases†, n (%) 22 (32.8%) 20 (29.4%) 17 (25.0%) 0.32 
Body Mass Index, mean ± 
SD 
25.7 ± 2.9 25.7 ± 2.9 25.7 ± 2.9 0.96 
Physical activity 
(min/week) 
540 (45; 
1170) 
480 (111; 
1176) 
518 (81; 1599) 0.63 
Data are presented as n(%), mean (± SD) or median (percentiles P10; P90), when appropriate.  
* P-values for linear trend based on chi-square test for categorical variables, F-test for continuous 
variables. 
† Chronic disease was defined as having either a cardiovascular disease (myocardial infarction, 
stroke, heart failure), cancer or diabetes mellitus. 
 
We analyzed paired DNA samples from 75 individuals (elderly men), which were 
collected in 1993 and in 2000. The mean LTL in 1993 was 5.03 kbp, whereas the 
mean LTL in 2000 was 4.76 kbp. The mean decline in leukocyte LTL during 7 
years of follow-up was 40.2 bp per year (95% confidence interval [CI]: 26.9-53.5; 
p<0.001). Although most individuals showed a decrease in TL, for 12 subjects 
(16%) we found an increase. Pearson’s correlation coefficient showed a 
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moderately strong relationship between LTL in 1993 and 2000 in 75 men 
(r=0.51; p<0.001) (Figure 1).  
 
 
Figure 1. Relationship between leukocyte telomere length in 1993 and 2000 for 75 elderly men. 
 
Results from the Kaplan-Meier analysis of survival according to LTL are depicted 
in Figure 2. No statistically significant differences in all-cause, cardiovascular or 
cancer mortality were found in relation to LTL tertiles. 
 
 
Figure 2. Kaplan-Meier analysis of survival according to the tertiles of leukocyte telomere length 
status in 203 Dutch men. In log-rank overall tests, men with a shorter telomere length had similar 
survival rates as compared to men with a longer telomere length. 
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Table 2 summarizes the results of the survival analysis according to tertiles of 
LTL. Again, LTL was not related to all-cause mortality. Both cardiovascular and 
cancer mortality were not related to LTL. Results from the sensitivity analyses 
with a lag time of 1 year showed no indication of a potential reverse causation 
owing to pre-existing chronic diseases (data not shown).  
 
Table 2. Hazard ratios of mortality for 203 elderly men according to tertiles of leukocyte telomere 
length 
 Telomere length in 1993    
 Tertile 1 Tertile 2 Tertile 3 P-value for trend * 
No of participants 67 68 68  
All-cause mortality: 
No. of cases 34 (50.7%) 32 (47.1%) 39 (57.4%)  
Crude 1 0.89 (0.55-1.44) 1.16 (0.73-1.83) 0.49 
Model 1 1 0.86 (0.53-1.40) 1.24 (0.78-1.96) 0.33 
Model 2 1 1.19 (0.70-2.03) 1.50 (0.87-2.58) 0.14 
Cardiovascular disease mortality: 
No. of cases 17 (25.4%) 15 (22.1%) 13 (19.1%)  
Crude 1 0.83 (0.42-1.67) 0.77 (0.37-1.58) 0.47 
Model 1 1 0.82 (0.41-1.65) 0.81 (0.39-1.67) 0.57 
Model 2 1 0.92 (0.44-1.94) 0.92 (0.40-2.14) 0.84 
Cancer mortality: 
No. of cases 12 (17.9%) 10 (14.7%) 14 (20.6%)  
Crude 1 0.78 (0.34-1.81) 1.18 (0.54-2.54) 0.63 
Model 1 1 0.77 (0.33-1.78) 1.25 (0.58-2.70) 0.53 
Model 2 1 1.12 (0.45-2.75) 1.39 (0.56-3.44) 0.47 
 
 * P-value for trend refers to a linear trend across tertiles of telomere length using the median 
values of each tertile.     
Crude: unadjusted in Cox proportional-hazards models,     
Model 1: adjusted for age,     
Model 2: additionally adjusted for smoking status, alcohol use, BMI, education, marital status, 
physical activity, and chronic diseases.  
      
Discussion 
In a prospective analysis among elderly men, we observed a substantial 
decrease in mean LTL per year between 1993 and 2000. LTL measured in 1993 
was strongly correlated with LTL measured in 2000. LTL was not related to all-
cause or disease specific mortality.  
Telomere length and mortality in elderly men: the Zutphen Elderly Study 
 71 
In previous cross-sectional studies the decrease in average TL ranged 
from 31-63 bp/year [36-40], and in prospective studies a mean decrease of 38-
71 bp/year was observed [8,13,14]. These studies included different study 
populations (i.e. premenopausal women, patients with colorectal carcinomas 
and healthy subjects) with a mean age ranged from 31.4-75 years. These results 
were in accord with the 40 bp average decrease in LTL per year in the present 
study. For 16 % of the subjects we found an increase in TL, which is consistent 
with five other prospective studies.  In about 10-34% of the subjects in these 
studies, a stabilization or increase in TL was observed with a time interval 
ranging from 2.5-12.9 years [8,13,14,41,42]. However, these results should be 
interpreted with caution because of random variation. 
With increasing age telomeres shorten, but they are also influenced by 
oxidative stress [43,44]. Several inflammatory diseases, such as cardiovascular 
diseases and cancer have been linked to chronic oxidative stress and 
accelerated telomere shortening [6,16]. Therefore, we hypothesized LTL is a 
marker for all-cause or cause-specific mortality, but this was not found in the 
present analysis. Likewise, three studies with similar study populations, e.g. 
elderly and the oldest old and similar follow-up periods, found also no 
association between TL and mortality [41,42,45]. A possible explanation for 
these negative findings might be that there is a higher degree of TL instability in 
the oldest old compared to younger populations.  In two recent studies carried 
out in younger populations an inverse association was observed between TL 
and survival [13,14]. Also in studies carried out in patients with coronary artery 
disease, diabetes or stroke survivors an association was found between TL and 
survival [3,9,12]. Other differences between the present study and the ones 
showing an association were: follow-up period (varying from 2.5 to 15 years), a 
higher number of participants (ranging from 510 to 1542 subjects) 
[6,9,13,14,46] and the method used to determine TL [3,5,7,8,12,46].  
In a study by Halaschek-Wiener et al. TL was measured in exceptionally 
healthy elderly. They concluded that there was less TL variation in the healthy 
oldest old when compared to younger subjects [47]. In the study by Cawthon et 
al. it was concluded that TL was a significant predictor of mortality for subjects 
aged 60-74 years, but in the older age group (of 75 years or older) this 
association was not significant. In the present study, LTL was determined with 
the same method as in the study by Cawthon [7]. These data support our 
findings that in the oldest old LTL is not related to mortality.  
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Shorter TL in leukocytes has been associated with CVD [8] and its risk 
factors, such as myocardial infarction [48] although not in all studies [49]. LTL 
has also been shown to predict myocardial infarction and stroke in men under 
73 years old [15] and shorter length of telomeres was shown to predict the 
occurrence of death or hospitalization in patients with chronic heart failure 
[50]. However, other studies, notably those with elderly cohorts, have failed to 
find an association between LTL and mortality [41,45]. In the present study we 
were also not able to find an association between LTL and CVD mortality. In 
previous studies, a positive instead of an inverse relationship was noted 
between long telomeres and risk of death through cancer for breast cancer 
[20], skin cancer [19], and non-Hodgkin lymphoma [16]. A possible explanation 
for this association may be that cancer is associated with increased telomerase 
activity that lengthens telomeres [51], which is normally very low or absent in 
somatic cells [52]. In the present study LTL was not related to total cancer.  
Potential limitations of our study should be considered. The Zutphen 
Elderly Study cohort is a random sample of the general population of white, 
Dutch elderly men, which may limit the generalizability of our findings to other 
ethnic groups, to women, and men of younger age. TL was determined in the 
total white blood cell population (WBC), which may not accurately reflect TL 
dynamics. Lymphocytes showed a greater age-related decline in TL [53] and 
recently it was shown that subpopulations of lymphocytes display differences in 
TL and in telomerase activity [54]. Determining TL in specific subpopulations of 
lymphocytes may therefore better reflect the age-related shortening of 
telomeres. For the individual diseases the number of subjects was too small and 
therefore we combined all cardiovascular diseases and all different types of 
cancer, but these endpoints were not related to LTL. This study has also several 
strengths. The high reliability of our TL analysis was confirmed in 20 samples 
with a different reference gene (reliability coefficient of 0.87, p<0.001), 
rendering potential fragmentation or loss of DNA during isolation unlikely. 
Finally, we had an almost complete mortality follow-up and could estimate the 
LTL shortening over 7 years of follow-up, whereas previous studies used mostly 
cross-sectional designs. 
In conclusion, our data showed that the average telomere shortening is 
40 bp per year in elderly men and LTL measured 7 years apart was strongly 
correlated. On the other hand we did not confirm the hypothesis that LTL is a 
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marker for mortality in elderly men. Future studies should focus on TL 
measurement in populations with a wider age range. 
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Abstract 
Chronic oxidative stress and systemic inflammation contribute to the pathology 
of several chronic diseases, among which chronic obstructive pulmonary 
disease (COPD). In addition, increased oxidative stress and inflammation have 
been observed to be negatively associated with telomere length (TL). Our aim 
was to investigate TL in COPD patients in relation to pulmonary and 
extrapulmonary disease severity. Furthermore, based on experimental evidence 
suggesting effects of oxidative stress on telomere shortening, we studied the 
association of TL with the antioxidant enzyme superoxide dismutase (SOD). 102 
COPD patients with moderate to severe COPD were studied and compared with 
19 healthy age matched controls. Patients were characterized by elevated levels 
of inflammatory markers (CRP, sTNF-receptors) and lower SOD-activity than 
controls (p<0.001), irrespective of SOD genotype. TL was negatively associated 
with age (p<0.01) and was significantly shorter in COPD patients than controls 
(p<0.05). Within the patient group age-adjusted TL variability could not be 
explained by lung function and smoking history but a modest association was 
found with percentage fat mass (p<0.05). These data provide evidence for a 
relationship between a disturbed oxidant/antioxidant balance and telomere 
shortening and indicate that preservation of fat mass may be protective in 
delaying telomere shortening in COPD patients. 
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Introduction 
Chronic systemic oxidative stress plays a major role in the pathophysiology of 
chronic obstructive pulmonary disease (COPD) [1]. COPD is characterized by 
incompletely reversible airflow obstruction associated with pulmonary 
inflammation in which monocytes and macrophages are the predominant 
inflammatory cells [1]. Tobacco smoking is the main risk factor for COPD. 
However, for reasons that are still poorly understood, only a small proportion of 
smokers eventually develops COPD [2]. Moreover, in COPD patients oxidative 
stress, resulting from an imbalance between the production of reactive oxygen 
species and the antioxidant defense, has been implicated with disease 
progression and complications such as cachexia [3]. Wasting of fat-free mass 
and at later stages also of fat mass is a common systemic impairment in COPD, 
adversely affecting functionality, morbidity and prognosis.  
In addition, several animal and in vitro models have shown that chronic 
oxidative stress induces an accelerated rate of telomere loss [4-6]. Telomeres 
are nucleoprotein structures at the end of chromosomes and consist of 4-15 
kbp of the hexanucleotides 5’-TTAGGG-3’ [6, 7]. Telomeres prevent 
chromosomal ends from being recognized as double strand breaks and protect 
them from end to end fusion and degradation [8]. In somatic cells, telomeres 
shorten with each cell division and cells are triggered into replicative 
senescence once telomeres shorten to a critical length [9, 10]. Since telomere 
length (TL) in somatic cells determines the number of cell divisions, TL has been 
proposed as a marker for biological age.  
Since cell division appeared to account only partially for the loss of 
telomeres seen in cells, it was suggested that other mechanisms, in particular 
oxidative stress, might be involved in accelerated telomere shortening [6, 11, 
12]. Recent studies indeed have linked telomere shortening to various chronic 
metabolic and inflammatory diseases such as atherosclerosis, diabetes type I 
and inflammatory bowel disease, conditions that are all characterized by 
systemic oxidative stress  [13-17]. Animal studies and in vitro models have 
shown that the antioxidant enzyme superoxide dismutase (SOD) may protect 
telomeres from shortening [4, 18]. We therefore hypothesized that telomere 
shortening might be accelerated in patients with COPD and serve as a 
biomarker of disease progression, and more specifically of the risk for muscle 
wasting.  
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The aim of this study was twofold. First, we wanted to investigate TL in 
COPD patients in relation to cachexia and muscle wasting. Since experimental 
evidence suggested that oxidative stress is an important determinant of 
telomere shortening, our second aim was to study the association of TL with the 
major antioxidant enzymes SOD and catalase. For this purpose, we measured TL 
in leukocytes of 102 COPD patients and compared these to 19 healthy, age-
matched controls. TL was measured using quantitative PCR [19]. In addition, 
SOD and catalase activity were determined as well as the V16A polymorphism 
in the gene encoding MnSOD.  
Subjects and Methods 
Study population  
One hundred and two clinically stable COPD patients with stage II-IV according 
to the Global Initiative for Chronic Obstructive Lung Disease guidelines were 
consecutively recruited on admission to a pulmonary rehabilitation center 
(CIRO, Horn, The Netherlands). Exclusion criteria were the presence of diseases 
such as malignancies, gastrointestinal or kidney abnormalities, metabolic or 
endocrine diseases and inflammatory diseases such as diabetes. Most patients 
were using medication to treat symptoms of the disease, including 
anticholinergica, β2-agonists, theophylline and inhaled- and oral 
corticosteroids. Written informed consent was obtained from all participants, 
and the study was approved by the ethical review board of the University 
Hospital Maastricht. Twenty healthy Dutch volunteers, gender- and age-
matched, were recruited by an advertisement in a local newspaper. 
Characteristics of the patients and healthy controls are listed in Table 1. Part of 
the data used in this study has been described elsewhere [20].  
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Table 1. Definition of abbreviations: HC: healthy controls 
 COPD HC 
Sex, M/F 71/31 15/5 
Age, yr 62.9   ± 9.3 60.7 ± 3.5 
Packyears of smoking 36.3   ± 23.1a 13.3 ± 18.0b 
Body composition 
FFMI 16.5   ± 2.2a 20.2   ± 2.5b 
FM (kg) 16.7   ± 6.6 16.4   ± 7.5 
BMI, kg/m2 22.3   ± 3.8a 25.7 ± 2.8b 
Lung function 
FEV1, % predicted 34.6   ± 13.5a 105.4 ± 16.1b 
DLCO, % predicted 49.2   ± 19.9a 109.6 ± 22.8b 
Medication 
Anticholinergics, % 76  
b2-agonists, % 86  
Inhaled corticosteroids, % 81  
Oral corticosteroids, % 30  
Theophylline, % 37  
Inflammation markers 
C-reactive proteinc 3.5 (0.4, 75.6)a 1.82 (0.16, 7.09)b 
sTNFR 1.02  ± 0.38a 0.91  ± 0.21b 
FEV1: forced expiratory volume in 1 s; DLCO: diffusing capacity for carbon monoxide. Data are 
presented as mean ± SD and tested with one-factor analysis of variance (ANOVA). Values not 
sharing a common superscript letter (a, b) are significantly different at p<0.05. c Values are median 
(range) and tested with the Mann-Whitney test. 
Pulmonary Function Tests  
All participants underwent flow volumes including measurement of FEV1 with 
the highest value from at least three properly performed measurements being 
used for analysis. Diffusion capacity for carbon monoxide (DLco) was measured 
by using the single breath method (Masterlab, Jaeger, Wűrzburg, Germany).  
The values obtained were expressed as a percentage of the reference value 
[21]. 
 
Body composition 
Body composition was estimated using single frequency (50kHz) bioelectrical 
impedance analysis (BIA; Xitron Technologies, San Diego, CA, USA). Fat-free 
mass (FFM) was calculated using the disease-specific equation proposed by 
Schols [22] and FFM of healthy controls was calculated using the equations of 
Lukaski [23]. FFM-index (FFMI) was calculated as FFM divided by height2 
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(kg/m2). Patients were classified as cachectic when their FFMI was lower than 
16 kg/m2 for men and lower than 15 kg/m2 for women. Fat mass (FM; kg) was 
estimated as total body weight minus FFM. 
Sample preparation 
Fasting venous blood samples (10 ml) were drawn into 
ethylenediaminetetraacetic acid (EDTA)-containing tubes (Becton Dickinson 
Vacutainer Systems, Plymouth, UK) in the early morning (08.00-09.00 hours). 
After centrifugation twice at 1000 x g for 10 minutes at 4°C within 2 hours of 
collection, plasma for CRP and white blood cells for DNA extraction were stored 
at -70ºC. Genomic DNA was extracted from the white blood cells by a salting 
out procedure [24]. The remaining red blood cells were washed twice with PBS. 
The hemolysates were diluted 10:1 with distilled water.  
TL measurement  
TL was determined by quantitative PCR as described by Cawthon [19]. From 7 
patients and 1 healthy subject, no PCR results could be obtained, due to poor 
quality of the DNA. Two master mixes were prepared, one with telomere 
primers and one with HBG primers (1x IQ SYBRgreen supermix from BioRad, CA, 
USA). Sequences and concentrations of the primers are shown in Table 2.  
 
Table 2. Primer sequences and concentrations 
Primer Sequence Concentration 
Telomere 1 CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT 100 nM  
Telomere 2 GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTACCCT 900 nM  
HBG forward GCTTCTGACACAACTGTGTTCACTAGC 300 nM  
HBG reverse CACCAACTTCATCCACGTTCACC 700 nM  
 
Sample DNA was pipetted in a 96-wells plate at a final concentration of 10 
ng/µl. 20µl of the mastermix was added and the plate was shortly centrifuged. 
Each sample was run in triplicates. For the standard curve a reference DNA 
sample was diluted serially to produce three concentrations of 1.25, 5 and 10 
ng/µl. Negative controls (MQ + mastermix) and positive controls were added 
every run. The positive controls were derived from two different Hela cell lines, 
one with relatively short telomeres (Hela S3: 5.5 kb) and one with long 
telomeres (Hela 229: 14-15 kb). Hela cell lines were kindly provided by Prof. 
Alexander Bürkle, University of Konstanz, Germany. The PCR was performed 
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using a BioRad MyiQ iCycler Single Color RT-PCR detection system using iQTM 
SYBR® Green Supermix, containing iTaq Polymerase, dNTPs, SYBRGreen I and 
buffers (BioRad, CA, USA).  
Superoxide dismutase (SOD) and catalase acitivity 
Hemoglobin (Hb) concentration in the 1:10 hemolysates was determined 
spectrophotometrically based on the the cyanomethemoglobin method . 
SOD-activity was determined according to the method of Sun et al [25]. 
This method is based on the generation of superoxide radicals produced by 
xanthine and xanthine oxidase, which react with nitro-blue tetrazolium (NBT) to 
form a NBT-diformazan. SOD was extracted in chloroform:ethanol mixture in 
the ratio of 0.15:0.25, shaken for 15 min and centrifuged at 2500g for 5 min at 
4°C and the supernatant was used for the assay. The reaction mixture was 
composed of 20 μl sample, 930 μl of substrate containing 0.5 mM xanthine 
(Sigma, St. Louis, USA), 0.5 mM NBT (Sigma, St. Louis, USA) in buffer and 40U/l 
of xanthine oxidase (Sigma, St. Louis, USA),. One unit of SOD was defined as the 
amount of enzyme necessary to produce 50% inhibition in the NBT reduction 
rate. SOD-activity was measured at 560 nm and expressed as units per 
milligram Hb. 
The catalase activity was measured according to Aebi [26] in reaction 
mixture containing 20 μl heamolysate in 100 mM phosphate buffer (pH 7.4). 
The reaction was started by addition of H2O2 (Merck, Germany) at a final 
concentration of 10 mM, and the rate was measured spectrophotometrically at 
240 nm (Perkin Elmer Lambda-series) for 1 min at 25°C. One unit of catalase 
activity was defined as the amount of catalase absorbed in 1 min at 25°C. The 
catalase activity was then calculated from the change in absorbance and finally 
expressed as U/g Hb. 
C-reactive protein (CRP) 
CRP was assessed in duplicate by high-sensitivity particle-enhanced 
immunonephelometry (N Hs CRP, Dade Behring). 
Polymorphism selection 
DNA sequence and allele frequency was obtained from the Cancer SNP 500 
database (http://snp500cancer.nci.nih.gov). 
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Genotyping of polymorphism 
Genotyping was performed on the DNA of the white blood cells of 84 COPD 
patients and 18 controls according to the validated method for genotyping [27, 
28]. PCR Primers MnSOD: Left 5’-GGTGACGTTCAGGTTGTTCA-3’; Right 5’-
GGCTGTGCTTTCTCGTCTTC-3’. 
The PCR was carried out in a T-gradient 96-well Thermal cycler 
(Biometra, Goettingen, Germany) in a 10 μl volume, containing PCR buffer 
(Invitrogen, Breda, The Netherlands), 0.2 mmol/l deoxynucleotide 
triphosphates (Invitrogen), and 40 ng template DNA. The final concentration of 
the primers was 0.1 μM/l. Afterwards, PCR products were incubated with 4 μl 
Exo-Sap-IT (Amersham, Roosendaal, The Netherlands) for 55 minutes at 37ºC to 
digest contaminating deoxynucleotide triphosphates and PCR primers. Enzymes 
were deactivated at 72ºC for 15 minutes. Genotyping was done by Single Base 
Extension (SBE) using SNaPshot (Applied Biosystems, Nieuwekerk a.d. IJssel, The 
Netherlands) as described previously [28]. SBE primers were designed using 
Primer 3 and Netprimer software to bind immediately adjacent 5’ to the specific 
SNP. SBE primer: 5’-CCTGGAGCCCAGATACCCCAAA-3’. After SBE, the samples 
were incubated at 37ºC for 1 hour with 1 unit shrimp alkaline phosphatase 
(Amersham) to degrade the unincorporated dideoxynucleotide triphosphates. 
Afterwards, SBE products were diluted and mixed with deionized formamide 
containing Genescan 120 LIZ size standard and denatured at 95ºC for 5 minutes. 
Subsequently, the samples were analyzed on an ABI Prism 3100 genetic 
analyzer using Genescan Analysis software.  
Statistical analysis 
Results are expressed as mean ± SD for all variables that were normally 
distributed, and as median (range) when not-normally distributed. Differences 
between COPD patients and healthy controls were tested using Student’s t-test 
for independent samples and the Mann Whitney U-test when not-normally 
distributed. Differences in the distribution of the genotypes between groups 
were examined by using the χ2 test. To study determinants of TL in COPD, 
multiple regression analysis was conducted with TL as the dependent variable 
and gender, age, CRP, smoking history (in packyears), parameters of body 
composition and SOD-activity as independent variables. A difference with 
p<0.05 was considered statistically significant. Statistical analyses were 
analyzed with SPSS for Windows (version 13.0; SPSS, Inc., Chicago, IL).  
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Results 
General characteristics of the subjects are shown in Table 1. COPD patients 
were characterized by lower values for FEV1, DLCO and FFMI (p<0.001) than the 
control group. COPD patients had shorter telomeres when compared to the 
control group (p<0.05; Figure 1A). Age negatively correlated with TL in patients 
(r = 0.079, p<0.05 ; Figure 2) and in controls (r = 0.145, p = 0.108; Figure 2). No 
associations of smoking history, lung function parameters, FFMI or CRP could be 
found with TL. COPD patients had lower levels of SOD-activity than healthy 
controls (p<0.001; Figure 1B). The distribution of SOD genotypes among 
patients and healthy controls is shown in Table 3.  
 
A.     B. 
 
Figure 1. Telomere length in white blood cells (A) and SODactivity (B) in red blood cells in healthy 
controls (HC), and COPD patients (*p < 0.001; **p < 0.05). Significantly different between the 
different groups based on Student’s t-test. Results are expressed as mean SEM. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Relationship between 
telomere length and age for healthy 
controls and patients. Telomere 
length significantly correlated with 
age in patients (rZ0.079; p < 0.05) 
and in the total study population 
(rZ0.087; p < 0.01). 
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Table 3. Distribution of genotype of COPD patients and controls. 
  COPD  HC  
  n   % n % 
MnSOD Total 84   18 
 TT 25 29.8 4 22.2 
 TC 34 40.5 8 44.4 
 CC 25 29.8 6 33.3 
Genotype T>C Effect polymorphism:  
  Decreased enzyme activity: less efficient antioxidant defense 
 
There was no significant association between SOD activity and the SOD 
polymorphism, neither in patients nor in controls. Furthermore, we found a 
correlation between SOD-activity and TL in the complete study population 
(Figure 3A), which was not dependent on SOD-genotype. This association 
remained statistical significant after controlling for age, gender, disease state 
(patient or control), smoking history and CRP (Table 4).  
 
Table 4.  Regression model with telomere length as the dependent variable 
Variables p-value 
Age 0.001  
SOD activity 0.012  
Smoking (packyears) 0.151  
Gender 0.198  
Disease (patient/control) 0.054  
C-reactive protein 0.472  
 
Catalase activity was also measured and tended to be lower in COPD patients, 
but no significant differences or correlations were observed (data not shown).  
Within the patient group, after controlling for age and gender, TL 
variability could not be explained by lung function and smoking history, but a 
modest association was found with percentage fat mass (r = 0.25, p<0.05; 
Figure 3B). 
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A.                 B. 
 
 
Figure 3. Associations between telomere length and SOD-activity in healthy controls (rZ0.048; 
pZ0.368) and COPD patients (rZ0.018; pZ121) (A) and between telomere length and fat mass in 
COPD patients (B). SOD-activity positively correlated with telomere length in the complete study 
population after adjustment for age, gender, disease state (patient or control), smoking history and 
CRP (rZ0.049; p < 0.05). Fat mass positively correlated with telomere length in COPD patients after 
adjustment for age and gender (rZ0.25; p < 0.05). 
Discussion 
This study presents three observations that warrant further investigation in 
larger population studies. Patients with moderate to severe COPD were 
characterized by shorter telomeres of their leukocytes than healthy age-
matched controls, which previously was reported for other chronic 
inflammatory diseases as well [13-17]. In addition, we observed that TL was 
positively associated with SOD-activity. Furthermore, within the patient group 
fat mass-index (FMI) and fat percentage were positively associated with TL.  
In this study, TL in leukocytes of COPD patients and in healthy controls 
appeared not related to smoking exposure, which is in contrast to data 
presented by Morla et al. [29], who observed an effect of cumulative smoking 
exposure on TL in lymphocytes of both healthy smokers and COPD patients. 
Several factors may explain this discrepancy, such as different white blood cell 
fractions that were studied, the fact that Morla et al. included only males in 
their study, and the relatively small population sizes of both studies. The 
general conclusion, however, was that chronic exposure to oxidative stress 
from cigarette smoking significantly contributed to accelerated telomere loss 
[29]. In our study population, we observed a decreased SOD-activity and a 
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slightly decreased catalase activity in COPD patients when compared to healthy 
controls, indicating a reduced antioxidant defense in patients. Together with 
the observation that TL in leukocytes of COPD patients was significantly shorter 
than TL in leukocytes of healthy, age-matched controls, these data indicate that 
increased oxidative stress is contributing to shortening of telomeres. In 
addition, a positive correlation between SOD-activity and TL was found for the 
entire study population, providing the first evidence that antioxidant defenses 
protects against telomere shortening in a human population. Until now, this has 
only been observed in animal models and in vitro studies [4, 18].  
When COPD patients were analyzed as a separate group, however, the 
association between SOD activity and TL was not as strong as found for the 
entire group. Moreover, in the patient group FMI and fat percentage were 
positively associated with TL, indicating that fat mass may have a role in 
protecting telomeres from shortening in COPD patients. Recently, Mizoue et al. 
[30] reported that weight loss was associated with increased markers of 
oxidative DNA damage, which also indicated that preservation of body mass 
may be protective against oxidative DNA damage. Paradoxally, in normal adult 
populations shorter TLs and telomere attrition were recently reported to be 
positively associated with fat mass and insulin resistance [31, 32]. The positive 
association found between fat mass and TL in COPD patients in our study may 
point to a pleiotropic effect of fat mass; a higher fat mass is associated with an 
increased risk for diseases associated with metabolic derangements, but in 
patients with a chronic inflammatory disease a higher fat mass appears to be 
associated with a better protection against degenerative processes.   
 
In COPD patients no association was found between the FFMI and 
telomere shortening, which was a surprising finding since a low FFMI was 
earlier found to be an independent predictor of mortality in COPD [33]. 
Previously, it was observed that in athletes with exercise-associated fatigue, the 
TL of skeletal muscle tissue was dramatically shortened and the authors 
suggested that this might indicate an exhaustion of the proliferative capacity of 
satellite cells [34]. Loss of telomeres may affect the regenerative capacity of 
skeletal muscle tissue and enhance muscle wasting. It remains to be 
determined, however, whether TL in muscle tissue of COPD patients is reduced, 
and whether this relates to muscle wasting. 
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It should be noted that this study has potential limitations. The control 
group is rather small when compared to the number of COPD patients. Despite 
this limitation, a difference in telomere length was observed between the two 
groups. This may indicate that with a larger control population these 
differences are likely to be more distinct. Furthermore, we studied COPD 
patients that were entering a rehabilitation programme. Although we corrected 
in our analysis for disease severity (cachectic/non-cachectic), there is a 
possibility that the findings can be different for COPD patients outside the clinic, 
which tend to have milder disease symptoms.  We should also mention that the 
number of subjects studied for the genetic association is relatively small and 
might therefore, not be definitive. 
The data obtained in this study indicate a relationship between a 
disturbed oxidant/antioxidant balance and TL shortening in a human 
population. However, it still needs to be determined whether shorter telomeres 
are a cause or consequence of this disturbed balance.  Future, longitudinal 
studies are required to unravel the relationship between chronic oxidative 
stress and telomere shortening and the potential consequences for the 
pathophysiology of COPD.  
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Abstract 
Chronic obstructive pulmonary disease (COPD) is characterized by incompletely 
reversible airflow obstruction and chronic systemic oxidative stress and 
inflammation play a major role in the pathophysiology of COPD. Telomere 
length has been observed to be inversely associated with increased oxidative 
stress and inflammation. Since chronic oxidative stress plays a major role in 
COPD, telomere length is hypothesized to reduce at a faster rate in COPD.  
The first aim of this study was to investigate telomere length in COPD 
patients in relation to oxidative stress and inflammation. The second aim of this 
study was to investigate the effects of caffeine, coffee, tea and alcohol intake, 
on telomere length in COPD patients and healthy controls. For this purpose, we 
measured telomere length in PBMCs of 89 COPD patients and compared these 
with 93 healthy, (ex-)smoking controls. In addition, the cytokines IL-8, IL-6 and 
TNF-α were determined as well as CRP, SOD and plasma homocysteine.  
We found that telomere length was shorter in COPD patients compared 
to controls. Cytokine plasma levels as well as CRP and homocysteine plasma 
levels were increased in COPD patients and SOD activity was decreased, 
indicating elevated oxidative stress in COPD patients. In addition, this study 
provides a first indication of the possible beneficial effects of coffee 
consumption and negative effects of alcohol consumption on telomere length. 
Future studies should focus on interventions with dietary antioxidants or anti-
inflammatory compounds such as those found in coffee and their possible 
beneficial health effects in patients with chronic inflammatory diseases.  
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Introduction 
Chronic obstructive pulmonary disease  (COPD) poses a major health problem 
with its still increasing prevalence[1]. COPD is characterized by incompletely 
reversible airflow obstruction associated with pulmonary and systemic 
inflammation, as is evident from increased levels of pro-inflammatory 
cytokines[2-5]. C-reactive protein  (CRP) has also been found to be increased in 
COPD and is often used as a clinical marker of systemic inflammation[4,6]. 
Moreover, in COPD patients, oxidative stress, resulting from an imbalance 
between the production of reactive oxygen species  (ROS) and the antioxidant 
defense, has been implicated with disease progression [7]. 
We previously reported that COPD patients have shorter leukocyte 
telomeres than healthy control subjects [8] and this was recently confirmed by 
a study by Savale et al. [9]. Since telomere length (TL) in somatic cells 
determines the number of cell divisions, TL has been proposed as a marker for 
biological age. Furthermore, TL has been observed to be inversely associated 
with increased oxidative stress and inflammation [10-12]. Recent studies indeed 
have linked telomere shortening to various chronic inflammatory diseases, 
which are all characterized by systemic oxidative stress [13-17].  
Consumption of food ingredients that counteract chronic oxidative stress 
may influence TL in patients suffering from COPD. Recently, coffee consumption 
has been positively associated with lung function as determined by forced 
expiratory volume in one second (FEV1) values in healthy subjects[18]. Coffee 
contains several components that may have beneficial health effects[19], and it 
has been previously shown that caffeine metabolites have anti-inflammatory 
properties, which are capable of inhibiting the inflammatory response in mouse 
lungs and ex vivo in blood of COPD patients [20].  
The first aim of this study was to investigate telomere length in 
peripheral blood mononuclear cells (PBMCs) in COPD patients in relation to 
oxidative stress and inflammation. The second aim of this study was to 
investigate the effects of caffeine, coffee, tea and alcohol intake on TL in COPD 
patients and healthy (ex-)smokers.  
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Subjects and Methods 
Study population  
89 Clinically stable COPD patients were recruited at a pulmonary rehabilitation 
center (CIRO, Horn, The Netherlands)[21]. Exclusion criteria were the presence 
of inflammatory diseases such as diabetes. Most patients were using 
medication to treat symptoms of the disease, including anticholinergics, β2-
agonists, theophylline and inhaled- and oral corticosteroids.  
93 Healthy (ex-) smokers were recruited as control subjects through the 
COSMO study [22]. Inclusion criteria were: Caucasian origin, 40 years of age or 
older, smoking history of 10 pack-years or more, and no history of inflammatory 
diseases. Written informed consent was obtained from all participants, and the 
study was approved by the ethical review board of the University Hospital 
Maastricht.  
Consumption questionnaire 
A questionnaire was filled out by all participating subjects to collect data on 
consumption of caffeine containing products i.e. coffee, espresso, tea, coke, ice 
tea and energy drinks, and alcoholic beverages. During an interview this 
information was orally confirmed. Caffeine intake was estimated using caffeine 
data from Nawrot et al. [23] and from Casal et al. [24]. These data were also 
reported by the European Food Information Council (http://www.eufic.org/).  
Lung function dataIn all participants the forced expiratory volume in one 
second (FEV1) was measured, with the highest value from at least three 
properly performed measurements being used for analysis (Masterlab, Jaeger, 
Würzburg, Germany).  
Body composition 
Body composition was estimated using single frequency (50kHz) bioelectrical 
impedance analysis  (BIA; Xitron Technologies, San Diego, CA, USA). Fat-free 
mass  (FFM) was calculated using the disease-specific equation proposed by 
Schols [25] and FFM of healthy controls was calculated using the equations of 
Lukaski [26]. Fat mass (FM; kg) was estimated as total body weight minus FFM. 
Body mass index (BMI) was calculated by dividing weight  (kg) by the square of 
the height (m2). 
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Sample preparation 
Venous blood samples (8 ml) were drawn into sodium citrate-containing cell 
preparation tubes  (Becton Dickinson Vacutainer Systems, Plymouth, UK). 500 µl 
whole blood was stored at -80ºC until SOD analysis. After centrifugation at 1800 
x g for 20 minutes at room temperature within 2 hours of collection, plasma for 
cytokine analysis and PBMCs for DNA extraction were stored at -80ºC. Genomic 
DNA was extracted using the QIAamp DNA Mini Kit (Qiagen, Venlo, The 
Netherlands). 
TL measurement  
TL was determined by quantitative PCR as described previously [8,27]. From 4 
patients no PCR results could be obtained, due to poor quality of the DNA.  
Two master mixes were prepared, one with telomere primers and one 
with Human β globin (HBG) primers (1x IQ SYBRgreen supermix from BioRad, 
CA, USA). Negative controls (MQ + mastermix) and reference samples with 
known TL were added to every run. The PCR was performed using a BioRad RT-
PCR detection system using iQTM SYBR® Green Supermix, containing iTaq 
Polymerase, dNTPs, SYBRGreen I and buffers (BioRad, CA, USA).  
Superoxide dismutase  (SOD) activity  
SOD-activity and hemoglobin (Hb) concentrations were determined as 
described previously [8]. SOD-activity was determined according to the method 
of Sun et al., which is based on the generation of superoxide radicals produced 
by xanthine and xanthine oxidase, which react with nitro-blue tetrazolium (NBT) 
to form NBT-diformazan [28]. SOD-activity was expressed as units per milligram 
Hb. 
C-reactive protein (CRP) and cytokine analysis 
For the measurement of CRP concentrations, blood collected in EDTA tubes was 
centrifuged at 1000 x g; 4°C for 10 min. Aliquots of plasma were immediately 
stored at -80°C. CRP levels were measured using a latex-enhanced 
immunoturbidimetric assay (ABX Pentra CRP CP, ABX Diagnostics). The 
detection limit of this method was 0.23 mg/L. IL-6, IL-8 and TNF-α were 
quantified with the PeliKineTM ELISA kits (Sanquin, Amsterdam, the 
Netherlands). Assays were performed according to manufacturer’s instructions.  
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Homocysteine  
Total plasma homocysteine (tHcy) levels were measured by HPLC as described 
by Ubbink and Vermaak [29]. Briefly, 10 µL of Tri (2-carboxylethyl) phosphine, 
25 µL internal standard and 25 µL PBS was added to 50 µL sample. After mixing 
this was incubated for 30 minutes at room temperature. Samples were 
centrifuged and 50 µL was transferred to an autosampler vial containing 10 µL 
of 1.55M NaOH, 125 µL of 0.125M borate buffer (containing 4mM EDTA, pH 9.5, 
and 50 µL of SBD-F, 1 g/L in borate buffer). After mixing, the solution was 
incubated for 1 hour at 60ºC. 10 µL was injected onto a C18 column to run at a 
flow rate of 1.5 mL/min. 
Statistical analysis 
Results are expressed as mean ± SEM. Differences between COPD patients and 
healthy controls were tested using Student’s t-test for the independent samples 
and the Mann Whitney U-test when not normally distributed. The association 
between variables was evaluated using the non-parametric Spearman’s rank 
correlation coefficient. To study the determinants of TL in COPD and controls, 
multiple regression analyses were conducted (Table 2 and 3). To evaluate the 
differences in TL, homocysteine and SOD activity in different age groups, we 
stratified the subjects by age (40-55 years, 56-65 years and 66 years and older). 
A difference with p<0.05 was considered statistically significant. Statistical 
analyses were analyzed with SPSS for Windows (version 15.0; SPSS Inc., 
Chicago, IL, USA). 
Results 
The characteristics of the patients and healthy controls are listed in Table 1. 
Controls consumed more coffee than COPD patients and had also a higher 
caffeine intake. Tea consumption was higher in the COPD patients, whereas 
alcohol consumption was higher in the control subjects. COPD patients were 
characterized by lower values for FEV1 (p<0.001) and were significantly older 
(p<0.001).  
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Table 1. General characteristics of healthy controls and COPD patients 
 Healthy controls  COPD patients 
Gender M/F 41/52 51/38 
Age (years) 52.3 ± 0.77** 63.0 ± 0.97** 
Smoking  (packyears) 32.13 ± 1.4 41.0 ± 3.69 
BMI (kg/m2) 26.38 ± 0.43 26.37 ± 0.69 
CRP (mg/l) 3.47 ± 0.42** 7.42 ± 1.08**  
FEV1 3.13 ± 0.06** 1.42 ± 0.07** 
Medication 
Anticholinergics (%)  85  (95%) 
β2-Agonists (%)  44  (49%) 
Inhaled corticosteroids (%)  21  (24%) 
Oral corticosteroids (%)  20  (22%)  
Theophylline (%)  20  (22%) 
Coffee consumption (cups/day) 6.14 ± 0.39** 4.60 ± 0.39** 
Caffeine intake (mg/day) 427.11 ± 22.96 391.28 ± 24.96 
Tea consumption (cups/day) 0.84 ± 0.20* 1.38 ± 0.20* 
Alcohol consumption (glasses/day) 0.65 ± 0.05* 0.44 ± 0.05* 
Telomere length (kbp) 6.32 ± 0.08** 5.35 ± 0.05** 
Data are presented as mean ± SEM and tested with a Student’s t-test for independent variables or a 
Mann Whitney U-test when not normally distributed. 
** Significantly different between patient and controls (p < 0.001). * Significantly different between 
patient and controls (p < 0.02). 
   
COPD patients had shorter telomeres when compared to the controls (p<0.001; 
Figure 1A) and TL was negatively correlated with age (r = 0.122, p<0.01). When 
stratified into three different age groups, mean TL was found to be significantly 
shorter in COPD patients than in controls within the same age group (Figure 1B, 
C and D).  
 
A.     B. 
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C.     D. 
 
   
 
 
 
 
 
 
 
 
 
Figure 1. TL in PBMC’s in COPD patients and healthy controls (A). TL in COPD patients (n = 21) and 
healthy controls (n = 59) in the age group 40-55 (B); TL in COPD patients (n = 35) and healthy 
controls (n = 29) in the age group 56-65 (C); and TL in COPD patients (n = 33) and healthy controls (n 
= 5) in the age group 66 years and older (D). Results are expressed as mean ± SEM. ** Significantly 
different between the two groups based on Mann Whitney U-test (p<0.001).  
 
tHcy levels were significantly lower in healthy controls than in COPD patients  
(p<0.05; Figure 2A) and positively correlated with age (r = 0.083, p<0.01). When 
stratified in three age groups, the difference in tHcy between COPD patients 
and controls was less pronounced (Figure 2B, C and D).  
 
A.     B. 
          
 
 
 
 
 
 
 
C.          D. 
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Figure 2. Plasma homocysteine levels in COPD patients and healthy controls (A). Plasma 
homocysteine in COPD patients and healthy controls in the age group 40-55 (B); in the age group 
56-65 (C); and in the age group 66 years and older (D). Results are expressed as mean ± SEM.  
* Significantly different between the two groups based on Mann Whitney U-test (p<0.05).  
COPD patients had lower levels of SOD activity than healthy controls (p<0.01;  
 
Figure 3A). When stratified into three age groups, the differences in SOD 
activity between COPD patients and controls remained significant (Figure 3B, C 
and D). Although in the controls an age-associated decrease in SOD activity was 
found, this was not significant. In COPD patients there was no association 
between age and SOD activity. 
 
A.            B. 
  
 
 
 
 
 
 
 
 
 
C.             D. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. SOD activity in blood of COPD patients and healthy controls (A). SOD activity in COPD 
patients and healthy controls in the age group 40-55 (B); in the age group 56-65 (C); and in the age 
group 66 years and older (D). Results are expressed as mean ± SEM. * Significantly different 
between the two groups based on Mann Whitney U-test (p<0.05). ** Significantly different 
between the two groups based on Mann Whitney U-test (p<0.01) 
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COPD patients had significantly higher CRP levels than control subjects  
(Figure 4).  
 
Figure 4. Plasma CRP levels in COPD patients and healthy controls. Results are expressed as mean ± 
SEM. * Significantly different between the two groups based on Mann Whitney U-test (p<0.01).  
 
In all patients and controls, cytokine levels were detectable. Plasma IL-6 levels 
were significantly higher in COPD patients and the same trend was observed 
with TNF-α (Figure 5A and B). No difference was found for plasma IL-8 
concentrations between patients and controls (Figure 5C) and we also found no 
association between cytokine levels and age. When analyzing both groups 
combined or separately, no associations between TL and smoking history, FEV1, 
FM, FFM or CRP were observed. 
 
A.           B. 
 
 
 
 
 
 
 
 
C.  
     Figure 5. Plasma IL-6 (A), TNF-α  (B) and IL-8 
     (C) levels in COPD patients and healthy  
     controls. Results are expressed as mean ±  
     SEM. * Significantly different between the  
     two groups based on Mann Whitney U-test 
     (p<0.05).
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In both the control group and the COPD group, coffee consumption was positively associated with 
TL and alcohol consumption was negatively associated with TL (Figure 6A and B), which remained 
after adjusting for age, gender, packyears, BMI, FEV1, and caffeine intake.  
 
A.                     B. 
             
Figure 6. Correlation between coffee consumption and TL in healthy controls (r = 0.062; p = 0.017) 
and COPD patients (r= 0.046; p = 0.061)  (A). Correlation between alcohol consumption and TL in 
healthy controls (r = 0.019; p = 0.114) and COPD patients (r = 0.066; p = 0.01) (B). The association 
between variables was evaluated using the non-parametric Spearman’s rank correlation coefficient. 
 
When analyzing TL in alcohol users versus non-alcohol users, TL was shorter in 
alcohol users (COPD patients p<0.056; healthy controls p<0.021). Coffee 
consumption could not be linked to FEV1 values, but was negatively associated 
with plasma CRP levels (p=0.013) and weakly negatively associated with IL-6 
(ns), TNF-α (ns) when both groups were combined. No correlations between 
caffeine intake or tea consumption and TL were observed.  
Using multiple regression analysis, the best predictors of TL in COPD 
patients were IL-8 and alcohol consumption (Table 2). Both markers were 
negatively associated with TL.  
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Table 2. Multiple Regression Analysis in healthy controls with TL as dependent variable 
Independent variables p-value 
IL-8 0.002 
Homocysteine 0.012 
Age 0.376 
Alcohol consumption 0.192 
Gender 0.719 
Packyears 0.206 
IL-6 0.554 
TNF-a 0.167 
CRP 0.671 
Caffeine 0.085 
Coffee 0.063 
BMI 0.753 
FEV1 0.977 
SOD  0.23 
Values are considered significantly different at p<0.05 
 
In the control group, TL was best predicted by IL-8 and homocysteine (Table 3). 
IL-8 was positively associated with TL, whereas homocysteine was negatively 
associated with TL. The best predictors of TL in the total study population were 
the presence of COPD (p=0.000), coffee consumption (p = 0.008) and IL-8 (p = 
0.037). 
 
Table 3. Multiple Regression Analysis in COPD patients with TL as dependent variable 
Independent variables P-value 
IL-8 0.01 
Alcohol consumption 0.014 
Age 0.28 
Homocysteine 0.143 
Gender 0.476 
Packyears 0.76 
IL-6 0.42 
TNF-a 0.317 
CRP 0.63 
Caffeine 0.527 
Coffee 0.193 
BMI 0.956 
FEV1 0.904 
SOD  0.318 
Values are considered significantly different at p<0.05 
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Discussion 
In the present study we confirmed results obtained in previous research which 
showed that leukocytes of COPD patients have shorter telomeres than those of 
healthy controls [8,9]. In this study we used DNA from the PBMCs instead of 
leukocytes, which is considered to better reflect systemic changes in TL, since 
lymphocytes are not directly derived from hematopoietic stem cells, making 
them better representatives of somatic cells [30]. To control for differences in 
age between the COPD and control group, we stratified the participants into 
three age groups: 40-55, 56-65 and 66 years and older. In all three age groups, 
COPD patients had significantly shorter telomeres than healthy (ex-)smoking 
controls. Accelerated aging has been postulated to play an important role in the 
pathogenesis of COPD, which is characterized by increased markers of oxidative 
stress and cell senescence in both lung cells and circulating leukocytes/PBMCs 
[7,31].  
We could not find a relationship between TL and tobacco smoke 
exposure, which was quantified as pack years of smoking, confirming previous 
results from other studies [8,9]. We observed increased levels of tHcy in COPD 
patients. Hyperhomocysteinemia was reported to induce vascular oxidative 
stress and to activate circulating mononuclear cells, indicating increased 
systemic inflammation and oxidative stress [32,33]. Previously, increased tHcy 
levels have been observed in COPD patients [34]. In this study, it was suggested 
that increased homocysteine levels were caused by a decreased concentration 
of B vitamins [34]. In our study we found increased tHcy levels in COPD patients 
which positively correlated with age. Therefore, we also stratified the 
participants into three age groups as described for TL. The difference in tHcy 
between COPD and controls disappeared with increasing age, indicating a 
strong influence of age on tHcy. We also found that tHcy was negatively 
associated with TL in controls (r = 0.061, p = 0.012), which was previously 
described by Bull et al. and Richards et al. for healthy populations [35,36]. The 
negative association observed in the controls may be due to their smoking 
history, as smoking is known to be associated with an increased tHcy level [37]. 
We indeed found a positive association between tHcy and smoking history in 
healthy controls (r = 0.189; p = 0.001), which was less pronounced in COPD 
patients (r=0.034; p = 0.039). It appears that in COPD patients in this study, 
homocysteine levels have a minor effect on TL.  
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Animal studies and in vitro models have shown that the antioxidant 
enzyme SOD may protect telomeres from shortening [38,39]. SOD activity was 
significantly lower in COPD patients, indicating a decreased antioxidant 
capacity. When stratified into age groups, this difference remained significant 
and although we could see a negative association between age and SOD activity 
in the healthy control subjects (p = 0.062), which was not observed in the COPD 
group. The lower SOD activity in COPD patients therefore is likely to be a 
consequence of the disease. 
In COPD patients, increased levels of circulating cytokines (IL-6, IL-8 and 
TNF-α) and acute phase proteins such as CRP have been reported [40,41]. The 
elevated CRP levels in patients with COPD are likely to be caused by systemic 
inflammation which is accompanied by an elevated expression of pro-
inflammatory cytokines [42]. We also observed that IL-6 and TNF-α were 
increased in COPD patients, but this was not found for IL-8. IL-6, which is 
thought to be the major cytokine involved in CRP release from the liver, was 
positively correlated with CRP in COPD patients in our study, as was also 
reported previously by others [42,43]. CRP has also been linked to BMI in COPD 
patients in several studies, suggesting an adipocyte-induced systemic 
inflammation [42,44]. Adipose tissue induces increased levels of adipocytokines, 
which in turn are involved in CRP release from the liver [45,46]. In our study, we 
could neither find an association between CRP and BMI, nor between CRP and 
fat mass in COPD patients, but we did find a positive association between CRP 
and BMI in the control subjects (r = 0.088, p = 0.002). This may indicate that 
obesity or overweight plays a less significant role in the elevated CRP levels in 
COPD patients in our study than in healthy controls. 
In both groups, coffee consumption was positively associated with TL, 
whereas alcohol was negatively associated with TL. Coffee contains antioxidant 
substances such as coffee melanoidins, brown-coloured nitrogen-containing 
anionic polymers [47], and chlorogenic acid [19,48], which may decrease 
oxidative stress, and protect the telomeres from oxidative damage and 
shortening.  
In our total study population, plasma CRP levels and to a lesser extent IL-
6 and TNF-α, were negatively associated with coffee consumption, indicating a 
possible attenuating effect of coffee on circulating pro-inflammatory mediators 
in the plasma. This may be explained by the presence of anti-inflammatory 
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compounds in coffee, which decrease the inflammatory response by inhibition 
of NF-κB [49], protecting the telomeres form accelerated shortening.  
Previously, high levels of coffee consumption have been linked to 
increased tHcy levels [50,51], but in our study we could not find an association 
between coffee consumption and increased homocysteine levels. This lack of 
association was also reported by Sakamoto et al. and by Esposito et al. [52,53]. 
Since TL could not be linked to caffeine intake, it is considered likely that other 
compounds present in coffee are associated with beneficial effects observed in 
this study.  
Although TL correlated with coffee in both groups, it appeared not to be 
the best predictor of TL. In the COPD group, TL was best predicted by IL-8 and 
alcohol consumption. TL was negatively associated with both parameters. 
Alcohol can increase the production of ROS in a number of different/concurrent 
ways, leading to increased damage to the telomeres [54]. 
Since IL-8 is associated with increased inflammation and proliferation of 
the lung tissue in COPD [55,56], this may explain the relation of IL-8 to 
accelerated shortening of the telomeres in COPD patients. Moreover, TNF-α 
was reported to inhibit the expression of human telomerase reverse 
transcriptase (hTERT) [57]. A reduced hTERT activity due to increased levels of 
TNF-α in COPD in combination with proliferative stimuli exerted by IL-8 may 
explain the increased telomere shortening in this group. In the control group, TL 
was best predicted by IL-8 and tHcy levels, but in this group IL-8 was positively 
associated with TL. This may indicate potentially adaptive effects of IL-8 in 
healthy smoking controls by diminishing the damaging effects on tissues 
exerted by cigarette smoke. A protective effect was previously reported by 
Wieczorowska-Tobis et al. [58], who observed a positive association of plasma 
IL-8 with survival to advanced age, in a study with centenarians. Since little is 
known about the function of IL-8 in healthy persons, future studies should try to 
further unravel these contradictory associations of IL-8. 
In general, it appears that nutritional lifestyle factors, such as 
consumption of foods high in antioxidants/anti-inflammatory compounds or 
alcohol consumption, can affect telomere shortening, both in healthy persons 
and in COPD patients. Recently, Mirabello et al. showed that a healthier lifestyle 
tended to be associated with longer telomeres, in a combined group of healthy 
subjects and prostate cancer cases. This healthy lifestyle was defined as low or 
no cigarette use, higher fruit and vegetable intake, lower BMI, and a higher 
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level of physical activity [59]. On the other hand, increased levels of oxidative 
stress and the intake of foods low in antioxidants and anti-inflammatory 
compounds have been associated with shorter telomeres [60]. 
This study confirms previous studies, indicating that COPD patients 
acquire an accelerated aging phenotype. It has to be taken into account that 
COPD is a heterogeneous disease, with varying severity between patients. The 
mechanisms resulting in these changes are also likely to be different, making it 
difficult to find a general therapeutic target [7,31]. This study provides a first 
indication for the possible attenuating effects of coffee consumption and 
accelerating effect of alcohol consumption on telomere shortening. Since coffee 
is a highly popular drink, it can have a substantial effect on both individual 
wellbeing and public health. In conclusion, a healthier lifestyle and 
interventions with dietary antioxidants or anti-inflammatory compounds such 
as those found in coffee appear worthwhile to be further investigated for their 
possible beneficial effects on telomere shortening and aging-associated 
degenerative processes in patients with COPD and other chronic inflammatory 
diseases.  
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Abstract 
Diabetes mellitus and hyperglycaemia cause severe damage to cells and tissues, 
and are marked by low grade inflammation and an increased production of 
reactive oxygen species leading to oxidative stress. Several animal and in vitro 
models have shown that chronic oxidative stress induces an accelerated rate of 
telomere shortening. Since diabetes is associated with chronic systemic 
oxidative stress and accelerated aging, dietary interventions with antioxidants 
and/or anti-inflammatory agents are therefore hypothesized to decrease the 
levels of oxidative stress and slow the rate of aging.  
In the present study, we hypothesized that chronic oxidative stress and 
systemic inflammation in diabetes lead to an increased rate of telomere 
shortening. We further investigated the effects of dietary interventions with the 
antioxidant n-acetylcysteine (NAC) and the anti-inflammatory flavonoid fisetin, 
on oxidative stress, inflammation and the rate of telomere shortening. A 24 
week dietary intervention with fisetin and NAC was performed in 
streptozotocin-induced diabetic Wistar rats. Kidney function parameters were 
determined and in leukocytes, oxidative-DNA damage was measured by 8-
oxodG staining and the Comet assay. In blood, heart and kidney, telomere 
length was determined and additionally changes in inflammatory, antioxidant 
and DNA repair gene expression were measured by quantitative PCR. We 
observed significantly shorter telomeres in the diabetic rat hearts, and both 
fisetin and NAC seemed to partially counteract this accelerated telomere 
shortening in heart. The diabetic status increased the expression of antioxidant, 
DNA repair and inflammation related genes in heart and kidneys. Moreover, 
dietary intervention with fisetin and NAC attenuated these responses. Results 
of this study provide evidence that antioxidant and anti-inflammatory dietary 
compounds can contribute to a reduction in oxidative stress and inflammatory 
conditions and partially counteract the accelerated telomere shortening in the 
diabetic heart. 
Introduction 
Diabetes mellitus and hyperglycaemia cause severe damage to cells and tissues, 
especially vital organs such as the kidneys and the heart. It has been 
demonstrated that patients with diabetes type 1 exhibit increased inflammation 
as demonstrated by increased plasma C-reactive protein (CRP) levels and 
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increased monocyte activity [1]. The increased low grade inflammation and 
production of reactive oxygen species (ROS) leads to oxidative stress [2,3]. An 
increase in 7,8-Dihydro-8-oxo-2'-deoxyguanosine (8-oxodG) levels in tissue of 
diabetic rats and in the urine of patients with diabetes [4] indicates that 
diabetes also induces oxidative DNA modifications. At present, increased 
oxidative stress and a reduced antioxidant defence are considered to contribute 
significantly to the development of complications in diabetes, such as vascular 
dysfunction, cardiovascular diseases and renal dysfunction [5].  
Several animal and in vitro models have shown that chronic oxidative 
stress induces an aging phenotype with an accelerated rate of telomere loss 
[6,7]. Telomeres are nucleoprotein structures at the end of chromosomes and 
they prevent chromosomal ends from being recognized as double strand breaks 
and protect them from end to end fusion and degradation [8-12]. In somatic 
cells, telomeres shorten with each cell division and cells are triggered into 
replicative senescence once the telomeres shorten to a critical length [13,14]. 
Cell division only partially accounts for the loss of telomeres seen in cells, so it 
was suggested that other mechanisms, in particular oxidative stress, might be 
involved in accelerated telomere shortening [12,15]. Due to their high content 
of guanines, telomeres were demonstrated highly sensitive to damage by 
oxidative stress [16,17]. Recent studies indeed have linked telomere shortening 
to various chronic metabolic and inflammatory diseases including diabetes [18-
22]. In addition higher glucose levels in patients with type 2 diabetes were 
associated with lower levels of plasma total antioxidant status, and this 
correlated with shorter telomeres [22]. Since diabetes is associated with chronic 
oxidative stress and accelerated aging, dietary interventions with antioxidants 
and/or anti-inflammatory agents are therefore hypothesized to decrease the 
levels of oxidative stress and slow the rate of aging.  
In the present study, we hypothesized that chronic oxidative stress and 
systemic inflammation in diabetes lead to an increased rate of telomere 
shortening. We also investigated the effects of dietary interventions with the 
antioxidant n-acetylcysteine (NAC) and the flavonoid fisetin, on oxidative stress, 
inflammation and the rate of telomere shortening. Fisetin is a flavonoid with 
antioxidant activity and is present in small amounts in fruits and vegetables 
such as strawberries, apples, onions and cucumber. It has been reported to 
exert anti-inflammatory effects and to inhibit the activation of NFκB [23] and of 
the nuclear enzyme poly(ADP-ribose) polymerase 1 (PARP1) [24,25]. PARP1 has 
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been reported to play a role in the development of diabetic complications 
[2,26]. In diabetic rats it has previously been shown that administration of NAC, 
an antioxidant and precursor of glutathione, is capable of lowering the glucose 
levels and reducing oxidative stress [27,28].  
The effects of 24 week dietary interventions with fisetin and NAC on 
telomere shortening were evaluated in streptozotocin-induced diabetic Wistar 
rats. Kidney function parameters were determined and DNA damage in 
leukocytes was measured by 8-oxodG staining and the Comet assay. In blood, 
heart and kidney, telomere length (TL) and changes in inflammatory, 
antioxidant and DNA repair gene expression were measured by quantitative 
PCR.  
Materials and Methods 
Animals and induction of diabetes 
Male Wistar rats (6 weeks old) were obtained from Charles River (Horst, the 
Netherlands) and allowed to acclimatize for 1 week. Animals were housed 
together with 2 or 3 animals/cage and had unlimited access to water and food. 
The experiments were approved by the Ethics Committee for Animal 
Experiments of Maastricht University (Maastricht, The Netherlands). Diabetes 
was induced by a single intra venous (IV) injection of streptozotocin (STZ) 
(65mg/kg). STZ induces an autoimmune process that results in the destruction 
of the Langerhans islets beta cells of the pancreas (Weiss 1982). The rats were 
considered diabetic if they had hyperglycemia (glucose ≥ 15 mmol/L) at 1 week 
after STZ injection. Glucose levels were measured 1 week after injection, at 12 
weeks and at 20 weeks. At week 0, 8, 16 and 23, the rats were placed in 
metabolic cages for urine collection and to obtain information on food and 
water intake.  
Experimental protocol 
Animals were divided in four groups that included a control group (n=6), a 
diabetic group (n=8), a diabetic group with fisetin intervention (n=8) and a 
diabetic group with n-acetylcysteine (NAC) intervention (n=8). When the 
diabetic state was confirmed one week after streptozotocin treatment, fisetin 
(Fit ingredients, Grenzach-Wyhlen, Germany) and NAC (Sigma-Aldrich, 
Zwijndrecht, The Netherlands) were administered through the food for 24 
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weeks. Fisetin and NAC were mixed through the regular pellets by Bio Services 
(Uden, The Netherlands). Fisetin and NAC were administered at concentrations 
of 120 mg/kg food and 7.5 g/kg food respectively. At this concentration, NAC 
has been shown to lower glucose levels and to reduce oxidative stress [27,28]. 
After 24 weeks, rats were sacrificed and blood and organs were collected 
for RNA and DNA isolation. Blood and organs for RNA isolation were stored in 
RNA later (Applied biosystems, Nieuwerkerk a/d lJssel, The Netherlands) to 
preserve the RNA. Samples were kept at 4°C for 24 hours and afterwards stored 
at -80°C until further processing. For DNA isolation blood and organs were snap-
frozen in liquid nitrogen and stored at -80°C until further processing.  
Markers of kidney function 
Rat kidney injury panel 1 was purchased from mesoscale diagnostics (MSD; 
K15162C-1). This assay detects lipocalin-2, osteopontin, and TIM-1 in a 
sandwich immunoassay and uses a competitive assay format to detect albumin. 
All reagents were provided with the MSD kit. Each 96-well plate had 4-carbon 
electrodes in the bottom of each well, each pre-coated with one of the 4-anti-
kidney injury markers antibodies of interest.  
After the blocking step, urine samples, standards and controls (premixed 
with albumin tracer) were added at 50 µl per well. The plate was sealed and 
incubated for 2 h at room temperature on an orbital shaker (600 rpm). At the 
end of the incubation the wells were washed three times using 200 µl PBS + 
0.05% Tween 20, soaking for 30 s and then discarding. Detection antibody was 
added at 25 µl per well, and the plate sealed and incubated for 2 h at room 
temperature on an orbital shaker (600 rpm). At the end of the incubation the 
plate was washed three times as before. 150 µl of the MSD Read Buffer was 
added to each well and the MSD plates were measured on the MSD Sector 
Imager 2400 plate reader. The raw data was measured as 
electrochemiluminescence signal (light) detected by photodetectors and 
analysed using the Discovery Workbench 3.0 software (MSD). A 4-parameter 
logistic fit curve was generated for each analyte using the standards, and the 
concentration of each sample was calculated. 
Comet assay 
DNA single strand breakage was determined by the Comet assay under alkaline 
conditions (pH > 13) according to the method of Singh et al. [29]. Shortly, 10 µl 
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of whole blood was mixed with 90 µl low melting point agarose (Sigma, 
Zwijndrecht, The Netherlands) and placed on the slides coated with 1% of 
normal melting point agarose. Further procedures were as described earlier 
[30]. The slides were stained with ethidium bromide and examined using a Zeiss 
Axioskop fluorescence microscope. One hundred cells per sample (two slides), 
randomly selected, were analysed using the image analysis system Comet Assay 
III (Perceptive Instruments, Haverhill, UK). DNA damage was expressed as tail 
moment (TM, the product of tail DNA content and mean tail migration 
distance). 
8-oxodG detection 
A Biotrin OxyDNA Assay kit (Biotrin, Lyon, France) was used for the evaluation 
of oxidative DNA damage in leukocytes. The Biotrin OxyDNA Assay is an in vitro 
fluorescent protein binding method used for the detection of  8-oxodG in fixed 
permeabilized cells. After cells have been fixed and permeabilized, the FITC 
labeled protein conjugate is added and binds to the 8-oxoguanine moiety 
present in the 8-oxoguanosine of oxidized DNA. The presence of oxidized DNA is 
indicated by a green/yellow fluorescence that can be read using a fluorescence 
microscope. Blood cells were fixed on a microscopic slide and were lysed in lysis 
buffer according to the protocol of the comet assay. Before staining, the cells 
were treated with 5mg/ml pepsin for 20 minutes at 37ºC. Afterwards, slides 
were washed in washing buffer supplied with the kit. Cells were incubated with 
100 µl of FITC-conjugate antibody specific for 8-oxodG (30x diluted) for 1 h in 
the dark at room temperature. Cells were washed in washing buffer and 
dehydrated in 70% EtOH, 95% EtOH and finally 100% EtOH. Slides were allowed 
to dry for 10 minutes. Cells were mounted with DAPI (to stain the nucleus) 
containing mounting medium. Cells were observed under a CCD (charge-
coupled device) camera-equipped fluorescence DMRBE microscope (Leica, 
Germany). The microscope was equipped with a cooled CCD camera. Both 
positive controls (cells exposed to H2O2) as well as negative controls (untreated 
cells) were included in the analysis. Cells were evaluated visually and classified 
from 0 to 3, based on the fluorescence intensity of the nuclear FITC-signal 
observed. For each animal, 2 slides were scored, 50 cells per slide. The scoring 
was done by a well trained technician with the slides coded in such a way, that 
it was not clear from which animal the cells were derived.  
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DNA isolation and telomere length measurement 
DNA was extracted using the QIAamp DNA Mini Kit (Qiagen, Venlo, The 
Netherlands) according to the manufacturer’s protocol and quantified using a 
Nanodrop instrument (Isogen Life Science, Belgium). TL was determined by 
quantitative PCR as described by Cawthon [21,31]. Two master mixtures were 
prepared, one with telomere primers and one with (PGK-1) primers (1x IQ 
SYBRgreen supermix from Biorad). Sequences and concentrations of the 
primers are shown in Table 1. The relative TL was calculated as the ratio of 
telomere repeats to single-copy gene copies (T/S ratio). This means that T/S = 1 
when the unknown DNA is identical to the reference DNA in its ratio of 
telomere repeat copy number to single copy gene copy number [31]. 
  
Table 1. Primer sequences and concentrations  
Primer Sequence (5’– 3’) Concentration 
Telomere pcr  
Telomere 1 CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT 100 nM 
Telomere 2 GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTACCCT 900 nM 
PGK1 forward CGGAGACACCGCCACTTG 1500 nM 
PGK1 reverse AAGGCAGGAAAATACTAAACAT 1500 nM 
Antioxidant related genes 
SOD3 forward CTTCCCAGCCGAGCAGAA 300 nM 
SOD3 reverse TCAGGTCCCCGAACTCATG 300 nM 
SOD2 forward CAGGACCCACTGCAAGGAA 300 nM 
SOD2 reverse CGTGCTCCCACACATCAATC 300 nM 
GPX1 forward AATTCCCTCAAGTACGTCCG 300 nM 
GPX1 reverse TCAGGTTCGATGTCGATGGT 300 nM 
CAT forward TCCTGAGAGAGTGGTACATGC 300 nM 
CAT reverse AAGGTGTGTGAGCCATAGCC 300 nM 
DNA repair related genes 
PARP1 forward CAGGGATTCCGTCTGGTGTT 300 nM 
PARP 1 reverse ACCTGAGCAATGTCGTAGACAATG 300 nM 
OGG1 forward CGGCTGGCAGCCTAAGAC 300 nM 
OGG1 reverse CCGGAAAAAGTTTCCCAGTTC 300 nM 
APEX1 forward GAATGTGGATGGGCTTCGA 300 nM 
APEX1 reverse AAGATGTCTGGTGCTTCTTCCTTT 300 nM 
Inflammation related genes 
COX2 forward GGGTTAAAAACCGACGCAATC 300 nM 
COX2 reverse TAGACCTGGTCGGTTTGATGTG 300 nM 
NADPH4 forward TGGGTGTCAAACAAGAGATTGC 300 nM 
NADPH4 reverse GGCTCAGGAGGTTCTTCATGTAG 300 nM 
IL1β forward GCACCTTCTTTTCCTTCATCTTTG 300 nM 
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IL1β reverse CACACTAGCAGGTCGTCATCATC 300 nM 
TNFα forward TGATCGGTCCCAACAAGGA 300 nM 
TNFα reverse GGGCCATGGAACTGATGAGA 300 nM 
IL6 forward GAAACCCTAGTTCATATCTTCAAACAAG 300 nM 
IL6 reverse CCATTAGGAGAGCATTGGAAGTTG 300 nM 
Other genes 
HO1 forward GGCCTGGCTTTTTTCACCTT 300 nM 
HO1 reverse CGAGCACGATAGAGCTGTTTGA 300 nM 
P53 forward GACAGCTTTGAGGTTCGTGTTTG 300 nM 
P53 reverse TGCTCTTCTTTTTTGCGGAAA 300 nM 
 
RNA isolation, cDNA syntheses and quantitative PCR 
Tissues were stored in RNA later until further processing. Tissues (± 30 mg) 
were homogenized in 1 ml Trizol using a mechanical homogenizer (Ultra turrax). 
RNA was isolated from the Trizol suspended cells according to the 
manufacturer’s protocol (Invitrogen, Carlsbad, CA, USA) and quantified using a 
Nanodrop instrument (Isogen Life Science, Belgium). 
Blood was stored in RNA later until further processing. RNA was isolated 
using the Mouse RiboPure™-blood RNA isolation kit according to the 
manufacturer’s protocol (Applied biosystems, Nieuwerkerk a/d lJssel, The 
Netherlands). RNA yields were determined by UV absorbance using a Nanodrop 
instrument (Isogen Life Science, Belgium). Reverse transcription reaction was 
performed using 500 ng of total RNA, which was reverse-transcribed into cDNA 
using iScriptTM cDNA synthesis kit (Biorad Laboratories, Hercules, CA, USA). The 
analyzed genes with primer sequences and concentrations are summarized in 
Table 1. 
Real time PCR was performed with a BioRad MyiQ Single Color RT-PCR 
detection system (Biorad) using SensiMixPlusSYBR & Fluorescein, 5 µl diluted 
(10x) cDNA and 0.3 µM primers in a total volume of 25 µl. PCR was conducted 
as follows: 10 minutes at 95°C, 35 cycles of 15 sec at 95°C, 30 sec at 60°C and 45 
sec at 72°C.  
After PCR a melt curve (60-95°C) was produced for product identification 
and purity. β-actin was included as housekeeping gene and a standard curve 
was included each run. Primer sequences are shown in Table 1. In each run a 
pool sample was added against which all samples were plotted. Data were 
analyzed using the MyiQ software system (Biorad) and were expressed as 
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relative gene expression (expressed as fold change, with the pooled DNA as 
reference sample) using the 2∆∆Ct method. 
Statistical analysis 
Results are shown as mean ± standard deviation/standard error of the mean, or 
as percentage. Differences between the groups were tested using One-way 
analysis of variance between groups. For comparisons between 2 groups, the 
Student’s t-test for the independent samples and the Mann Whitney U-test 
when not normally distributed was used.  Percentages (with the control rats as 
a reference group) were calculated for the gene expression results. With these 
percentages, the results of respectively the antioxidant related genes, the DNA 
repair related genes and the inflammation related genes could be grouped 
together. A difference with p<0.05 was considered statistically significant. 
Statistical analyses were analyzed with SPSS for Windows (version 15.0; SPSS 
Inc., Chicago, IL, USA). 
Results 
General characteristics 
No mortality was observed in control rats, diabetic rats, or the intervention 
groups. The rats in the three diabetic groups had a significantly lower total 
bodyweight than control rats at week 24. In contrast, the relative weight of 
kidneys and heart was significantly higher in the diabetic groups. The mean 
intake of fisetin was 12.84 ± 5.27 mg/kg bodyweight, and the mean intake of 
NAC was 774.58 ± 178.36 bodyweight. No effect of the dietary interventions 
was observed on total body weight or the weight of the organs (Table 2). The 
diabetic rats consumed more food than the control group over the 24 week 
period (p<0.01).  
We also found that the glucose levels were increased in the diabetic 
groups (p<0.001) during the whole experiment.  
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Table 2. General characteristics of the study groups 
 
Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on 
N-acetylcysteine 
diet 
Total bodyweight (g) 488.83 ± 21.82 309.38 ± 37.76* 337.63 ± 31.96* 350.63 ± 61.97* 
Relative weight heart  
(% of total bodyweight) 0.299 ± 0.021 0.321 ± 0.033* 0.323 ± 0.058* 0.339 ± 0.039* 
Relative weight left  
kidney (% of total 
bodyweight) 
0.319 ± 0.022 0.403 ± 0.049* 0.447 ± 0.081* 0.50 ± 0.0116* 
Relative weight right 
kidney (% of total 
bodyweight)  
0.327 ± 0.026 0.396 ± 0.051* 0.443 ± 0.047* 0.495 ± 0.099* 
Blood glucose levels  
after 20 weeks (mmol/l) 5.57 ± 0.60 30.14 ± 4.67* 30.16 ± 4.02* 24.74 ± 9.72* 
Data are presented as mean ± SD. * Significantly different from the control rats based on a Mann 
Whitney U-test (p<0.01). 
Kidney function 
In Table 3 kidney function parameters are shown. Kidney function is 
significantly decreased in diabetic rats as can been seen by enhanced excretion 
of kidney injury molecule-1 (TIM1), lipolcalin-2 and osteopontin. Fisetin and 
NAC had no significant influences on these kidney parameters but TIM1 is 
significantly decreased in the fisetin and NAC intervention groups compared to 
the diabetic rats.  
 
Table 3. Kidney function parameters 
 Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on 
N-acetylcysteine 
diet 
CCr (mL/min/100g BW) 0.67 ± 0.05 0.90 ± 0.25 1.09 ± 0.24 1.07 ± 0.24 
TIM1 (ng/mg Creatinine) 0.49 ± 0.18 1.89 ± 0.69* 1.18 ± 0.81** 1.22 ± 0.60** 
Lipocalin-2 (ng/mg 
Creatinine) 193.5 ± 64.66 878.8 ± 590.81* 1738.9 ± 3874.32 1160.0 ± 1233.54 
Osteopontin (ng/mg 
Creatinine) 3.45 ± 1.54 49.0 ± 35.94* 49.64 ± 52.17 194.56 ± 231.41 
Albumin (ng/mg 
Creatinine) 334.5 ± 446.86 2161.1 ± 3149.45 717.6 ± 656.57 2203.3 ± 1850.94 
Data are presented as mean ± SD.  
* Significantly different from the control group, based on a Mann Whitney U-test (p<0.001). 
**Significantly different from the diabetic group, based on a Mann Whitney U-test (p<0.05). 
CCr: Creatinine clearance rate; TIM1: kidney injury molecule 1 
Telomere length 
TL was measured by quantitative PCR in DNA isolated from white blood cells 
(WBC), heart and kidney. No significant differences were observed between the 
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four groups for TL in the kidney and white blood cells. In the heart, the 
telomeres of the diabetic rats were significantly shorter. Fisetin and NAC 
appeared to counteract this effect in the heart, but this was not statistically 
significant (Figure 1A, B and C). 
 
A.                    B. 
     
C. 
 
Figure 1. TL in the different groups in the blood (A), heart (B) and the kidney (C). Data are presented 
as T/S ratio ± SEM. * Significantly different from the control group based on One-way analysis of 
variance (p<0.05) 
Oxidative DNA damage 
As an index of oxidative DNA damage, DNA strand breaks in WBC were 
measured using the Comet assay. No significant differences were observed in 
DNA damage between the four groups (Table 4). Additionally we measured the 
formation of 8-oxodG in WBC of the rats using fluorescence labeling. In cells 
treated with H2O2 to induce 8-oxodG within the nuclei of the cells, positive 
staining could be obtained via binding of the FITC conjugated 8-oxodG antibody. 
On the contrary we could not observe any 8-oxodG in untreated cells. 
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Quantitation of the signal by scoring of positive nuclei showed an increase of 8-
oxodG in WBC of the diabetic rats, although this was not significant. 
Unexpectedly, we also observed a nonsignificant increase in the fisetin 
intervention group (Table 4). For NAC, no effects were observed.  
 
Table 4. Level of oxidative DNA damage in white blood cells as measured by the Comet assay and 8-
oxodG fluorescence staining. 
 
Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on  
N-acetylcysteine 
diet 
Comet assay (mean tail 
moment) 0.27 ± 0.08 0.27± 0.21 0.22 ± 0.08 0.23 ± 0.05 
8-oxodG (percentage of 
control group) 100 ± 69.73 117.29 ± 47.84 134.74 ± 59.31 99.25 ± 51.0 
Data are presented as mean tail moment ± SD (Comet assay) or as percentage positive cells (8-
oxodG). Differences in values between groups were tested with a Mann Whitney U-test. No 
significant differences were observed. 
 
Data of the comet assay were expressed as mean tail moment and data of the 
8-oxodG staining were expressed as percentages of the control group, and the 
combined measurements (both expressed as percentages of the control group) 
were used to analyze effects on oxidative DNA damage using ANOVA. Although 
the observed differences were not significant, we did observe a trend towards 
higher levels of DNA damage in the diabetic group and an attenuating effect for 
both interventions. 
Gene expression 
Gene expression was measured in blood, heart and kidney. Genes involved in 
inflammation, antioxidant defense, and DNA repair were selected. Diabetic rats 
showed a significant upregulation of catalase and glutathione peroxidase 1 
(GPX1) transcription in heart and kidney. Furthermore, an upregulation of the 
genes 8-oxoguanine DNA glycosylase 1 (OGG1), NADPH-oxidase 4 (NOX4) and 
interleukin 1β (IL1β) in the heart and tumor necrosis factor α (TNFα) in the 
kidney was observed.  Apurinic apyrimidinic endonuclease redox effector 
factor-1 (APE1/REF1), catalase, p53, OGG1, GPX1 and PARP1 showed a 
tendency to be downregulated in the kidney in the fisetin group when 
compared to the diabetic rats without intervention (Table 5, 6 and 7). 
Inflammation related genes were not detectable in blood. 
 To investigate whether genes involved in similar processes were 
influenced by the diabetic status or by one of the interventions, we classified 
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the genes into three groups: Antioxidant defense, DNA repair and inflammation 
related genes (Table 5, 6 and 7). The antioxidant genes were significantly 
upregulated in the diabetic group compared to non-diabetic controls, both in 
the heart and the kidney. In addition, DNA repair genes as well as inflammatory 
genes were significantly upregulated in the heart of the diabetic group. Dietary 
intervention with fisetin caused a significant decrease in the expression of 
antioxidant genes and DNA repair genes in the kidney of rats compared to de 
diabetic rats without intervention. In blood, an increased expression of DNA 
repair genes was observed in the fisetin group when compared to the diabetic 
group without intervention. In diabetic rats that were treated with NAC, 
transcription of inflammation associated genes in the kidney showed a 
tendency to be decreased when compared to diabetic rats without 
interventions, but this was not statistically significant. 
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Table 5. Transcription of antioxidant related genes (A), DNA repair related genes (B) and 
inflammation related genes (C) in the rat heart expressed as percentage ± SD from the control 
group 
A.     
Diabetic rats on N-
acetylcysteine diet 
Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on 
N-acetylcysteine 
diet 
HO1 100 ± 36.14 97.10 ± 22.56 91.72 ± 32.30 86.71 ± 35.04 
CAT 100 ± 23.28 226.05 ± 129.55* 194.61 ± 46.67 151.11 ± 75.45 
SOD2 100 ± 6.66 92.37 ± 12.74 87.68 ± 17.59 98.65 ± 11.93 
SOD3 100 ± 20.78 121.88 ± 24.66 121.13 ± 21.06 110.63 ± 34.67 
GPX1 100 ± 13.51 148.71 ± 34.80* 122.49 ± 33.42 127.36 ± 31.54 
Mean expression of all 
antioxidant related genes 100 ± 20.79 137.22 ± 76.79* 123.53 ± 49.22 114.89 ± 46.73 
Significantly different from the control group, based on a Mann Whitney U-test (p< 0.05). 
 
 
B.     
DNA repair related genes in 
the heart 
Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on 
N-acetylcysteine 
diet 
OGG1 100 ± 13.57 120.65 ± 12.36* 112.65 ± 18.31 116.50 ± 15.77 
PARP-1 100 ± 17.86 96.93 ± 7.52 108.38 ± 14.21 103.49 ± 23.23 
P53 100 ± 61.49 132.85 ± 81.45 327.03 ± 345.87 86.05 ± 36.90 
APE1/REF1 100 ± 3.61 121 ± 26.18 108.62 ± 13.84 104.67 ± 13.48 
Mean expression of all DNA 
repair related genes 100 ± 30.57 117.56 ± 43.31 151.36 ± 190.54 102.24 ± 25.46 
Significantly different from the control group, based on a Mann Whitney U-test (p<0.05). 
 
 
C.     
Inflammation related genes 
in the heart 
Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on 
N-acetylcysteine 
diet 
IL1β 100 ± 25.98 216.47 ± 74.18* 176.90 ± 30.03 157.87 ± 59.81 
TNFα 100 ± 28.85 126.58 ± 47.11 122.15 ± 27.53 107.59 ± 41.51 
IL6 100 ± 57.54 100.34 ± 51.51 93.80 ± 29.63 97.48 ± 57.70 
COX2 100 ± 9.11 103.57 ± 31.86 87.93 ± 22.35 105.91 ± 33.63 
NADPH-ox 4 100 ± 23.83 130.28 ± 26.10* 128.26 ± 24.94 120.03 ± 32.70 
Mean expression of all 
inflammation related genes 100 ± 30.71 135.45 ± 63.22* 121.81 ± 37.53 
# 117.78 ± 49.08 
* Significantly different from the control group, based on a Mann Whitney U-test (p<0.05). 
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Table 6. Transcription of antioxidant related genes (A), DNA repair related genes (B) and 
inflammation related genes (C) in the rat kidney expressed as percentage ± SD from the control 
group.  
A.     
Antioxidant related genes  
in the kidney 
Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on 
N-acetylcysteine 
diet 
HO1 100 ± 11.98 134.84 ± 65.15 129.13 ± 48.32 88.19 ± 18.52 
CAT 100 ± 26.93 167.23 ± 73.04* 73.14 ± 70.34** 73.14 ± 70.34 
SOD2 100 ± 35.22 94.23 ± 18.61 69.93 ± 30.27 109.89 ± 12.77 
SOD3 100 ± 16.62 114.38 ± 59.70 141.90 ± 95.13 95.97 ± 19.77 
GPX1 100 ± 18.57 154.78 ± 51.55* 61.46 ± 41.01** 147.97 ± 45.80 
Mean expression of all 
antioxidant related genes 100 ± 21.70 133.10 ± 60.13* 81.18 ± 50.04** 122.00 ± 48.06 
* Significantly different from the control group, based on a Mann Whitney U-test (p<0.05). 
**Significantly different from the diabetic group, based on a Mann Whitney U-test (p 0.05). 
 
B.     
DNA repair related genes in 
the kidney 
Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on 
N-acetylcysteine 
diet 
OGG1 100 ± 29.82 111.31 ± 21.09 70.08 ± 29.21** 101.48 ± 13.63 
PARP-1 100 ± 14.91 99.78 ± 14.58 56.74 ± 26.86** 100.65 ± 19.15 
P53 100 ± 17.19 99.43 ± 14.41 73.01 ± 19.11** 100.57 ± 13.73 
APE1/REF1 100 ± 18.54 111.08 ± 17.49 80.86 ± 18.81** 113.73 ± 23.73 
Mean expression of all DNA 
repair related genes 100 ± 19.51 105.40 ± 17.30 66.79 ± 24.41** 104.11 ± 17.79 
**Significantly different from the diabetic group, based on a Mann Whitney U-test (p<0.05). 
 
C.     
Inflammation related genes 
in the kidney 
Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on 
N-acetylcysteine 
diet 
IL1β 100 ± 38.95 94.98 ± 18.10 74.19 ± 51.43 113.11 ± 63.40 
TNFα 100 ± 25.35 152.07 ± 45.68* 143.28 ± 91.60 138.48 ± 42.85 
IL6 100 ± 89.91 66.93 ± 55.51 51.72 ± 33.64 62.88 ± 31.07 
COX2 100 ± 15.94 99.41 ± 25.69 178.09 ± 134.9 95.29 ± 24.69 
NADPH-ox 4 100 ± 19.99 115.07 ± 45.06 68.26 ± 60.19 98.28 ± 26.67 
Mean expression of all 
inflammation related genes 100 ± 43.85 142.27 ± 172.77 103.73 ± 89.95 100.66 ± 45.34 
* Significantly different from the control group, based on a Mann Whitney U-test (p<0.05). 
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Table 7. Transcription of antioxidant related genes (A) and DNA repair related genes (B) in white 
blood cells  expressed as percentage ± SD from the control group. 
A.     
Antioxidant related genes in 
the blood 
Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on 
N-acetylcysteine 
diet 
HO1 100 ± 43.95 97.86 ± 42.42 135.96 ± 97.02 116.10 ± 119.83 
SOD2 100 ± 48.15 74.46 ± 9.50 112.16 ± 32.32 68.92 ± 15.03 
SOD3 100 ± 42.05 98.57 ± 42.75 141.90 ± 95.13 126.62 ± 126.81 
Mean expression of all 
antioxidant related genes 100 ± 41.47 90.30 ± 35.53 130.01 ± 78.16 103.88 ± 88.40 
Differences in values between groups were tested with a Mann Whitney U-test. No significant 
differences were observed. 
 
 
B.     
DNA repair related genes  
in the blood 
Control rats Diabetic rats Diabetic rats  
on Fisetin diet 
Diabetic rats on 
N-acetylcysteine 
diet 
OGG1 100 ± 36.91 62.56 ± 8.82* 112.01 ± 51.65 64.72 ± 21.63 
P53 100 ± 41.51 100.81 ± 38.13 122.40 ± 72.07 94.58 ± 66.22 
APE1/REF1 100 ± 36.04 62.37 ± 26.60 103.15 ± 39.56 58.95 ± 17.17 
Mean expression of all DNA 
repair related genes 100 ± 35.39 75.25 ± 31.98 112.52 ± 54.16 72.75 ± 42.67 
Differences in values between groups were tested with a Mann Whitney U-test. * Significantly 
different from the control group, based on a Mann Whitney U-test (p<0.05). 
Discussion 
In the present study we induced diabetes in rats by a single injection of 
streptozotocin (STZ) and we observed after 24 weeks increased blood glucose 
levels, a decrease in body weight and an increase in relative heart and kidney 
weights. As a marker of accelerated aging we determined TL and found in the 
DNA of heart tissue a significantly shorter TL when compared to non-diabetic 
rats. In the kidney and in WBC no effect could be detected. Previously, others 
showed telomere shortening in the rat heart after 12 weeks of severe renal 
failure, as can also occur in diabetes and hypertension [32]. Since this was not 
observed during mild renal failure as measured by plasma creatinine, 
proteinuria and focal glomerulosclerosis, these data indicated that severe renal 
failure may lead to hypertrophy and telomere shortening in the heart [32].  In 
our study, we also observed severe renal failure, and increased telomere 
shortening in the heart. There is accumulating evidence that oxidative stress 
may be involved in telomere shortening in the diabetic heart. The telomeric 
DNA structure, with its high content of guanines, has an enhanced vulnerability 
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towards oxidative DNA damage. Moreover, repair of single-strand breaks in 
telomeres is less efficient than in the bulk of the genome [33]. Additionally, 
reactive oxygen species (ROS) may have a negative effect on signaling proteins 
which in turn can modulate cellular processes, leading to cardiac growth 
remodeling and dysfunction [34].  
In WBC no effects on telomere length could be observed. A possible 
explanation may be that the effects of the diabetic status are more pronounced 
in target tissues such as heart and kidney as compared to WBC, which are for 
the greater part directly derived from the hematopoietic stem cells. Since these 
hematopoietic cells possess telomerase activity, TL in WBC may be less sensitive 
for the effects of hyperglycemia [35].  
To examine whether oxidative stress in diabetic rats leads to DNA 
damage we measured DNA strand breaks and 8-oxodG detection in WBC. No 
significant increase in oxidative DNA damage could be detected with the Comet 
assay in WBC of diabetic rats, but levels of 8-oxodG tended to be increased. 
Although in several human studies higher levels of 8-oxodG and DNA strand 
breaks were reported in type II diabetic patients [4,36], there are also studies in 
which no association between oxidative stress, as measured by 8-oxodG and 
the Comet assay in WBC, and glycaemic control in diabetic patients (type I and 
type II diabetes) was found [37,38].  
Furthermore, we measured gene expression of genes involved in 
antioxidant defense, DNA repair and inflammation, in blood, heart and kidney. 
In heart and kidney, we observed significant changes caused by the diabetic 
status of the rats and as well as effects of dietary interventions. Both catalase 
and GPX1 gene expression were significantly increased in the heart en the 
kidney, indicating increased oxidative stress caused by the diabetic status. 
Several studies previously showed an increase in catalase activity in the heart 
and the kidney of diabetic rats supporting the increased gene expression of 
catalase found in our study [39,40]. Catalase as well as GPX1 is involved in the 
detoxification of radicals, and previous studies showed that protection against 
oxidative stress requires the up-regulation of catalase activity, i.e. catalase 
activity is increased under conditions of oxidative stress [40,41]. 
We did not observe any effects on the expression of the antioxidant 
enzymes superoxide dismutase 2 and 3 (SOD2 and 3) and the stress responsive 
enzyme haem oxygenase 1 (HO-1). Previous studies indicated that the 
expression of extracellular SOD (SOD3) might be more sensitive to oxidative 
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stress caused by diabetes, but in our study we could not find evidence to 
support this hypothesis [42]. Sadi et al. also showed that decreasing levels of 
catalase activity and gene expression was counterbalanced by increasing levels 
of GPX activity and gene expression in diabetes, indicating that very delicate 
mechanisms may regulate the activities of the antioxidant enzymes [42]. In our 
study we did not observe these effects with regard to catalase and GPX1 gene 
expression. 
In concordance with the results from the oxidative stress parameters in 
the blood, we could not observe any significant changes in antioxidant gene 
expression in the blood, but OGG1 was significantly downregulated in diabetic 
rats when compared to the non-diabetic controls. OGG1 is a DNA repair gene 
that removes 8-oxodG from the DNA [43] and previously it has been 
demonstrated that diabetes type I was associated with a decrease in OGG1 
expression and accumulation of 8-oxodG in kidney cortex of diabetic rats [44]. 
In our study we saw the same tendency in WBC, in the kidneys no effect was 
observed, and in the heart of diabetic rats we observed an increase in the 
expression of OGG1. This may indicate that oxidative stress induced DNA 
damage in the heart is inducing an up-regulation of OGG1. Other studies have 
also reported an enhancing effect of oxidative DNA damage on over-expression 
of OGG1 [43,45]. In our study, we observed differential expression of OGG1 in 
WBC and in the heart of diabetic rats, which may be explained by differences in 
tissue-specific control of the expression of genes [46]. 
Diabetic rats showed increased expression of inflammation related genes 
both in the heart and the kidney, indicating an increase in oxidative stress and 
inflammation. More specifically, the expression of TNF-α and NOX4 was 
increased in both organs. NOX4 as well as cyclooxygenase 2 (COX2) have been 
recognized as important sources of ROS and play a role in the development of 
inflammatory diseases [47,48].  Furthermore, it has been demonstrated that 
NOX4 is a major source of ROS in the kidney of diabetic animals [49] and the 
production of ROS increases the transcription of NF-κB, causing an increase in 
the inflammatory response by enhanced transcription of pro-inflammatory 
genes such as TNF-α [50].  
We hypothesized that n-acetyl cysteine (NAC) and fisetin may counteract 
the deleterious effects of the diabetic state. The intervention with fisetin and 
NAC during 24 weeks after induction of diabetes appeared to be capable of 
partially counteracting telomere shortening in both the heart and the kidney. 
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Furthermore, intervention with fisetin resulted in a reduced expression of 
antioxidant genes and DNA repair genes in the kidney of diabetic rats when 
compared to the diabetic rats without intervention. This might be explained by 
the fact that fisetin is an antioxidant and an inhibitor of NFκB [23] and the DNA-
repair associated enzyme PARP1, which is also a co-activator of NFκB 
[25,51,52]. Flavonoids undergo extensive metabolism prior to entry in the 
systemic circulation. The liver is the main organ responsible for the 
biotransformation, but the kidney is also involved in their metabolism and 
excretion [53,54]. This may explain the effects of fisetin on gene expression in 
the kidney, which were not observed in the heart. In a similar study with 
diabetic rats, intervention with the flavonoid quercetin attenuated renal 
damage, by decreasing the level of oxidative stress, as measured by lipid 
peroxidation [55]. We observed a decrease in TIM1, indicating protective 
effects of fisetin on kidney function. A recent study also showed that PARP 
activation plays an important role in kidney disease in long-term diabetes type 
1, and that PARP inhibitors appear to be useful in the prevention and treatment 
of diabetic nephropathy [56]. 
Intervention with NAC did not induce significant changes in gene 
expression in heart, kidney and blood when compared to the diabetic group 
without intervention. Several intervention studies with STZ induced diabetic 
rats showed protective effects of NAC [27,28,50,57,58]. Most studies 
administered NAC at a dose of 1.5g/kg bodyweight, for eight weeks through the 
drinking water, which is approximately twice the dose received by rats in our 
study. Only one study performed a long-term intervention of 24 weeks [58]. 
These studies all reported that NAC lowered the glucose levels, inhibited lipid 
peroxidation, restored antioxidant activity and decreased inflammation related 
cytokines, such as TNF-α. This was attributed to its free radical scavenging 
activity, leading to decreased levels of inflammation and oxidative stress 
[27,28,50,57,58].  
Conclusions 
In summary, in our study significantly shorter telomeres were observed in the 
diabetic rat hearts and administration of both fisetin and NAC via the diet 
seemed to partially counteract this accelerated telomere shortening in heart. 
The diabetic status increased the expression of pro-inflammatory and oxidative 
stress related genes in heart and kidneys, indicating increased levels of 
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oxidative stress in these organs. Although these are counteracted by the 
increased expression of DNA repair genes and antioxidant genes, still a 
significant reduction in TL in heart was found. Moreover, dietary intervention 
with fisetin and NAC was found to attenuate these responses. Dietary 
intervention with fisetin caused a significant decrease in the expression of 
antioxidant genes and DNA repair genes in the kidney of rats compared to de 
diabetic rats without intervention, possibly related to the role of kidneys in 
excretion and elimination of fisetin. In diabetic rats treated with NAC, 
transcription of inflammation associated genes in the kidney showed a 
tendency to be decreased when compared to diabetic rats without 
interventions, but this was not statistically significant. Results of this study 
provide evidence that antioxidant and anti-inflammatory dietary compounds 
can contribute to a reduction in oxidative stress and inflammatory conditions 
and a reduction in the rate of telomere shortening in the diabetic rat heart. 
Future studies should focus on evaluation of the effects of prolonged 
interventions with higher doses or measures that increase the biological 
availability of the administered compounds. This may provide more insight in 
the efficacy of treatment with dietary anti-oxidant and anti-inflammatory 
compounds on diabetes induced complications and accelerated aging.  
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The major objective of the studies presented in this thesis was to examine the 
relationship between chronic oxidative stress and telomere shortening and the 
possible use of telomere length (TL) as a biological marker of aging, disease 
progression, and mortality.  
To investigate this, we focussed in chapter 2 and 3 on the general 
population, whereas in chapter 4 and 5 the differences between healthy 
individuals and patients with chronic obstructive pulmonary disease (COPD) 
were studied. In chapter 6 we evaluated the effects of interventions with fisetin 
and n-acetylcysteine on telomere shortening and markers of oxidative stress in 
a diabetic rat model. 
This general discussion will integrate the most important findings of this 
thesis and potential areas for future research will also be discussed.  
Main findings 
TL is influenced by several factors and besides the end-replication problem, 
oxidative stress appears to play an important role. High levels of oxidative stress 
increase the rate of shortening of the ends of the chromosomes and a good 
antioxidant status and antioxidant defence are hypothesized to decrease the 
rate of telomere shortening [1-3]. The most common sources of oxidative stress 
and inflammation are unhealthy nutrition, little exercise, obesity, chronic 
emotional stress and chronic diseases, such as atherosclerosis, inflammatory 
bowel disease, and diabetes, in which telomeres were hypothesized and 
confirmed to be shorter in patients suffering from such chronic inflammatory 
diseases [4-8].  Previous research showed that the incidences of several aging-
related chronic diseases were lower in Southern than Northern Europe, 
indicating a potential role for a higher antioxidant status and lower levels of 
oxidative stress in people living around the Mediterranean Sea [9-12]. For 
measurement of TL in DNA we applied a quantitative PCR technique. This 
technique is high-throughput, time-saving and requires only small amounts of 
DNA. We studied leukocyte TL (LTL) in elderly men from two different regions in 
Europe, from Zutphen (the Netherlands) and Crete (Greece). These groups were 
previously identified to differ with respect to lifestyle, and more specifically, 
they consume a different diet. We found that Greek elderly men had 
significantly longer LTL compared to their Dutch counterparts. The endogenous 
antioxidants albumin and uric acid were positively associated with longer 
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telomeres. Dietary antioxidants including carotenoïds and tocopherols were not 
observed to be associated with LTL. 
The next step was to measure LTL in the general elderly male population 
over a period of time. This would give us information on the individual rate of 
telomere shortening and the potential use of LTL as a marker for all-cause and 
disease specific mortality. We found that LTL declined with a mean of 40.2 bp 
per year. We observed a good correlation between LTL in 1993 and 2000 for 75 
men, but we could not confirm previous research showing that LTL is a marker 
for mortality. LTL was neither associated with the risk of cardiovascular disease 
mortality nor with cancer mortality. After studying the general population, we 
performed two different COPD - control studies. COPD is characterized by 
incompletely reversible airflow obstruction. Chronic systemic oxidative stress 
and inflammation play a major role in the pathophysiology of COPD [13-16]. In 
the first study we observed shorter LTL in COPD patients compared to healthy 
controls and also found a positive association between LTL and blood SOD 
activity and in COPD patients a modest positive association between LTL and fat 
mass. In the second study we additionally measured the cytokines IL-8, IL-6 and 
TNF-α as well as CRP, SOD and plasma homocysteine. Coffee, tea and alcohol 
consumption were also assessed in relation to inflammation and TL in 
lymphocytes. We found that COPD patients had shorter telomeres than their 
healthy counterparts, after adjusting for age. The best predictors of TL in the 
total study population (healthy controls as well as COPD patients included) 
were the presence of COPD, coffee consumption and IL-8. This study gives a 
first indication for the potential beneficial effects of coffee consumption and for 
negative effects of alcohol consumption on TL.  
Finally we investigated the effects of dietary interventions on TL in a 
diabetic rat model. Rats were injected with streptozotocin to induce diabetes, a 
disease that is also accompanied by chronic oxidative stress [17,18]. The effect 
of fisetin, a flavonoid, and n-acetylcysteine, an antioxidant, administered via the 
food, was investigated. Several markers of oxidative stress were measured, TL 
was determined and gene expression of relevant genes was measured by 
quantitative PCR. We observed significantly shorter telomeres in the diabetic 
rat hearts, and both fisetin and NAC seemed to partially counteract this 
accelerated telomere shortening. The diabetic status increased the expression 
of antioxidant, DNA repair and inflammation related genes in heart and kidneys. 
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Moreover, dietary intervention with fisetin and NAC reduced/attenuated these 
responses. 
Discussion and future directions 
Several aspects of the potential application of TL as a marker for disease 
progression and mortality and the potential protective effects of antioxidants, 
either taken as supplements or consumed with the diet, since these are present 
mostly in fruits and vegetables, require further discussion.  
Telomere length: marker for mortality? 
Cross-sectional studies have indicated that TL might be a relevant biomarker of 
disease progression and survival. However, this needs to be confirmed by 
longitudinal studies. To address these questions, we measured LTL in a 
prospective study (chapter 3) in male subjects from the Zutphen Elderly Study. 
TL was measured in 203 men in 1993 and 75 surviving subjects in 2000. We 
found that LTL declined with a mean rate of 40.2 bp per year. We could not 
confirm previous research showing that TL is a marker for mortality. LTL was 
neither associated with the risk of cardiovascular disease mortality nor with 
cancer mortality in our study population. Likewise, three studies with similar 
study populations, e.g. elderly and the oldest old and similar follow-up periods, 
also found no association between LTL and mortality (bisschoff, martin-ruiz and 
nordfjall). A possible explanation for these negative findings might be that there 
is a higher degree of TL instability in the oldest old compared to younger 
populations, as we discussed in chapter 3, which makes elderly men over 70 
years not representative of the younger population. Furthermore, as humans 
reach advanced age, a survival effect may modify associations with LTL [19]. 
Recent research confirms that people older than 86 years of age exhibit longer 
telomeres than younger individuals, suggesting that the rate of telomere 
attrition may be an important determinant of overall survival in the general 
population. The relatively older group may be affected by survival bias that 
selected out individuals with aging-related disease or those who would have 
died before reaching the age of 85 years, leaving the survivors with relatively 
longer telomeres [20]. Investigation into cellular mechanisms involved in 
telomere attrition across age groups might ultimately unravel the underlying 
mechanisms causing this difference. 
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Protection of telomeres by antioxidants? 
In chapter 2 we compared LTL in 109 Greek elderly men and in 143 Dutch 
elderly men. We aimed to compare LTL between these two European regions 
and to investigate the possible relationship between antioxidant 
status/oxidative stress levels and LTL within these two European regions that 
were previously found to have marked differences in oxidative stress status [9-
12]. 
Greek elderly men had significantly longer LTL compared to their Dutch 
counterparts. In Greek men a positive association was found between LTL and 
plasma zeaxanthin and albumin, whereas in Dutch men a positive relationship 
was found with uric acid. When both groups were combined, albumin and uric 
acid levels remained positively correlated with LTL. Oxidative stress parameters 
could not be linked to LTL, except for hydroperoxides which were positively 
associated with LTL in Zutphen. High levels of the enzyme gamma-glutamyl 
transferase (GGT) are associated with an increased turnover of glutathione, 
indicating an increased antioxidant status [21]. However, when we determined 
the ratio between hydroperoxides and GGT we found that the increase in 
hydroperoxides was more pronounced than the increase in GGT in the men 
from Zutphen, indicating higher levels of oxidative stress. Although this was not 
expected, it is known that oxidant species can act as signalling molecules 
promoting cell survival [22]. If the concentration of hydroperoxides is high, 
oxidation processes may lead to irreversible damage, followed by cell death. 
However, hydroperoxides are also capable of inhibition of phosphatases that 
negatively regulate cell survival pathways [23], promoting cell survival. The data 
of our study indicate that endogenous antioxidants play an important role in 
protecting telomeres from shortening. In Greek men, also zeaxanthin was 
positively associated with LTL, indicating that dietary antioxidants additionally 
contribute to telomere stability. Several studies have reported positive 
associations between telomere length and the use of nutritional supplements 
such as vitamin C, E and folic acid [24-27]. Recently, omega-3 fatty acids have 
also been found to be inversely associated with the rate of telomere shortening 
over time [28].  
Supplementation with omega-3 fatty acids has been associated with 
lower levels of F2-isoprostanes, an established standard for measurement of 
systemic oxidative stress, and with higher levels of the antioxidant enzymes 
catalase and superoxide dismutase [29]. Furthermore, daily supplementation 
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with omega-3 fish oil, was associated with a significant increase in telomerase 
activity in normal adult human leukocytes [7].  
To answer the question whether these supplements are also capable of 
reducing the mortality risk, prospective intervention studies with these 
supplements are required. 
TL as a marker of disease progression in COPD: what about 
nutrition? 
In chapter 4 we investigated LTL in COPD patients in relation to pulmonary 
function and disease severity, i.e. cachexia. Furthermore, based on 
experimental evidence suggesting the effects of oxidative stress on telomere 
shortening, we studied the association of LTL with the antioxidant enzyme 
superoxide dismutase (SOD). 102 COPD patients with moderate to severe COPD 
were studied and compared with 19 healthy age-matched controls. Patients 
were characterized by elevated levels of inflammatory markers (CRP, sTNF-
receptors) and lower SOD-activity than healthy controls, irrespective of SOD 
genotype. LTL was negatively associated with age and was significantly shorter 
in COPD patients than in controls. Within the patient group age-adjusted LTL 
variability could not be explained by lung function and smoking history, but a 
modest association was found with the percentage of fat mass. These data 
provide evidence for a relationship between a disturbed oxidant/antioxidant 
balance and telomere shortening and indicate that preservation of fat mass 
may be protective in delaying telomere shortening in COPD patients. 
In chapter 5 we investigated TL in COPD patients and healthy (ex-
)smoking controls in relation to oxidative stress and inflammation. The second 
aim of this study was to investigate the potential protective effects of caffeine, 
coffee and tea intake on TL in COPD patients and healthy (ex) smokers. For this 
purpose, we measured TL in PBMCs of 89 COPD patients and compared these 
with 93 healthy controls. In addition, the cytokines IL-8, IL-6 and TNFα were 
determined as well as CRP, SOD and plasma homocysteine. Coffee 
consumption, tea consumption, caffeine intake and alcohol consumption were 
assessed by a questionnaire. 
We found that COPD patients had shorter TL than healthy controls, even 
after controlling for age. This study gives a first indication for the potential 
beneficial effects of coffee consumption and for negative effects of alcohol 
consumption on TL. Coffee consumption has been associated with reduced risks 
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for type 2 diabetes [30,31] and the occurrence of diabetic complications, and it 
was proposed that coffee contains compounds with antioxidant and anti-
inflammatory activity [32-34]. Recently, Cassidy et al. showed that a diet high in 
cereal fiber was positively associated with LTL. They also concluded that a diet 
high in plant-based foods may favourably influence TL via anti-inflammatory 
and antioxidant mechanisms [35]. Other studies also indicated that a high 
intake of plant-based diets and whole grains is inversely associated with risk 
factors for chronic disease [36,37]. Interestingly, Ornish et al. showed that a 
healthy lifestyle (lifestyle modifications included a lowfat, plant-based diet high 
in fruits, vegetables, unrefined grains, legumes, and low in refined 
carbohydrates; moderate exercise and stress management) was associated with 
an increase in telomerase activity in PBMCs and that a decrease in LDL 
cholesterol was associated with an increase in telomerase activity [7]. In 
addition, statins, which exhibit anti-inflammatory effects, were also found to be 
capable of decreasing the cardiovascular risk and inhibit the rate of telomere 
shortening in vitro [38,39]. This indicates that a reduction of inflammation may 
be associated with a decrease the rate of telomere shortening. In our study, we 
also found that cytokine plasma levels as well as CRP and homocysteine plasma 
levels were increased in COPD patients and SOD activity was decreased, 
indicating elevated inflammation and oxidative stress in COPD patients. Future 
studies should elucidate whether interventions with dietary antioxidants or 
anti-inflammatory compounds, for instance with bioactive substances found in 
coffee, are able to reduce inflammation and oxidative stress, and reduce 
disease progression in patients with chronic inflammatory diseases.  
It has to be taken into account that the studies described in chapter 4 
and 5 differ in several aspects. First of all, in chapter 4, we measured TL in 
blood leukocytes whereas in chapter 5, we determined TL in PBMCs. 
Measurement of TL in leukocytes has been reported to be less accurate than in 
PBMCs, because PBMCs showed a greater age-related decline in TL [40,41] and 
subpopulations of lymphocytes displayed differences in TL and in telomerase 
activity [42]. However, a very recent study demonstrated that there is 
synchrony among leukocyte subsets throughout the human lifespan. It was 
found that individuals with long telomeres in one subset also have long 
telomeres in other leukocyte subsets. Therefore it was concluded that LTL is a 
useful index of TL in other subsets of blood cells [43].  
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Secondly, we did not find a relationship between fat mass and TL in 
chapter 5, whereas we did in chapter 4. Importantly to note here is that we 
studied quite different groups of COPD patients in both studies. In chapter 4, 
we studied TL in severely ill COPD patients with many of them having cachectic 
symptoms. In chapter 5, the COPD group studied consisted of a more 
heterogeneous sample of the COPD population, with only few patients showing 
cachectic symptoms. Previous studies investigating the association between fat 
mass/obesity and COPD also found contradictory results. On the one hand it has 
been hypothesized that fat mass has a negative effect on the prognosis of 
COPD, but on the other hand it has also been speculated that fat mass may be 
protective [44-47]. Adipose tissue was found to produce over 50 adipokines, 
including TNF-α and IL-6, causing an enhanced inflammatory state [48], which is 
associated with the development of cardiovascular diseases and diabetes [49]. 
On the other hand, it has to be taken into account that body fat can be 
subdivided in visceral fat and subcutaneous fat. Unlike visceral fat, 
subcutaneous fat may confer survival advantages in patients subject to 
catabolic events such as infectious complications. It may therefore be 
hypothesized that subcutaneous fat provides greater energy stores, which 
protects against the risk of complications [50].      
In both chapters 4 and 5 we did not find a relationship between smoking 
and TL, although this was expected since smoking is a major source of ROS. 
Previous studies also showed contradictory results. In some studies smoking 
was associated with shorter telomeres [51], but not in all [52], which may be 
explained that these studies may have been under powered to detect an 
association (n<1000 participants). In studies with larger numbers of participants 
a small significant correlation has been observed between TL and smoking, and 
appears therefore likely that this relationship is only detectable in studies with 
sufficiently large sample sizes [53].  
Can dietary interventions with flavonoids or antioxidants 
attenuate the rate of telomere shortening? 
In chapter 6 the effects of the flavonoid fisetin and the antioxidant n-
acetylcysteine on telomere shortening in a diabetic rat model was described. 
Diabetes mellitus and hyperglycaemia cause severe damage to cells and tissues, 
especially the arteries and vital organs such as the kidneys and the heart. The 
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disease is also marked by low grade inflammation and an increased production 
of reactive oxygen species leading to oxidative stress [17,18].  
Since diabetes is associated with chronic oxidative stress and accelerated 
aging, dietary interventions with antioxidants and/or anti-inflammatory agents 
were therefore hypothesized to decrease the levels of oxidative stress and slow 
the rate of aging. We also hypothesized that chronic oxidative stress and 
systemic inflammation in diabetes lead to an increased rate of telomere 
shortening and investigated the effects of dietary interventions with the 
antioxidant n-acetylcysteine (NAC) and the anti-inflammatory flavonoid fisetin, 
on oxidative stress, inflammation and the rate of telomere shortening. The 
effects of 24-week dietary interventions with fisetin and NAC on oxidative 
stress, inflammation and telomere shortening were evaluated in streptozotocin-
induced diabetic Wistar rats. We observed significantly shorter telomeres in the 
diabetic rat hearts, and both fisetin and NAC seemed to partially counteract this 
accelerated telomere shortening in the heart. The diabetic status increased the 
expression of antioxidant, DNA repair and inflammation related genes in heart 
and kidneys. Moreover, dietary intervention with fisetin and NAC attenuated 
these responses. Interestingly, in addition to its antioxidant and PARP-1 
inhibiting activity, fisetin has also been identified as a sirtuin activator [54]. 
Sirtuins are deacetylases that are dependent on NAD+ for their activity. Calorie 
restriction, which increases lifespan and is beneficial in age-related disorders, 
was capable of activating sirtuins [55]. The nuclear sirtuin SIRT1 has been found 
to promote longevity mammalian cells in several ways [55]. SIRT1 was reported 
to down-regulate p53 activity, thereby increasing lifespan, cell survival, and 
neuroprotection [55]. This implies that not only the antioxidant and PARP-
inhibiting properties of fisetin may have an effect on TL and disease 
progression, but also its sirtuin activating property warrants further 
investigation.  
Future studies should focus on evaluation of the effects of prolonged 
interventions with  higher doses or measures that increase the biological 
availability of the administered compounds. Trials longer than 24 weeks in 
diabetic rats are probably not achievable, and not ethically approvable, since 
the health of these animals deteriorates significantly during 24 weeks. Although 
in human studies TL is mainly studied in white blood cells (WBC), animal studies 
usually only focus on target organs. To our knowledge we are the first to have 
measured TL in the WBC of rats, but we did not observe any effects on TL. A 
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possible explanation may be that the effects of the diabetic status are more 
pronounced in target tissues such as heart and kidney as compared to WBC, 
which are for the greater part directly derived from the hematopoietic stem 
cells. Since these hematopoietic cells have been shown to possess telomerase 
activity, TL in WBC may be less sensitive for the effects of hyperglycemia [42]. 
Previous research also suggests a tissue-specific regulation of telomeres during 
aging in the rat [56]. Cherif et al. showed that the percentage of short 
telomeres increased with age in the kidney, liver, pancreas and lung, but not in 
the brain. The liver, kidney, pancreas and lung are expanding cell populations 
while the brain is a more static cell population [56]. Previous human as well as 
animal studies, showed that increased levels of oxidative stress, as in 
hypertension and hemodynamic stress, induced accelerated telomere 
shortening in arterial tissue, the aorta and in the myocardium [57-61]. In 
leukocyte DNA as well as in monocyte DNA, accelerated telomere shortening 
was found in type 2 diabetes patients [8,62]. Few studies have investigated 
telomere shortening in patients with type 1 diabetes and these results are not 
conclusive. Jeanclos et al. showed that TL in patients with diabetes type 1 was 
significantly shorter than TL in healthy control subjects [63]. In a study by 
Fyhrquist et al. no difference was found in TL between healthy controls and 
patients with diabetes type 1, but patients with progressive nephropathy had 
the shortest telomeres [64]. On the contrary, in a study by Astrup et al., no 
difference was found in TL between diabetes type 1 patients with or without 
diabetic nephropathy [65]. Although we confirmed in our study the increased 
(tissue-specific) rate of telomere shortening in diabetes type 1 in a rat model, 
our knowledge on telomere shortening in patients with type 1diabetes is still 
limited.  
Does lifestyle matter? 
As discussed in chapter 2, Cretan men were approximately 5 years younger, in 
terms of LTL, when compared to their Dutch peers. Additionally in chapter 5 we 
reported that coffee consumption was associated with increased LTL, whereas 
alcohol consumption was associated with shorter telomeres. These data 
provide evidence for the hypothesis that lifestyle and dietary factors do 
influence TL and possibly also life expectancy. Besides nutritional factors [35] 
that are involved in the rate of telomere shortening, other environmental and 
lifestyle factors seem to play a pivotal role in telomere biology. Shortened 
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telomeres have been associated with psychological stress [66], low physical 
activity levels [67], BMI [68,69], smoking [68,69] and socioeconomic status [51]. 
In addition to lifestyle, genetic background also plays a role in telomere 
maintenance as will be discussed in the last section of this discussion.  
Telomerase in (accelerated) aging and gene-environment 
interactions 
Although we did not measure telomerase activity in our studies, it may also play 
a role in healthy ageing as well as in accelerated aging.  
It has been shown that stress and senescence can influence telomerase 
levels in lymphocytes [70,71]. Changes in telomerase activity in cell types such 
as lymphocytes, endothelial cells and tissue stem/progenitor cells could 
influence processes relevant for healthy ageing. Importantly, even lifestyle 
factors known to promote cancer and cardiovascular disease could affect 
telomerase function. Recently, it has been shown in a longitudinal study that 
improvements in nutrition and lifestyle were associated with increases in 
telomerase activity which were associated with decreases in low-density 
lipoprotein cholesterol and psychological distress [7]. Thus, comprehensive 
lifestyle changes could significantly increase telomerase activity, stabilise 
telomeres and decrease oxidative stress within tissues and organs [72]. In 
addition to telomerase activity, it is likely that many of the proteins that are 
important in regulating TL and function, such as the telomere repeat binding 
factors, and proteins involved in DNA repair, will also have an important role in 
healthy/accelerated aging since they can regulate the action of telomerase at 
telomeres [73]. 
Furthermore, variations in the two major genes associated with 
telomerase activity, hTERT and hTERC, have been described. Atzmon et al. 
identified a common hTERT haplotype that is associated with both exceptional 
longevity and longer telomeres. They concluded that variations in the 
telomerase gene are associated with a better maintenance of the telomeres 
which may be associated with healthier aging [20]. On the other hand, there 
have also been several mutations (hTERT, hTERC and in dyskerin gene 1) 
described that cause telomerase deficiencies, which results in failure to 
elongate or maintain telomeres and induce progressive shortening [40].  
Not only telomerase activity, but also TL appears to be partly genetically 
determined [74,75]. In a study by Nordfjäll et al., TL was investigated in PBMCs 
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of 132 individuals from 49 unrelated families using quantitative PCR. A 
statistically significant association between TL comparing father-son (P = 0.011, 
n = 20) and father-daughter (P = 0.005, n = 22) pairs was found while this was 
not found in mother-offspring pairs. In this study a relationship between TL and 
genetics was demonstrated, and evidence for a father-to-offspring heritage was 
obtained [75]. More evidence for genetic factors influencing TL was obtained 
from a study by Okuda et al. In this study, TL was determined by Southern blot 
analysis in white blood cells from newborns. TL was not different between male 
and female newborns, but there was a high variability among donors. This 
indicates that variations among adults may be in large part attributed to genetic 
determinants that probably start exerting their effect in utero [76]. In a twin-
study by Slagboom et al., TL was determined by Southern blot analysis in 123 
twin pairs, both dizygous and monozygous twins of 2-95 years of age. Statistical 
analysis in 115 pairs, 2-63 years of age, indicated a 78% heritability for mean TL 
in this age cohort. Telomeric restriction fragment length variation among 
unrelated individuals was higher than variation within twin pairs, and the 
variation within monozygous twins was observed to be least [77]. In conclusion, 
TL appears to be a highly heritable trait. 
Since there is quite some variation in TL among individuals of the same 
age, polymorphisms in genes associated with telomere maintenance, oxidative 
stress and DNA repair were hypothesized to be involved in TL regulation. In a 
study by Broberg et al., polymorphisms in genes involved in the metabolism of 
genotoxic carcinogens and DNA repair were determined in the DNA of patients 
with bladder cancer and in the DNA of control subjects. In this study no 
association was found between cancer risk, TL, smoking and susceptibility 
genotypes [78]. In a recent study by Starr et al., it was found that some 
polymorphisms related to oxidative stress are also linked to increased telomere 
shortening [79]. The related genes in which polymorphisms were found 
included: 2 mitochondrial genes, heme oxygenase 2,  vimentin (stress 
response), ceruloplasmin (involved in the catalyzation of Fe2+ to Fe3+), 
methionine sulfoxide reductase A,  lipoprotein carriage gene and nitric oxide 
synthase 3 [79]. It can be concluded that the clinical manifestation of 
inflammation/oxidative stress related diseases depends on several factors, 
among which inherited TL and telomerase activity, exposure of specific tissues 
to pathogens (i.e. oxidative damage), and tissue-specific genetic alterations that 
result in an increase in cellular turnover.  
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Conclusions 
Based on the results presented in this thesis, it can be concluded that telomeres 
shorten faster under conditions of chronic inflammation and oxidative stress. 
Furthermore, we showed that endogenous antioxidants, exogenous 
antioxidants as well as foods containing antioxidants are associated with 
reduced telomere shortening. This was found in elderly male populations, in 
COPD patients and in diabetic rats. We conclude that lifestyle factors do not 
only contribute to disease risk, but also affect TL. To confirm our results and to 
investigate the potential beneficial effects of antioxidants and anti-
inflammatory compounds, either administered as supplements, or consumed 
with the diet, on the rate of telomere shortening, future studies should focus on 
interventions with these compounds. Preferably these studies should be 
prospective, and genetic determinants should also be taken into account. Since 
beneficial effects may be expected specifically in patients with chronic oxidative 
stress, such as COPD and diabetes patients, these are considered relevant 
target populations. If future studies can confirm that TL is causally involved in 
the development and progression of these age-associated diseases, it will pave 
the way for new therapeutic or preventive strategies. 
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Dit proefschrift beschrijft de relatie tussen chronisch oxidatieve stress en 
telomeerverkorting, en de mogelijke effecten van voedingsinterventies op deze 
relatie. Telomeren zijn de uiteinden van onze chromosomen en ze verkorten 
met elke celdeling. De hypothese die in dit proefschrift is onderzocht luidt: 
onder condities van chronische oxidatieve stress vindt er een versnelde 
telomeerverkorting plaats wat leidt tot versnelde veroudering en 
ouderdomsgerelateerde aandoeningen. 
Om dit te onderzoeken, hebben we ons in hoofdstuk 2 en 3 gericht op 
de algemene (oudere) populatie. Vervolgens hebben we in hoofdstuk 4 en 5 de 
verschillen tussen gezonde mensen en mensen met chronisch obstructief 
longlijden (COPD) bestudeerd. In hoofdstuk 6 hebben we gekeken naar de 
effecten van voedingsinterventies met fisetine en n-acteylcysteine op 
telomeerverkorting en markers voor oxidatieve stress in een diermodel (diabete 
ratten). 
Belangrijkste bevindingen 
De telomeerlengte (TL) wordt door verschillende factoren beïnvloed. Naast het 
zogenaamde “end-replication problem” lijkt oxidatieve stress/schade ook een 
belangrijke rol te spelen. Hoge concentraties van deze oxidatieve stress, oftewel 
DNA beschadigende deeltjes, zorgen voor een versnelde verkorting van de 
uiteinden van de chromosomen. Daarom wordt er ook wel gedacht dat een 
goede antioxidant status en antioxidant verdediging in het lichaam deze 
versnelde verkorting tegen kan gaan. Aangezien oxidatieve stress betrokken is 
bij een heleboel chronische ziekten, zoals hart- en vaatziekten, diabetes, 
chronische darmziekten en COPD, werd er gespeculeerd en bevestigd dat de 
telomeren korter zijn bij patiënten die aan deze ziektes lijden. Uit voorgaand 
onderzoek is gebleken dat de incidentie van verscheidene 
ouderdomsgerelateerde aandoeningen lager is in het zuiden van Europa dan in 
het noorden. Dit impliceert een potentiële rol voor een hogere antioxidant 
status en lagere niveaus van oxidatieve stress in mensen die leven rond het 
Middellandse Zee gebied. Om de TL te kunnen bepalen in het DNA, maakten we 
gebruik van de zogenaamde kwantitatieve PCR techniek. Deze techniek is niet 
alleen snel, maar er kunnen ook veel monsters tegelijk gemeten worden en er 
zijn slechts kleine hoeveelheden DNA nodig. Allereerst bestudeerden we in 
hoofdstuk 2 de TL in leukocyten (LTL) in oudere mannen uit 2 verschillende 
regio’s in Europa: Zutphen (Nederland) en Kreta (Griekenland). Van deze 2 
Nederlandse samenvatting 
 
 169 
groepen is bekend dat ze een verschillende leefstijl en voeding hebben. In deze 
studie vonden wij dat Griekse oudere mannen duidelijk langere telomeren 
hadden dan hun Nederlands leeftijdsgenoten. Verder vonden we ook dat de 
endogene antioxidanten, albumine en urinezuur, positief geassocieerd waren 
met LTL.  
De volgende stap was om LTL te meten in de algemene oudere 
mannelijke populatie over de tijd (hoofdstuk 3). Dit zou ons informatie kunnen 
verschaffen over de individuele snelheid waarmee de telomeren verkorten, en 
de mogelijkheid om LTL te gebruiken als een marker voor (ziekte specifieke) 
mortaliteit. Uit de resultaten van deze studie bleek, dat LTL afnam met 40.2 bp 
per jaar en dat LTL niet was geassocieerd met cardiovasculaire mortaliteit en 
ook niet met mortaliteit door kanker.  
In hoofdstuk 4 en 5 hebben we TL in 2 COPD-controle studies 
onderzocht. COPD wordt gekenmerkt door obstructie van de luchtwegen en is 
een verzamelnaam voor chronische bronchitis en longemfyseem. Chronische 
systemische oxidatieve stress en ontstekingsreacties spelen hierin een grote rol. 
In hoofdstuk 4 zagen we dat COPD patiënten kortere telomeren hadden dan de 
gezonde controles en we vonden een positieve associatie tussen LTL en SOD 
activiteit (een antioxidant die in het lichaam voorkomt) en vetmassa. In 
hoofdstuk 5 hebben we een aantal extra bepalingen gedaan, waaronder de 
cytokines IL-8, IL-6 en TNF-α, als ook CRP, SOD en plasma homocysteine. Verder 
hebben we gekeken naar koffie, thee en alcoholconsumptie in relatie tot 
inflammatie en TL. We zagen dat er een negatieve associatie bestond tussen TL 
en COPD en we toonden aan dat koffie consumptie mogelijk positief 
geassocieerd was met TL, terwijl alcohol consumptie negatief geassocieerd was 
met TL. In het laatste hoofdstuk hebben we de effecten van 
voedingsinterventies op TL bestudeerd in een diabetisch ratten model. De 
ratten werden geïnjecteerd met streptozotocine, waardoor diabetes werd 
geïnduceerd, een aandoening die gekenmerkt wordt door chronisch oxidatieve 
stress. De effecten van fisetine, een flavonoid, en n-acetylcysteine (NAC), een 
antioxidant, werden onderzocht. Verschillende markers van oxidatieve stress 
werden gemeten, als ook TL en de genexpressie van relevante genen. In het 
hart van de diabete ratten vonden we significant kortere telomeren in 
vergelijking met de gezonde controle ratten. Zowel fisetine als NAC leken deze 
verkorting gedeeltelijk tegen te gaan. In de diabete ratten was de expressie van 
antioxidant genen, DNA herstel genen en inflammatie gerelateerde genen 
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verhoogd. Verder zagen we dat de interventie met fisetine en NAC deze 
responsen verminderden. 
 
Samenvattend kan geconcludeerd worden dat, gebaseerd op de resultaten in 
dit proefschrift, de telomeren sneller verkorten onder omstandigheden van 
chronisch oxidatieve stress. Verder toonden we aan dat enzymatische 
antioxidanten, endogene antioxidanten als ook voeding die antioxidanten 
bevat, positief geassocieerd zijn met TL. Dit vonden we in gezonde mensen, 
COPD patiënten en in diabete ratten. Leefstijl lijkt dus niet alleen een effect te 
hebben op de gezondheid, maar ook op de telomeren. Om deze resultaten te 
bevestigen en om de mogelijk positieve effecten van antioxidanten, zowel in 
supplementen als in fruit en groenten, op TL verder te onderzoeken, zouden 
toekomstige studies zich moeten richten op interventies met anti-
inflammatoire stoffen in patiënten met een chronische ziekte zoals COPD of 
diabetes. Daarnaast is het van belang dat er meer prospectieve studies worden 
uitgevoerd en dat er rekening gehouden wordt met de genetische 
determinanten die ook een rol spelen bij TL. 
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Na ruim 4 jaar onderzoek en vele leerervaringen rijker is het dan zover, het 
proefschrift is bijna af. In dit laatste, maar meestal als eerst gelezen hoofdstuk, 
wil ik graag een aantal mensen bedanken en in het bijzonder de mensen die me 
altijd onvoorwaardelijk zijn blijven steunen. 
 
Allereerst wil ik de proefpersonen bedanken die hebben deelgenomen aan mijn 
onderzoek. Ze deinsden niet terug voor bloedafnames, vragenlijsten en de 
bepaling van hun lichaamssamenstelling. Werken met patiënten geeft een heel 
goed beeld van wat een slopende ziekte zoals COPD met iemand doet. Mede 
dankzij deze ervaringen ben ik tot de conclusie gekomen dat ik op mijn best 
functioneer in de patiëntenzorg. 
 
Mijn promotor Frederik-Jan van Schooten wil ik bedanken voor de mogelijkheid 
om op de afdeling GRAT te kunnen promoveren. Jij zette altijd de puntjes op de 
i, bedankt! Professor Wouters wil ik ook graag bedanken voor zijn interesse en 
het mogelijk maken van mijn onderzoek. Mijn copromotor Geja Hageman wil ik 
graag bedanken voor haar enthousiasme en haar enorme inspiratie. Ik heb erg 
veel bewondering voor jouw inzet. Zelfs als de resultaten tegenvielen wist jij er 
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bepaling. Daarnaast wil ik graag Karen en Sandra bedanken voor de hulp met 
“de laatste loodjes”. 
 
Uiteraard wil ik ook mijn kamergenootjes bedanken. Toen ik net begon zat ik 
samen met Hans, Danitsja en Lonneke op de kamer. Ik wil hen graag bedanken 
voor alle tips die ze me hebben gegeven als beginnende AIO. Al snel kwam 
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Veroudering overkomt ons allemaal, maar bij mensen met een chronische 
ziekte lijkt dit proces sneller te verlopen. Zou het niet mooi zijn als we dit 
proces zouden kunnen tegengaan of vertragen? Om dit mogelijk te maken, 
moeten we eerst weten wat er gebeurt tijdens het proces van veroudering. 
Telomeren 
Het blijkt dat de uiteinden van onze chromosomen (waar ons erfelijk materiaal 
zich op bevindt) steeds een stukje korter worden: de telomeren. Deze 
telomeren beschermen ons erfelijke materiaal (het DNA) en ze zijn vergelijkbaar 
met het harde stukje plastic op het uiteinde van een schoenveter. Wanneer dit 
stukje plastic verdwijnt, gaat de schoenveter rafelen en is deze niet langer 
bruikbaar. Met elke celdeling (het proces waarbij cellen zich vermenigvuldigen 
met als gevolg groei of vervanging van weefsels) worden de telomeren een 
stukje korter. Wanneer de telomeer een kritieke lengte bereikt, stopt de cel 
met functioneren. Dit is geassocieerd met veroudering en 
ouderdomsgerelateerde aandoeningen.  
Chronische ziekten (“the bad guys”) 
Chronische ziekten (zoals bijvoorbeeld diabetes, hart- en vaatziekten, 
chronische longziekten en chronische darmziekten) worden gekenmerkt door 
verhoogde productie van radicalen, stofjes die schade toebrengen aan het DNA. 
Dit wordt ook wel oxidatieve stress genoemd en kan de telomeren beschadigen, 
waardoor deze sneller verkorten. Dit gaat dan weer gepaard met versnelde 
veroudering en ouderdomsgerelateerde aandoeningen. 
De doelstelling van het onderzoek dat in dit proefschrift staat 
beschreven, was om te onderzoeken of er daadwerkelijk een snellere 
telomeerverkorting optreedt onder condities van chronisch oxidatieve stress.  
Antioxidanten (“the good guys”) 
Naast de radicalen, ofwel de oxidanten, zijn er ook de zogenaamde 
antioxidanten: stofjes die in staat zijn om deze radicalen te verwijderen. 
Voorbeelden van antioxidanten zijn vitamine E en C, maar ook lichaamseigen 
enzymen zoals superoxide dismutase en catalase.  
Een tweede doel van dit onderzoek was dan ook om te kijken of een 
verhoogde antioxidantcapaciteit of een verhoogde inname van antioxidanten, 
ervoor kan zorgen dat de negatieve effecten van de radicalen kunnen worden 
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teruggedraaid, met als uiteindelijke gevolg, een minder snelle 
telomeerverkorting.  
Telomeren: beginning to understand the end? 
We hebben inderdaad kunnen bevestigen dat mensen met een chronische 
longziekte (COPD) kortere telomeren hebben in vergelijking met gezonde 
leeftijdsgenoten. Daarnaast hebben we ook kunnen vaststellen dat 
antioxidanten een positief effect hebben op de telomeerlengte. Toch moeten 
we niet vergeten dat er meerdere factoren van invloed zijn op het 
verouderingsproces, en we dus niet alles kunnen toeschrijven aan 
telomeerverkorting. Ook moeten we in ons achterhoofd houden dat de 
telomeren niet alleen beïnvloed worden door invloeden van buitenaf, maar dat 
er ook een genetische achtergrond aan ten grondslag ligt. Denk aan het verschil 
tussen schoenveters: je hebt sterke en minder sterke varianten, wat op zich al 
bepalend is voor de levensduur van je veters. Zo is het ook voor de telomeren: 
bij de geboorte zijn er al verschillen die medebepalend zijn voor het verloop van 
iemands leven.  
Samenvattend zouden we dan ook kunnen stellen dat de telomeerlengte 
een zeer interessante en relevante maat is voor chronische aandoeningen en 
het verouderingsproces.  
